Compounds > phosphotyrosine
Page last updated: 2024-09-22

phosphotyrosine

Description

Phosphotyrosine: An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O(4)-phospho-L-tyrosine : A non-proteinogenic L-alpha-amino acid that is L-tyrosine phosphorylated at the phenolic hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID30819
CHEMBL ID286939
CHEBI ID37788
SCHEMBL ID1152
MeSH IDM0028374

Synonyms (55)

Synonym
(2s)-2-amino-3-[4-(phosphonooxy)phenyl]propanoic acid
phosphotyrosine (py)
bdbm22597
l-3-(4-hydroxyphenyl)alanine 4'-phosphate
phospho-l-tyrosine
l-tyrosine-o-phosphate
l-tyrosine, dihydrogen phosphate (ester)
o-phosphotyrosine
l-tyrosine, o-phosphono-
tyrosine, phosphate (6ci)
tyrosine o-phosphate
l-tyrosine, dihydrogen phosphate (ester) (9ci)
tyrosine, di-h phosphate (7ci)
tyrosine, dihydrogen phosphate (ester), l- (8ci)
o-phospho-l-tyrosine
l-phosphotyrosine
C06501
phosphonotyrosine
21820-51-9
phosphotyrosine
DB01962
CHEBI:37788 ,
o(4)-phosphono-l-tyrosine
o(4)-phospho-l-tyrosine
o-phosphono-l-tyrosine
CHEMBL286939
P0959
(2s)-2-amino-3-(4-phosphonooxyphenyl)propanoic acid
2r86c98kdx ,
unii-2r86c98kdx
AKOS015856720
AKOS015894042
SCHEMBL1152
tyrosine phosphate
DCWXELXMIBXGTH-QMMMGPOBSA-N
ptyr
(s)-2-amino-3-(4-phosphonooxy-phenyl)-propionic-acid
J208.898C ,
DTXSID00176234
h-tyr(po3h2)-oh
phosphoric acid 4-((s)-2-carboxy-2-aminoethyl)phenyl ester
l-tyrosine-o-phosphoric acid
tyrosine, dihydrogen phosphate (ester), l-
o-phospho-l-tyrosine (h-l-tyr(po3h2)-oh)
mfcd00002603
J-014304
h-tyr(po)-oh
(s)-2-amino-3-(4-(phosphonooxy)phenyl)propanoic acid
h-tyr(h2po3)-oh
AS-19190
Q19805940
EN300-7366217
h-tyr(h2po3)-oh; l-tyrosine-o-phosphate
CS-W012494
HY-W011778

Research Excerpts

Overview

ExcerptReference
"Phosphotyrosine (pY) serves as a docking site for the recognition proteins containing pY-binding (pYB) modules, such as the SH2 domain, to mediate cell signal transduction. "( Ai, D; An, J; Bai, X; Chen, P; Dong, H; Guo, Z; Tian, S; Zhai, G; Zhang, K; Zhang, Y, 2019)
"Phosphotyrosine (pTyr) is an essential component of biological signaling, often being a determinant of protein-protein interactions. "( Beselman, A; Boresch, S; Leitgeb, M; MacKerell, AD, 2005)
"Antiphosphotyrosine blotting is a technique for detecting tyrosine-phosphorylated substrates by the use of antibodies that recognize these residues on a wide variety of proteins. "( Siegel, JN, 2001)
"Phosphotyrosine is an essential structure required for the interactions of these proteins with the PDGF receptor."( Escobedo, JA; Kaplan, DR; Kavanaugh, WM; Turck, CW; Williams, LT, 1991)

Effects

ExcerptReference
"Phosphotyrosine has previously been found concentrated at adherens junctions, where bundles of actin filaments terminate, but video-enhanced contrast-differential interference contrast and confocal interference reflection microscopy demonstrated that the filopodial tips were not adherent to the substrate."( Goldberg, DJ; Wu, DY, 1993)

Actions

ExcerptReference
"Phosphotyrosine signaling plays a major role in the control of many important biological functions such as cell proliferation and apoptosis. "( Buhs, S; Gerull, H; Nollau, P, 2017)
"Phosphotyrosine signaling plays a vital role in cell regulation--from receptor activation, through stimulation of signal networks and nuclear targeting, to final cellular responses. "( Gineitis, A; Kulyte, A; Magnusson, KE; Navakauskiene, R; Treigyte, G, 2001)
"The phosphotyrosine residues enhance receptor catalytic activity and/or provide docking sites for downstream signaling proteins."( Hubbard, SR, 2002)

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
immunogenAn antigen capable, on its own, of inducing an immune response.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
L-tyrosine derivativeA proteinogenic amino acid derivative resulting from reaction of L-tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-tyrosine by a heteroatom.
O(4)-phosphotyrosineA non-proteinogenic alpha-amino acid that is tyrosine phosphorylated at the phenolic hydroxy group.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

phosphotyrosine is involved in 1 pathway(s), involving a total of 5 unique proteins and 19 unique compounds

PathwayProteinsCompounds
Tyrosine Biosynthesis519

Protein Targets (4)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (193)

Processvia Protein(s)Taxonomy
protein phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
intracellular zinc ion homeostasisTyrosine-protein kinase LckHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase LckHomo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
hemopoiesisTyrosine-protein kinase LckHomo sapiens (human)
platelet activationTyrosine-protein kinase LckHomo sapiens (human)
T cell differentiationTyrosine-protein kinase LckHomo sapiens (human)
T cell costimulationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase LckHomo sapiens (human)
Fc-gamma receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell activationTyrosine-protein kinase LckHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase LckHomo sapiens (human)
release of sequestered calcium ion into cytosolTyrosine-protein kinase LckHomo sapiens (human)
regulation of lymphocyte activationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of leukocyte cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
innate immune responseTyrosine-protein kinase LckHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
primary ovarian follicle growthProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of cytokine productionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
epidermal growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transforming growth factor beta receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
spermatogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
learning or memoryProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to xenobiotic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mechanical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to acidic pHProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of gene expressionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of glucose metabolic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein processingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
skeletal muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of smooth muscle cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
macroautophagyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
forebrain developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
T cell costimulationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of protein-containing complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein destabilizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to nutrient levelsProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomere maintenance via telomeraseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to insulin stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of intracellular estrogen receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of integrin activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of toll-like receptor 3 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
adherens junction organizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
substrate adhesion-dependent cell spreadingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of dephosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of hippo signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intracellular signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
entry of bacterium into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
osteoclast developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ERBB2 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
angiotensin-activated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
odontogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of vascular permeabilityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stress fiber assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transcytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Notch signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Ras protein signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of insulin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein autophosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neurotrophin TRK receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
oogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
progesterone receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
leukocyte migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of small GTPase mediated signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mineralocorticoidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
myoblast proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to electrical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of mitochondrial depolarizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomerase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
uterus developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
branching involved in mammary gland duct morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell projection assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intestinal epithelial cell developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
interleukin-6-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hydrogen peroxideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to interleukin-1Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to lipopolysaccharideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to peptide hormone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to progesterone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fatty acidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hypoxiaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fluid shear stressProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of podosome assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
DNA biosynthetic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of heart rate by cardiac conductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein localization to nucleusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of TORC1 signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to prolactinProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of male germ cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ovarian follicle developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of lamellipodium morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor-beta signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of early endosome to late endosome transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of anoikisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of caveolin-mediated endocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell differentiationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
innate immune responseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
symbiont entry into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
actin cytoskeleton organizationGrowth factor receptor-bound protein 2Homo sapiens (human)
epidermal growth factor receptor signaling pathwayGrowth factor receptor-bound protein 2Homo sapiens (human)
Ras protein signal transductionGrowth factor receptor-bound protein 2Homo sapiens (human)
insulin receptor signaling pathwayGrowth factor receptor-bound protein 2Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayGrowth factor receptor-bound protein 2Homo sapiens (human)
Schwann cell developmentGrowth factor receptor-bound protein 2Homo sapiens (human)
positive regulation of actin filament polymerizationGrowth factor receptor-bound protein 2Homo sapiens (human)
receptor internalizationGrowth factor receptor-bound protein 2Homo sapiens (human)
endodermal cell differentiationGrowth factor receptor-bound protein 2Homo sapiens (human)
natural killer cell mediated cytotoxicityGrowth factor receptor-bound protein 2Homo sapiens (human)
myelinationGrowth factor receptor-bound protein 2Homo sapiens (human)
signal transduction in response to DNA damageGrowth factor receptor-bound protein 2Homo sapiens (human)
insulin-like growth factor receptor signaling pathwayGrowth factor receptor-bound protein 2Homo sapiens (human)
B cell receptor signaling pathwayGrowth factor receptor-bound protein 2Homo sapiens (human)
branching involved in labyrinthine layer morphogenesisGrowth factor receptor-bound protein 2Homo sapiens (human)
cellular response to ionizing radiationGrowth factor receptor-bound protein 2Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processGrowth factor receptor-bound protein 2Homo sapiens (human)
regulation of MAPK cascadeGrowth factor receptor-bound protein 2Homo sapiens (human)
signal transductionGrowth factor receptor-bound protein 2Homo sapiens (human)
DNA damage checkpoint signalingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
triglyceride metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
axonogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
brain developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
heart developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cerebellar cortex formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of chondrocyte differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microvillus organizationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interferon-beta productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organism growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
organ growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
atrioventricular canal developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ERBB signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein-containing complex assemblyTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ossificationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of glucose importTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of insulin secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein export from nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
neurotrophin TRK receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organismal reproductive processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
genitalia developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
inner ear developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
homeostasis of number of cells within a tissueTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cortisol secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of growth hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
face morphogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
intestinal epithelial cell migrationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cellular response to epidermal growth factor stimulusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (48)

Processvia Protein(s)Taxonomy
phosphotyrosine residue bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
protein serine/threonine phosphatase activityTyrosine-protein kinase LckHomo sapiens (human)
protein bindingTyrosine-protein kinase LckHomo sapiens (human)
ATP bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase LckHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase LckHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD4 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD8 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
identical protein bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase LckHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
ATPase bindingTyrosine-protein kinase LckHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
protein kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein kinase C bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signaling receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
insulin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATP bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase activator activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
enzyme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
heme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nuclear estrogen receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
SH2 domain bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transmembrane transporter bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cadherin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATPase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phosphoprotein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
BMP receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
connexin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
scaffold protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phosphotyrosine residue bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
RNA bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
transmembrane receptor protein tyrosine kinase adaptor activityGrowth factor receptor-bound protein 2Homo sapiens (human)
guanyl-nucleotide exchange factor adaptor activityGrowth factor receptor-bound protein 2Homo sapiens (human)
epidermal growth factor receptor bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
neurotrophin TRKA receptor bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
protein bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
SH3 domain bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
protein kinase bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
protein phosphatase bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
identical protein bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
insulin receptor substrate bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
ephrin receptor bindingGrowth factor receptor-bound protein 2Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
phosphoprotein phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
signaling receptor complex adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptide hormone receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
molecular adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (35)

Processvia Protein(s)Taxonomy
pericentriolar materialTyrosine-protein kinase LckHomo sapiens (human)
immunological synapseTyrosine-protein kinase LckHomo sapiens (human)
cytosolTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase LckHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
podosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nucleoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrial inner membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
lysosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
late endosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytosolProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
actin filamentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
caveolaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell junctionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ruffle membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neuronal cell bodyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic growth coneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
membrane raftProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
perinuclear region of cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
extracellular exosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
synaptic membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
glutamatergic synapseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
postsynaptic specialization, intracellular componentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic filopodiumProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nucleusGrowth factor receptor-bound protein 2Homo sapiens (human)
nucleoplasmGrowth factor receptor-bound protein 2Homo sapiens (human)
nucleolusGrowth factor receptor-bound protein 2Homo sapiens (human)
cytoplasmGrowth factor receptor-bound protein 2Homo sapiens (human)
endosomeGrowth factor receptor-bound protein 2Homo sapiens (human)
Golgi apparatusGrowth factor receptor-bound protein 2Homo sapiens (human)
cytosolGrowth factor receptor-bound protein 2Homo sapiens (human)
plasma membraneGrowth factor receptor-bound protein 2Homo sapiens (human)
cell-cell junctionGrowth factor receptor-bound protein 2Homo sapiens (human)
cell cortexGrowth factor receptor-bound protein 2Homo sapiens (human)
vesicle membraneGrowth factor receptor-bound protein 2Homo sapiens (human)
extracellular exosomeGrowth factor receptor-bound protein 2Homo sapiens (human)
COP9 signalosomeGrowth factor receptor-bound protein 2Homo sapiens (human)
Grb2-EGFR complexGrowth factor receptor-bound protein 2Homo sapiens (human)
cytoplasmGrowth factor receptor-bound protein 2Homo sapiens (human)
plasma membraneGrowth factor receptor-bound protein 2Homo sapiens (human)
nucleoplasmGrowth factor receptor-bound protein 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID159243In vitro binding to Phospholipase C-gamma SH2 domain1995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
AID201450In vitro binding to SH-PTP2-N (SHP-2) SH2 domain1995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
AID224161In vitro binding to p56 Lck SH2 domain1995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
AID75324In vitro binding to Growth factor receptor bound protein 21995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
AID205504In vitro binding to Src SH2 domain1995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
AID155521In vitro binding to p85-C SH2 domain1995Journal of medicinal chemistry, Apr-14, Volume: 38, Issue:8
Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6,391)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990414 (6.48)18.7374
1990's3161 (49.46)18.2507
2000's1971 (30.84)29.6817
2010's711 (11.13)24.3611
2020's134 (2.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (0.06%)5.53%
Reviews195 (3.01%)6.00%
Case Studies17 (0.26%)4.05%
Observational0 (0.00%)0.25%
Other6,259 (96.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
titanium[no description available]medium70titanium group element atom
caseins[no description available]medium300
tyrosine[no description available]medium2,4060amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
zirconium[no description available]medium10titanium group element atom
yttrium[no description available]medium10d-block element atom;
rare earth metal atom;
scandium group element atom
fluorides[no description available]medium130halide anion;
monoatomic fluorine
alendronate[no description available]medium201,1-bis(phosphonic acid);
primary amino compound		bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
acid phosphatase[no description available]medium370
calpastatin[no description available]medium10polypeptideEC 3.4.22.52 (calpain-1) inhibitor;
EC 3.4.22.53 (calpain-2) inhibitor
calpain[no description available]medium120
methane[no description available]medium20alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
gold[no description available]medium60copper group element atom;
elemental gold
uridine triphosphate[no description available]medium30pyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
carbachol[no description available]medium240ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
serine[no description available]medium560L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
threonine[no description available]medium360amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
ganglioside, gd2[no description available]medium10
fluorine[no description available]medium60diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
phenylalanine[no description available]medium440amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
histidine[no description available]medium170amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
phosphohistidine[no description available]medium50
phenyl acetate[no description available]medium60benzenes;
phenyl acetates
n-formylglycine[no description available]medium10N-acylglycine;
N-formyl amino acid
glycine[no description available]medium70alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
epidermal growth factor[no description available]medium3770
su 11248[no description available]medium30monocarboxylic acid amide;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
phosphoserine[no description available]medium3510non-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative		human metabolite
phosphothreonine[no description available]high1950L-threonine derivative;
non-proteinogenic L-alpha-amino acid;
O-phosphoamino acid		Escherichia coli metabolite
arginine[no description available]medium270arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
tyrosine o-sulfate[no description available]medium130aryl sulfate;
L-tyrosine derivative;
O-sulfoamino acid		human metabolite
sulfur[no description available]medium10chalcogen;
nonmetal atom		macronutrient
triazoles[no description available]medium1001,2,3-triazole
phosphatidylcholines[no description available]medium301,2-diacyl-sn-glycero-3-phosphocholine
histamine[no description available]medium80aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
paxilline[no description available]medium1550diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol		anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
tetradecanoylphorbol acetate[no description available]medium2110acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
chlorine[no description available]medium130halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
vanadates[no description available]medium2390trivalent inorganic anion;
vanadium oxoanion		EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
pervanadate[no description available]medium520
leucine[no description available]medium110amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
4-nitrophenylphosphate[no description available]medium200aryl phosphatemouse metabolite
nitrophenols[no description available]medium220
stearates[no description available]medium10
stearoyl chloride[no description available]medium10
imatinib mesylate[no description available]medium300methanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
naphthoquinones[no description available]medium40
benzofurans[no description available]medium20
2-acetylfuranonaphthoquinone[no description available]medium10
thromboplastin[no description available]medium20
bp-1-102[no description available]medium10
n-methylaspartate[no description available]medium90amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound		neurotransmitter agent
ouabain[no description available]medium5011alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone		anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
lysine[no description available]medium190aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
glutamic acid[no description available]medium210glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
proanthocyanidin[no description available]medium10
procyanidin[no description available]medium10proanthocyanidin
equol[no description available]medium20hydroxyisoflavans
epichlorohydrin[no description available]medium10epoxide;
organochlorine compound
piperidines[no description available]medium60
decitabine[no description available]medium102'-deoxyribonucleoside
ovalbumin[no description available]medium80
adenine[no description available]medium206-aminopurines;
purine nucleobase		Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pci 32765[no description available]medium10acrylamides;
aromatic amine;
aromatic ether;
N-acylpiperidine;
pyrazolopyrimidine;
tertiary carboxamide		antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
alpha-synuclein[no description available]medium30
erlotinib hydrochloride[no description available]medium80hydrochloride;
terminal acetylenic compound		antineoplastic agent;
protein kinase inhibitor
quinazolines[no description available]medium280azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
bibw 2992[no description available]medium10aromatic ether;
enamide;
furans;
monochlorobenzenes;
organofluorine compound;
quinazolines;
secondary carboxamide;
tertiary amino compound		antineoplastic agent;
tyrosine kinase inhibitor
sepharose[no description available]medium40
sirolimus[no description available]medium120antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol		antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
titanium dioxide[no description available]medium50titanium oxidesfood colouring
fluorophosphate[no description available]medium10fluorine molecular entity;
phosphoric acid derivative
organophosphonates[no description available]medium120divalent inorganic anion;
phosphite ion
tungstate[no description available]medium50divalent inorganic anion;
tungsten oxoanion
rhosin[no description available]medium10D-tryptophan derivative;
hydrazone;
quinoxaline derivative		antineoplastic agent;
RhoA inhibitor;
RhoC inhibitor
gastrins[no description available]medium90
substance p[no description available]medium50peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
crenolanib[no description available]medium10aminopiperidine;
aromatic ether;
benzimidazoles;
oxetanes;
quinolines;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
ng-nitroarginine methyl ester[no description available]medium30alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
tempo[no description available]medium10aminoxyls;
piperidines		catalyst;
ferroptosis inhibitor;
radical scavenger
GDC-0623[no description available]medium10hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
niacinamide[no description available]medium40pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
crizotinib[no description available]medium103-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
dactolisib[no description available]medium20imidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas		antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
cyclin d1[no description available]medium140
aminoimidazole carboxamide[no description available]medium30aminoimidazole;
monocarboxylic acid amide		mouse metabolite
acetylcysteine[no description available]medium170acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
aica ribonucleotide[no description available]medium201-(phosphoribosyl)imidazolecarboxamide;
aminoimidazole		cardiovascular drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
u 73122[no description available]medium90aromatic ether;
aza-steroid;
maleimides		EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
selenic acid[no description available]medium10selenium oxoacid
fluorescein-5-isothiocyanate[no description available]medium80fluorescein isothiocyanate
1,2-distearoylphosphatidylethanolamine[no description available]medium10phosphatidylethanolamine zwitterion;
phosphatidylethanolamine		human metabolite
glycidyl nitrate[no description available]medium10
go 6976[no description available]medium50indolocarbazole;
organic heterohexacyclic compound		EC 2.7.11.13 (protein kinase C) inhibitor
acetylglucosamine[no description available]medium50N-acetyl-D-glucosamineepitope
uridine diphosphate glucuronic acid[no description available]medium10UDP-D-glucuronic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
uridine diphosphate glucose[no description available]medium10UDP-D-glucosefundamental metabolite
verlukast[no description available]medium10
glycolipids[no description available]medium100
malachite green[no description available]medium20organic chloride saltantibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent
c.i. 42510[no description available]medium40
oligonucleotides[no description available]medium80
2,3-diphosphoglycerate[no description available]medium20bisphosphoglyceric acid;
tetronic acid derivative		human metabolite
3-phosphoglycerate[no description available]medium10monophosphoglyceric acid;
tetronic acid derivative		algal metabolite;
fundamental metabolite
2-phosphoglycerate[no description available]medium10monophosphoglyceric acid;
tetronic acid derivative
deoxyglucose[no description available]medium280
cryptotanshinone[no description available]medium10abietane diterpenoidanticoronaviral agent
phenanthrenes[no description available]medium10
g(m3) ganglioside[no description available]medium90alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide;
sialodiosylceramide;
sialotriaosylceramide		mouse metabolite
g(m2) ganglioside[no description available]medium20N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-acylsphingosine;
sialotriaosylceramide		antigen
nitrofen[no description available]medium20organic molecular entityEC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
erythrosine[no description available]medium60
cefoxitin[no description available]medium10L-serine derivative;
non-proteinogenic L-alpha-amino acid		tumour antigen
paraquat[no description available]medium10organic cationgeroprotector;
herbicide
adenosine diphosphate[no description available]medium190adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
kainic acid[no description available]medium60dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid		antinematodal drug;
excitatory amino acid agonist
myristic acid[no description available]medium150long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
s 1033[no description available]medium40(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide		anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
ag-490[no description available]medium120catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide		anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
glutaral[no description available]medium30dialdehydecross-linking reagent;
disinfectant;
fixative
sarcosine[no description available]medium10N-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines		Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
genistein[no description available]medium20507-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
sarkosyl[no description available]medium10
oxidopamine[no description available]medium20benzenetriol;
catecholamine;
primary amino compound		drug metabolite;
human metabolite;
neurotoxin
dasatinib[no description available]medium801,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
thiazoles[no description available]medium2801,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
cysteine[no description available]medium330cysteiniumfundamental metabolite
transforming growth factor alpha[no description available]medium300
arsenic[no description available]medium310metalloid atom;
pnictogen		micronutrient
oxophenylarsine[no description available]medium300arsine oxidesantineoplastic agent;
apoptosis inducer;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
urea[no description available]medium40isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
3-phenylpropionic acid[no description available]medium10benzenes;
monocarboxylic acid		antifungal agent;
human metabolite;
plant metabolite
sq-23377[no description available]medium280cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite
ag 1879[no description available]medium200aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine		beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
ro 31-8220[no description available]medium80imidothiocarbamic ester;
indoles;
maleimides		EC 2.7.11.13 (protein kinase C) inhibitor
angiotensin ii[no description available]medium510amino acid zwitterion;
angiotensin II		human metabolite
aldosterone[no description available]medium2011beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
leptin[no description available]medium140
wortmannin[no description available]medium700acetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound		anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
inositol 3,4,5-trisphosphate[no description available]medium10
niclosamide[no description available]medium10benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide		anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
stattic[no description available]medium201-benzothiophenes;
C-nitro compound;
sulfone		antineoplastic agent;
radiosensitizing agent;
STAT3 inhibitor
alanine[no description available]medium120alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine[no description available]medium10
diethyl phosphate[no description available]medium10dialkyl phosphatehuman xenobiotic metabolite;
mouse metabolite
phosphonic acid[no description available]medium10
phosphoric acid[no description available]medium20phosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
guanosine triphosphate[no description available]medium310guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
involucrin[no description available]medium10
bromochloroacetic acid[no description available]medium602-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
alpha-chymotrypsin[no description available]medium50
proline[no description available]medium140amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
nephrin[no description available]medium40
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene[no description available]medium20BODIPY compound
myelin basic protein[no description available]medium240
glycerophosphoinositol 4,5-bisphosphate[no description available]medium220
neuropeptide y[no description available]medium10
bradykinin[no description available]medium260oligopeptidehuman blood serum metabolite;
vasodilator agent
orabase[no description available]medium10
chitosan[no description available]medium10
galactose[no description available]medium50D-galactose;
galactopyranose		Escherichia coli metabolite;
mouse metabolite
acetylgalactosamine[no description available]medium10N-acetyl-D-hexosamine;
N-acetylgalactosamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
4-hydroxy-2-nonenal[no description available]medium304-hydroxynon-2-enal;
4-hydroxynonenal
fingolimod hydrochloride[no description available]medium10hydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
sphingosine[no description available]medium140sphing-4-eninehuman metabolite;
mouse metabolite
3-hydroxybutyric acid[no description available]medium10(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid		human metabolite
sorbitol[no description available]medium30glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
glyoxylic acid[no description available]medium102-oxo monocarboxylic acid;
aldehydic acid		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2-oxindole[no description available]medium10gamma-lactam;
indolinone
aspartic acid[no description available]medium120aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
malonic acid[no description available]medium20alpha,omega-dicarboxylic acidhuman metabolite
colforsin[no description available]medium330acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol		adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine[no description available]medium10N-substituted diamine;
pyridines;
tertiary amino compound		apoptosis inducer;
chelator;
copper chelator
pyrroles[no description available]medium120pyrrole;
secondary amine
su 5402[no description available]medium20
g(m1) ganglioside[no description available]medium80alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine;
sialotetraosylceramide
akb-9778[no description available]medium10
tetramethylrhodamine[no description available]medium20xanthene dye
interleukin-8[no description available]medium130
5-carboxytetramethylrhodamine succinimidyl ester[no description available]medium10
atovaquone[no description available]medium10hydroxy-1,2-naphthoquinone
mocetinostat[no description available]medium50aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
heme[no description available]medium10
dihydroxyphenylalanine[no description available]medium30hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative		human metabolite
fibrinogen[no description available]medium230iditolfungal metabolite
n-formylmethionine leucyl-phenylalanine[no description available]medium360tripeptide
5,7-dihydroxy-4',6-dimethoxyflavone[no description available]medium10dihydroxyflavone;
dimethoxyflavone		plant metabolite
harmine[no description available]medium20harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
6-cyano-7-nitroquinoxaline-2,3-dione[no description available]medium10quinoxaline derivative
geranylgeranylacetone[no description available]medium10
noscapine[no description available]medium20aromatic ether;
benzylisoquinoline alkaloid;
cyclic acetal;
isobenzofuranone;
organic heterobicyclic compound;
organic heterotricyclic compound;
tertiary amino compound		antineoplastic agent;
antitussive;
apoptosis inducer;
plant metabolite
bendamustine hydrochloride[no description available]medium10
endothelin-1[no description available]medium100
isoproterenol[no description available]medium110catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
ag 556[no description available]medium20
tamoxifen[no description available]medium50stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
fucose[no description available]medium10fucopyranose;
L-fucose		Escherichia coli metabolite;
mouse metabolite
clodronic acid[no description available]medium101,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound		antineoplastic agent;
bone density conservation agent
ag-1296[no description available]medium20quinoxaline derivative
etoposide[no description available]medium130beta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound		antineoplastic agent;
DNA synthesis inhibitor
i(3)so3-galactosylceramide[no description available]medium30galactosylceramide sulfate;
N-acyl-beta-D-galactosylsphingosine
casein kinase ii[no description available]medium80
inositol 1,4,5-trisphosphate[no description available]medium390myo-inositol trisphosphatemouse metabolite
chlorpromazine[no description available]medium30organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
sphingosine kinase[no description available]medium10
lysophosphatidic acid[no description available]medium401-acyl-sn-glycerol 3-phosphate
losartan potassium[no description available]medium410
cholanic acid[no description available]medium20cholanic acids
betadex[no description available]medium80cyclodextrin
cicaprost[no description available]medium10monoterpenoid
hydroxyurea[no description available]medium30one-carbon compound;
ureas		antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
cycloheximide[no description available]medium190antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
glycogen[no description available]medium150
methotrexate[no description available]medium20dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
indazoles[no description available]medium30indazole
sodium glutamate[no description available]medium10monosodium glutamateflavouring agent
peroxynitrous acid[no description available]medium30nitrogen oxoacid
4-butyrolactone[no description available]medium30butan-4-olidemetabolite;
neurotoxin
staurosporine[no description available]medium571ammonium ion derivative
pseudomonas aeruginosa autoinducer[no description available]medium10N-acyl homoserine lactone
okadaic acid[no description available]medium360ketal
homoserine[no description available]medium10amino acid zwitterion;
homoserine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
arachidonic acid[no description available]medium210icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
caffeine[no description available]medium50purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
dephostatin[no description available]medium40
cyclosporine[no description available]medium90
oleic acid[no description available]medium60octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
cycloolivil[no description available]medium10lignan
ethyl acetate[no description available]medium10acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
oleuropein[no description available]medium10beta-D-glucoside;
catechols;
diester;
methyl ester;
pyrans;
secoiridoid glycoside		anti-inflammatory agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
NF-kappaB inhibitor;
nutraceutical;
plant metabolite;
radical scavenger
phenylethyl alcohol[no description available]medium10benzenes;
primary alcohol		Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
3,4-dihydroxyphenylethanol[no description available]medium10catechols;
primary alcohol		antineoplastic agent;
antioxidant;
metabolite
iridoids[no description available]medium10
damnacanthal[no description available]medium10aldehyde;
monohydroxyanthraquinone
su 6656[no description available]medium30
3,3',4,5'-tetrahydroxystilbene[no description available]medium70catechols;
polyphenol;
resorcinols;
stilbenol		antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
1,7-phenanthroline[no description available]medium70phenanthroline
stilbenes[no description available]medium80stilbene
phosphoglycolate[no description available]medium10carboxyalkyl phosphateEscherichia coli metabolite;
mouse metabolite
lignans[no description available]medium20
2,3-bis(3'-hydroxybenzyl)butyrolactone[no description available]medium10lignan
uridine diphosphate n-acetylglucosamine[no description available]medium10
tetracycline[no description available]medium20
pirinixic acid[no description available]medium20aryl sulfide;
organochlorine compound;
pyrimidines
n-oleoylethanolamine[no description available]medium10endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-acylethanolamine 18:1		EC 3.5.1.23 (ceramidase) inhibitor;
geroprotector;
PPARalpha agonist
chlortetracycline[no description available]medium50
1-methyl-3-isobutylxanthine[no description available]medium1203-isobutyl-1-methylxanthine
activins[no description available]medium10
enalaprilat anhydrous[no description available]medium10dicarboxylic acid;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1-anilino-8-naphthalenesulfonate[no description available]medium20aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
anandamide[no description available]medium20endocannabinoid;
N-acylethanolamine 20:4		human blood serum metabolite;
neurotransmitter;
vasodilator agent
lapatinib[no description available]medium10furans;
organochlorine compound;
organofluorine compound;
quinazolines		antineoplastic agent;
tyrosine kinase inhibitor
carmustine[no description available]medium20N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
podophyllotoxin[no description available]medium30furonaphthodioxole;
lignan;
organic heterotetracyclic compound		antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
cytarabine[no description available]medium30beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
prednisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
melphalan[no description available]medium10L-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
terbium[no description available]medium30f-block element atom;
lanthanoid atom
guanosine monophosphate[no description available]medium20guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane[no description available]medium10
cytochalasin d[no description available]medium360
quinpirole[no description available]medium10pyrazoloquinolinedopamine agonist
sphingosine 1-phosphate[no description available]medium60sphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
glucose, (beta-d)-isomer[no description available]medium110D-glucopyranoseepitope;
mouse metabolite
octyl glucoside[no description available]medium30beta-D-glucosideplant metabolite
emerin[no description available]medium10
calcimycin[no description available]medium370benzoxazole
transforming growth factor beta[no description available]medium250
zithromax[no description available]medium10macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
2-tert-butylhydroquinone[no description available]medium20hydroquinonesfood antioxidant
cadmium[no description available]medium20cadmium molecular entity;
zinc group element atom
pd 173074[no description available]medium10aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
fluorouracil[no description available]medium10nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
cyclic gmp[no description available]medium1303',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
adenosine[no description available]medium50adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
methionine[no description available]medium150aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
argon[no description available]medium10monoatomic argon;
noble gas atom;
p-block element atom		food packaging gas;
neuroprotective agent
calcitriol[no description available]medium80D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
lithocholic acid[no description available]medium10bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid		geroprotector;
human metabolite;
mouse metabolite
sorafenib[no description available]medium30(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide		angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
isoxazoles[no description available]medium40isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
gefitinib[no description available]medium50aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
epidermal growth factor receptor antagonist
neuromedin b[no description available]medium20
neurokinin b[no description available]medium20polypeptide
colchicine[no description available]medium90alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
chloroquine[no description available]medium40aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
arginyl-glycyl-aspartic acid[no description available]medium120oligopeptide
thromboxane b2[no description available]medium30thromboxanes Bhuman metabolite;
mouse metabolite
cerium[no description available]medium10f-block element atom;
lanthanoid atom
ceric oxide[no description available]medium10cerium molecular entity;
metal oxide
c-peptide[no description available]medium41
8-aminohexylamino camp[no description available]medium10
vorinostat[no description available]medium20dicarboxylic acid diamide;
hydroxamic acid		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
ephrin-a5[no description available]medium20
thapsigargin[no description available]medium280butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone		calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
zinc oxide[no description available]medium10zinc molecular entity
alpha-aminopyridine[no description available]medium10
fg 9041[no description available]medium10quinoxaline derivative
nifedipine[no description available]medium50C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
ketamine[no description available]medium10cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
quinoxalines[no description available]medium40mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
biotin[no description available]medium80biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
potassium chloride[no description available]medium110inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
valproic acid[no description available]medium20branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
3-nitrotyrosine[no description available]medium902-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
dodecylphosphocholine[no description available]medium10phosphocholinesdetergent
phosphorylcholine[no description available]medium30phosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
5-methylcytosine[no description available]medium10methylcytosine;
pyrimidines		human metabolite
cytosine[no description available]medium10aminopyrimidine;
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
5-hydroxymethylcytosine[no description available]medium10aminopyrimidine;
aromatic primary alcohol;
nucleobase analogue;
pyrimidone		human metabolite;
mouse metabolite
osteogenic growth peptide[no description available]medium10
y 27632[no description available]medium20aromatic amide
spiperone[no description available]medium10aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound		alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
coumermycin[no description available]medium10aromatic amide;
coumarins;
glycoside;
heteroarenecarboxylate ester;
pyrroles		antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
DNA synthesis inhibitor;
Hsp90 inhibitor;
topoisomerase IV inhibitor
nsc 74859[no description available]medium20amidobenzoic acid;
monohydroxybenzoic acid;
tosylate ester		STAT3 inhibitor
pyrimethamine[no description available]medium10aminopyrimidine;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
phospho-l-arginine[no description available]medium30L-arginine derivative;
non-proteinogenic L-alpha-amino acid;
phosphagen;
phosphoamino acid		animal metabolite
hydrobromic acid[no description available]medium10gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
isoprene[no description available]medium10alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
phenylephrine[no description available]medium40phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
blister[no description available]medium10cyclic ketone;
pyrroloquinoline;
tertiary alcohol;
tertiary alpha-hydroxy ketone		inhibitor
chlorpyrifos[no description available]medium10chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate[no description available]medium10
gx 15-070[no description available]medium10
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid[no description available]medium90polyamino carboxylic acid;
tetracarboxylic acid		chelator
egtazic acid[no description available]medium300diether;
tertiary amino compound;
tetracarboxylic acid		chelator
h 89[no description available]medium10N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
simvastatin[no description available]medium30delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
orotic acid[no description available]medium10pyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
carboxyamido-triazole[no description available]medium30
deoxycholic acid[no description available]medium10bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human blood serum metabolite
homocysteine[no description available]medium30amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
adenylyl imidodiphosphate[no description available]medium30adenosine 5'-phosphate
deuterium[no description available]medium20dihydrogen
hydrogen[no description available]medium70elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
metallothionein[no description available]medium60
adenosine monophosphate[no description available]medium70adenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
cangrelor[no description available]medium10adenosine 5'-phosphate;
aryl sulfide;
nucleoside triphosphate analogue;
organochlorine compound;
organofluorine compound;
secondary amino compound		P2Y12 receptor antagonist;
platelet aggregation inhibitor
iloprost[no description available]medium20carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
penicillamine[no description available]medium70non-proteinogenic alpha-amino acid;
penicillamine		antirheumatic drug;
chelator;
copper chelator;
drug allergen
u 0126[no description available]medium60aryl sulfide;
dinitrile;
enamine;
substituted aniline		antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
s-nitro-n-acetylpenicillamine[no description available]medium40
pyrimidinones[no description available]medium10
rosiglitazone[no description available]medium10aminopyridine;
thiazolidinediones		EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
nickel[no description available]medium20metal allergen;
nickel group element atom		epitope;
micronutrient
3-methylcholanthrene[no description available]medium10ortho- and peri-fused polycyclic arenearyl hydrocarbon receptor agonist;
carcinogenic agent
leupeptins[no description available]medium100
benzyloxycarbonylleucyl-leucyl-leucine aldehyde[no description available]medium70amino aldehyde;
carbamate ester;
tripeptide		proteasome inhibitor
lactacystin[no description available]medium50lactam;
S-substituted L-cysteine
fasudil[no description available]medium30isoquinolines;
N-sulfonyldiazepane		antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
1-(5-isoquinolinesulfonyl)-2-methylpiperazine[no description available]medium240isoquinolines;
N-sulfonylpiperazine		EC 2.7.11.13 (protein kinase C) inhibitor
mannitol[no description available]medium30mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
rtki cpd[no description available]medium150
hydrazine[no description available]medium30azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
pd 98059[no description available]medium380aromatic amine;
monomethoxyflavone		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
europium[no description available]medium10f-block element atom;
lanthanoid atom
sodium dodecyl sulfate[no description available]medium30organic sodium saltdetergent;
protein denaturant
su 5614[no description available]medium10organochlorine compound;
oxindoles;
pyrroles		vascular endothelial growth factor receptor antagonist
arginyl-glycyl-aspartyl-serine[no description available]medium50
kt 5720[no description available]medium40carboxylic ester;
gamma-lactam;
hemiaminal;
indolocarbazole;
organic heterooctacyclic compound;
semisynthetic derivative;
tertiary alcohol		EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester[no description available]medium40
adenosine-3',5'-cyclic phosphorothioate[no description available]medium20nucleoside 3',5'-cyclic phosphorothioate
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one[no description available]medium240chromones;
morpholines;
organochlorine compound		autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
parthenolide[no description available]medium20germacranolide
sesquiterpenes[no description available]medium20
iodine[no description available]medium30diatomic iodinenutrient
propylthiouracil[no description available]medium10pyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
monensin[no description available]medium20cyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal		antifungal agent;
coccidiostat;
ionophore
ym-90709[no description available]medium10quinoxaline derivative
tretinoin[no description available]medium200retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
dinoprostone[no description available]medium180prostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
edetic acid[no description available]medium110ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
ergosterol[no description available]medium103beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols		fungal metabolite;
Saccharomyces cerevisiae metabolite
thymidine[no description available]medium300pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
eptifibatide[no description available]medium10homodetic cyclic peptide;
macrocycle;
organic disulfide		anticoagulant;
platelet aggregation inhibitor
tirofiban[no description available]medium10L-tyrosine derivative;
piperidines;
sulfonamide		anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
sdz psc 833[no description available]medium10homodetic cyclic peptide
verapamil[no description available]medium30aromatic ether;
nitrile;
polyether;
tertiary amino compound
n-(9-acridinyl)maleimide[no description available]medium10
n-(4-(2-benzimidazolyl)phenyl)maleimide[no description available]medium10
lysophosphatidylcholines[no description available]medium601-O-acyl-sn-glycero-3-phosphocholine
deoxyribose[no description available]medium10deoxypentosehuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
bisindolylmaleimide i[no description available]medium150
methylcellulose[no description available]medium10
captopril[no description available]medium20alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
cucurbitacin i[no description available]medium10cucurbitacin;
tertiary alpha-hydroxy ketone		antineoplastic agent;
plant metabolite
sincalide[no description available]medium60oligopeptide
cholecystokinin[no description available]medium50
benzylamine[no description available]medium10aralkylamine;
primary amine		allergen;
EC 3.5.5.1 (nitrilase) inhibitor;
plant metabolite
phosphorus[no description available]medium50monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
1,1-diethyl-2-hydroxy-2-nitrosohydrazine[no description available]medium10organic anion
8-((4-chlorophenyl)thio)cyclic-3',5'-gmp[no description available]medium103',5'-cyclic purine nucleotide;
aryl sulfide;
organochlorine compound;
ribonucleotide		protein kinase agonist
2,2'-(hydroxynitrosohydrazono)bis-ethanamine[no description available]medium20
hexachlorobenzene[no description available]medium10aromatic fungicide;
chlorobenzenes		antifungal agrochemical;
carcinogenic agent;
persistent organic pollutant
oxalic acid[no description available]medium10alpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
cgp 77675[no description available]medium10
galactosamine[no description available]medium10D-galactosamine;
primary amino compound		toxin
bucladesine[no description available]medium1703',5'-cyclic purine nucleotide
n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide[no description available]medium40isoquinolines;
sulfonamide
hirudin[no description available]medium30
bromodeoxyuridine[no description available]medium110pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
4-o-methyl-12-o-tetradecanoylphorbol 13-acetate[no description available]medium10
4-methoxyamphetamine[no description available]medium10
amphetamine[no description available]medium10primary amine
acetylleucyl-leucyl-norleucinal[no description available]medium10aldehyde;
tripeptide		cysteine protease inhibitor
phenoxyacetic acid[no description available]medium10aromatic ether;
monocarboxylic acid		allergen;
Aspergillus metabolite;
human xenobiotic metabolite;
plant growth retardant
salicylates[no description available]medium30monohydroxybenzoateplant metabolite
phosphorus radioisotopes[no description available]medium600
ecdysterone[no description available]medium1014alpha-hydroxy steroid;
20-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
ecdysteroid;
phytoecdysteroid		animal metabolite;
plant metabolite
dactinomycin[no description available]medium50actinomycinmutagen
4-phosphonomethylphenylalanine[no description available]medium50
sodium tungstate(vi)[no description available]medium10inorganic sodium saltreagent
4-hydroxycoumarin[no description available]medium10hydroxycoumarin
agar[no description available]medium50
4-aminophenylphosphate[no description available]medium30
chromium[no description available]medium40chromium group element atom;
metal allergen		micronutrient
thiazolyl blue[no description available]medium20organic bromide saltcolorimetric reagent;
dye
docetaxel anhydrous[no description available]medium10secondary alpha-hydroxy ketone;
tetracyclic diterpenoid		antimalarial;
antineoplastic agent;
photosensitizing agent
diphenyleneiodonium[no description available]medium30organic cation
deferoxamine[no description available]medium40acyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
dithiothreitol[no description available]medium1101,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol		chelator;
human metabolite;
reducing agent
pd 123319[no description available]medium40imidazopyridineangiotensin receptor antagonist;
endothelin receptor antagonist;
vasoconstrictor agent
cgp 42112a[no description available]medium30benzyl ester;
oligopeptide;
pyridinecarboxamide		angiotensin receptor agonist;
anti-inflammatory agent;
antineoplastic agent;
neuroprotective agent;
vasodilator agent
cyanine dye 3[no description available]medium20
carbocyanines[no description available]medium30cyanine dye;
organic iodide salt		fluorochrome
3-aminotyrosine[no description available]medium10
4-nitrophenylalanine[no description available]medium10C-nitro compound
trichostatin a[no description available]medium10antibiotic antifungal agent;
hydroxamic acid;
trichostatin		bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
cadaverine[no description available]medium30alkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
monodansylcadaverine[no description available]medium30aminonaphthalene;
primary amino compound;
sulfonamide;
tertiary amino compound		EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor;
fluorochrome;
protective agent
concanavalin a[no description available]medium240
tacrolimus[no description available]medium70macrolide lactambacterial metabolite;
immunosuppressive agent
anthralin[no description available]medium20anthracenesantipsoriatic
latrunculin b[no description available]medium20cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
thiazolidines[no description available]medium60thiazolidine
losartan[no description available]medium40biphenylyltetrazole;
imidazoles		angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
oxamic acid[no description available]medium10dicarboxylic acid monoamideEscherichia coli metabolite
lactic acid[no description available]medium202-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
cytochalasin b[no description available]medium140cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
leukotriene b4[no description available]medium50dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid		human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
indomethacin[no description available]medium100aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
latrunculin a[no description available]medium30cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
phalloidine[no description available]medium30homodetic cyclic peptide
fluorescein[no description available]medium402-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
ferroin[no description available]medium10
teriflunomide[no description available]medium10(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide		drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
pyrimidine[no description available]medium10diazine;
pyrimidines		Daphnia magna metabolite
leflunomide[no description available]medium20(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide		antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
pd 173955[no description available]medium10aryl sulfide;
dichlorobenzene;
methyl sulfide;
pyridopyrimidine		tyrosine kinase inhibitor
ap23464[no description available]medium10
taurine[no description available]medium30amino sulfonic acid;
zwitterion		antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
trifluoperazine[no description available]medium40N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
picropodophyllin[no description available]medium20furonaphthodioxole;
lignan;
organic heterotetracyclic compound		antineoplastic agent;
insulin-like growth factor receptor 1 antagonist;
plant metabolite;
tyrosine kinase inhibitor
butorphanol[no description available]medium10morphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
midostaurin[no description available]medium21benzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound		antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
singlet oxygen[no description available]medium10chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
methylinositol[no description available]medium11
inositol[no description available]medium41cyclitol;
hexol
gamma-aminobutyric acid[no description available]medium20amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
cytochrome c-t[no description available]medium20
theophylline[no description available]medium20dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
glucagon[no description available]medium50peptide hormone
lestaurtinib[no description available]medium10indolocarbazole
glycyl-arginyl-glycyl-aspartyl-serine[no description available]medium20
androstenedione[no description available]medium1017-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
oxytocin[no description available]medium20heterodetic cyclic peptide;
peptide hormone		oxytocic;
vasodilator agent
lucifer yellow[no description available]medium10organic lithium saltfluorochrome
diazinon[no description available]medium10organic thiophosphate;
pyrimidines		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
nematicide;
xenobiotic
chromomycin a3[no description available]medium10
carnitine[no description available]medium10amino-acid betainehuman metabolite;
mouse metabolite
amlodipine[no description available]medium10dihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound		antihypertensive agent;
calcium channel blocker;
vasodilator agent
tryptophan[no description available]medium50erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan		antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
pd 166326[no description available]medium10
morphine[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
phenethyl isothiocyanate[no description available]medium20isothiocyanateantineoplastic agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite
naphthalimides[no description available]medium10
alpha-methylphenylalanine[no description available]medium10benzenes;
monocarboxylic acid
brij-58[no description available]medium10
allylglycine[no description available]medium20
glutamine[no description available]medium50amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
hydroxyl radical[no description available]medium30oxygen hydride;
oxygen radical;
reactive oxygen species
cucurbitacins[no description available]medium1011-oxo steroid
8-bromo cyclic adenosine monophosphate[no description available]medium1003',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound		antidepressant;
protein kinase agonist
iminodiacetic acid[no description available]medium10amino dicarboxylic acid;
glycine derivative;
non-proteinogenic alpha-amino acid		chelator
cellulose[no description available]medium10glycoside
tn14003[no description available]medium10
sorbic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
sorbic acid
heparitin sulfate[no description available]medium20
magnesium sulfate[no description available]medium10magnesium salt;
metal sulfate;
organic magnesium salt		anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
transferrin[no description available]medium50
4-hydroxy-5-nitrophenyl acetic acid[no description available]medium10monocarboxylic acid anion
2-nitro-5-thiocyanobenzoic acid[no description available]medium10
nitrites[no description available]medium30monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species		human metabolite
fibrin[no description available]medium30peptide
geldanamycin[no description available]medium70
pentoxifylline[no description available]medium10oxopurine
albuterol[no description available]medium10phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
pulmicort[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
nocodazole[no description available]medium70aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes		antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
warfarin[no description available]medium10benzenes;
hydroxycoumarin;
methyl ketone
rhodostomin[no description available]medium10
sulfites[no description available]medium10divalent inorganic anion;
sulfur oxide;
sulfur oxoanion
alkenes[no description available]medium10
staurosporine aglycone[no description available]medium100
1,2,3,4-tetrahydroisoquinoline[no description available]medium10isoquinolines
sulfamic acid[no description available]medium10sulfamic acids
bl 4162a[no description available]medium10imidazoquinazolineanticoagulant;
antifibrinolytic drug;
cardiovascular drug;
platelet aggregation inhibitor
phenylhydrazine[no description available]medium20phenylhydrazinesxenobiotic
imidazole[no description available]medium10imidazole
reboxetine[no description available]medium10aromatic ether
fluoxetine[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
haloperidol[no description available]medium10aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
dapi[no description available]medium10indolesfluorochrome
phosphoramidic acid[no description available]medium10phosphoric acid derivative
15-deoxyprostaglandin j2[no description available]medium10
prostaglandin d2[no description available]medium10prostaglandins Dhuman metabolite;
mouse metabolite
galactose[no description available]medium10
lewis x antigen[no description available]medium40
halothane[no description available]medium10haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
l 451167[no description available]medium20
thymine[no description available]medium10pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite
picolinic acid[no description available]medium10pyridinemonocarboxylic acidhuman metabolite;
MALDI matrix material
tyrphostin ag 1024[no description available]medium10alkylbenzene
bis(maltolato)oxovanadium(iv)[no description available]medium20
acetaldehyde[no description available]medium10aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
xanthenes[no description available]medium20xanthene
sd 1029[no description available]medium10
1-hexadecyl-2-acetyl-glycero-3-phosphocholine[no description available]medium1702-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
n,n-diisopropylethylamine[no description available]medium10tertiary amino compound
2-(1h-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate[no description available]medium10
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine[no description available]medium10imidazopyridine;
primary amino compound		carcinogenic agent;
mutagen
lidocaine[no description available]medium10benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
bupivacaine[no description available]medium10aromatic amide;
piperidinecarboxamide;
tertiary amino compound
ferric ammonium citrate[no description available]medium10
buthionine sulfoximine[no description available]medium30diastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide		EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
asbestos, crocidolite[no description available]medium20
econazole[no description available]medium20dichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
thimerosal[no description available]medium10alkylmercury compoundantifungal drug;
antiseptic drug;
disinfectant;
drug allergen
methylmercuric chloride[no description available]medium10chlorine molecular entity;
mercury coordination entity;
one-carbon compound
mercuric chloride[no description available]medium50mercury coordination entitysensitiser
p-chloromercuribenzoic acid[no description available]medium20chlorine molecular entity;
mercuribenzoic acid
quinolinic acid[no description available]medium10pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
vasotocin[no description available]medium10
n-acetylneuraminic acid[no description available]medium20N-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
n-glycolylneuraminic acid[no description available]medium10N-acylneuraminic acid
methacycline[no description available]medium201,2-diglyceride
ro 31-7549[no description available]medium40
brefeldin a[no description available]medium20macrolide antibioticPenicillium metabolite
ap20187[no description available]medium10aromatic ether;
carboxylic ester;
N-acylpiperidine;
tertiary amino compound		ligand
aminosalicylic acid[no description available]medium10aminobenzoic acid;
phenols		antitubercular agent
hydrogen carbonate[no description available]medium30carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
nicotine[no description available]medium203-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate[no description available]medium301,1-diunsubstituted alkanesulfonate
palmitic acid[no description available]medium40long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
adenosine 5'-o-(3-thiotriphosphate)[no description available]medium10nucleoside triphosphate analogue
pazopanib[no description available]medium10aminopyrimidine;
indazoles;
sulfonamide		angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
protocatechualdehyde[no description available]medium10dihydroxybenzaldehyde
salvianolic acid B[no description available]medium101-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol		anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
3,4-dihydroxyphenyllactic acid[no description available]medium102-hydroxy monocarboxylic acid;
catechols
diacetyldichlorofluorescein[no description available]medium10
rottlerin[no description available]medium30aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone		anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
cediranib[no description available]medium10aromatic ether
thiophenes[no description available]medium10mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
propranolol[no description available]medium20naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
chelerythrine[no description available]medium30benzophenanthridine alkaloid;
organic cation		antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
nsc-87877[no description available]medium10
trifluoroacetic acid[no description available]medium10fluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
carbodiimides[no description available]medium20carbodiimide
fumonisin b1[no description available]medium10diester;
fumonisin;
primary amino compound;
triol		carcinogenic agent;
metabolite
isoleucine[no description available]medium20aspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
lewis y antigen[no description available]medium10
daidzein[no description available]medium307-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid[no description available]medium40
phytoestrogens[no description available]medium10
methyl methanesulfonate[no description available]medium20methanesulfonate esteralkylating agent;
apoptosis inducer;
carcinogenic agent;
genotoxin;
mutagen
reserpine[no description available]medium10alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
taurolithocholic acid[no description available]medium10bile acid taurine conjugate;
monocarboxylic acid amide		human metabolite
taurochenodeoxycholic acid[no description available]medium10bile acid taurine conjugatehuman metabolite;
mouse metabolite
taurolithocholic acid 3-sulfate[no description available]medium10steroid sulfate oxoanionhuman metabolite
ursodoxicoltaurine[no description available]medium10bile acid taurine conjugateanti-inflammatory agent;
apoptosis inhibitor;
bone density conservation agent;
cardioprotective agent;
human metabolite;
neuroprotective agent
silicon[no description available]medium10carbon group element atom;
metalloid atom;
nonmetal atom
davallialactone[no description available]medium10
valine[no description available]medium30L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide[no description available]medium10benzamides;
benzodioxoles;
imidazoles;
pyridines		EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
ceruletide[no description available]medium10oligopeptidediagnostic agent;
gastrointestinal drug
mercury[no description available]medium20elemental mercury;
zinc group element atom		neurotoxin
dihydrotestosterone[no description available]medium2017beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
manganese[no description available]medium230elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
phorbols[no description available]medium70diterpene;
terpenoid fundamental parent
cytidine monophosphate[no description available]medium20cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
uridine monophosphate[no description available]medium20pyrimidine ribonucleoside 5'-monophosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
thymidine monophosphate[no description available]medium10thymidine 5'-monophosphatefundamental metabolite
glutathione disulfide[no description available]medium10glutathione derivative;
organic disulfide		Escherichia coli metabolite;
mouse metabolite
p-azobenzenearsonate[no description available]medium10
vanadium[no description available]medium170elemental vanadium;
vanadium group element atom		micronutrient
perylene[no description available]medium10ortho- and peri-fused polycyclic arene;
perylenes
hypericin[no description available]medium10
azides[no description available]medium50pseudohalide anionmitochondrial respiratory-chain inhibitor
herbimycin[no description available]medium8601,4-benzoquinones;
lactam;
macrocycle		antimicrobial agent;
apoptosis inducer;
herbicide;
Hsp90 inhibitor;
tyrosine kinase inhibitor
cyanogen bromide[no description available]medium40
phenobarbital[no description available]medium10barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
sodium azide[no description available]medium30inorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
guanylyl imidodiphosphate[no description available]medium40nucleoside triphosphate analogue
ag-213[no description available]medium310
muramidase[no description available]medium80
tyrphostin ag 1112[no description available]medium10
ha 1004[no description available]medium20isoquinolines
guanosine 5'-o-(2-thiodiphosphate)[no description available]medium20nucleoside diphosphate analogue
guanosine diphosphate[no description available]medium130guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
masoprocol[no description available]medium20nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
fisetin[no description available]medium103'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
quercetin[no description available]medium807-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
3-hydroxyflavone[no description available]medium10flavonols;
monohydroxyflavone
sodium fluoride[no description available]medium60fluoride saltmutagen
troglitazone[no description available]medium20chromanes;
thiazolidinone		anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
3-o-methylglucose[no description available]medium80D-aldohexose derivative
hexamethylene bisacetamide[no description available]medium30acetamides
suramin[no description available]medium140naphthalenesulfonic acid;
phenylureas;
secondary carboxamide		angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
dizocilpine maleate[no description available]medium30maleate salt;
tetracyclic antidepressant		anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
bicuculline[no description available]medium20benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines		agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin
st 638[no description available]medium60
fura-2[no description available]medium50
s-allylcysteine[no description available]medium10L-alpha-amino acid zwitterion;
S-hydrocarbyl-L-cysteine		antineoplastic agent;
metabolite
s-allylmercaptocysteine[no description available]medium10
phorbol-12,13-didecanoate[no description available]medium10
thrombin receptor peptide sfllrnp[no description available]medium10
thrombin receptor peptide (42-55)[no description available]medium20
ryanodine[no description available]medium10
erbstatin[no description available]medium100
lavendustin a[no description available]medium110aromatic amine
indo-1[no description available]medium10indolesfluorochrome
aluminum fluoride[no description available]medium30aluminium coordination entity
thromboxane a2[no description available]medium80epoxy monocarboxylic acid;
thromboxanes A		mouse metabolite
alprostadil[no description available]medium40prostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
sq 30741[no description available]medium10
apyrase[no description available]medium10
phosphatidylethanol[no description available]medium50
brimonidine tartrate[no description available]medium20
indo-1 pentaacetoxymethyl ester[no description available]medium10
4-chloromercuribenzenesulfonate[no description available]medium10arenesulfonic acid;
arylmercury compound
uric acid[no description available]medium60uric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
tyrphostin a23[no description available]medium90catechols
dimethyl sulfoxide[no description available]medium90sulfoxide;
volatile organic compound		alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
tiazofurin[no description available]medium101,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide		antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug
ribavirin[no description available]medium101-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide		anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
lipid a[no description available]medium50dodecanoate ester;
lipid A;
tetradecanoate ester		Escherichia coli metabolite
ethylmaleimide[no description available]medium90maleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
lovastatin[no description available]medium30delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
kaempferol[no description available]medium207-hydroxyflavonol;
flavonols;
tetrahydroxyflavone		antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
adenosine diphosphate ribose[no description available]medium60ADP-sugarEscherichia coli metabolite;
mouse metabolite
pioglitazone[no description available]medium40aromatic ether;
pyridines;
thiazolidinediones		antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
ucn 1028 c[no description available]medium120
tyrphostin 25[no description available]medium110benzenetriol
phorbol 12,13-dibutyrate[no description available]medium170butyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone
paclitaxel[no description available]medium30taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
mastoparan[no description available]medium10mastoparans;
peptidyl amide		antimicrobial agent
exp3174[no description available]medium10biphenylyltetrazole;
imidazoles;
organochlorine compound		metabolite
choline[no description available]medium10cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
methylene blue[no description available]medium10organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
s-nitroso-n-acetylpenicillamine[no description available]medium20nitroso compound;
nitrosothio compound		nitric oxide donor;
vasodilator agent
dimercaprol[no description available]medium20dithiol;
primary alcohol		chelator
cholecalciferol[no description available]medium30D3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone		geroprotector;
human metabolite
metribolone[no description available]medium1017beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid		androgen
3,3'-dithiobis(sulfosuccinimidyl propionate)[no description available]medium10
1-butanol[no description available]medium30alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
phosphatidylbutanol[no description available]medium20
pituitrin[no description available]medium60
miconazole[no description available]medium10dichlorobenzene;
ether;
imidazoles
3,3'-dipropyl-2,2'-thiadicarbocyanine[no description available]medium10
acetone[no description available]medium10ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
8-azidoadenosine 5'-triphosphate[no description available]medium10
raffinose[no description available]medium10raffinose family oligosaccharide;
trisaccharide		mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2-aminoisobutyric acid[no description available]medium102,2-dialkylglycine zwitterion;
2,2-dialkylglycine
methylprednisolone[no description available]medium106-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
du-21220[no description available]medium10benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
ristocetin[no description available]medium10glycopeptide;
heterodetic cyclic peptide;
macrocycle;
tetrasaccharide derivative		antibacterial drug;
antimicrobial agent;
bacterial metabolite;
platelet-activating factor receptor agonist
linoleic acid[no description available]medium10octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
13-hydroxy-9,11-octadecadienoic acid[no description available]medium10octadecadienoic acid
aluminum chloride[no description available]medium20aluminium coordination entityLewis acid
1,2-dimethylhydrazine[no description available]medium10hydrazinesalkylating agent;
carcinogenic agent
dimethylhydrazines[no description available]medium10
mercaptoethanol[no description available]medium30alkanethiol;
primary alcohol		geroprotector
durapatite[no description available]medium20
bw-755c[no description available]medium10
4-n,n-dimethylaminoazobenzene-4'-sulfonyl chloride[no description available]medium30
p-dimethylaminoazobenzene[no description available]medium30azobenzenes
aspirin[no description available]medium90benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
azoxymethane[no description available]medium10
phosphoric acid, trisodium salt[no description available]medium10sodium phosphate
vesnarinone[no description available]medium10organic molecular entity
pyrazines[no description available]medium10diazine;
pyrazines		Daphnia magna metabolite
amiloride[no description available]medium50aromatic amine;
guanidines;
organochlorine compound;
pyrazines		diuretic;
sodium channel blocker
emodin[no description available]medium30trihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
2,2'-azobis(2-amidinopropane)[no description available]medium10monoazo compound
tyrphostin a9[no description available]medium10alkylbenzenegeroprotector
5'-methylthioadenosine[no description available]medium10thioadenosinealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
tautomycin[no description available]medium20
flecainide[no description available]medium10aromatic ether;
monocarboxylic acid amide;
organofluorine compound;
piperidines		anti-arrhythmia drug
eflornithine[no description available]medium40alpha-amino acid;
fluoroamino acid		trypanocidal drug
8-bromocyclic gmp[no description available]medium503',5'-cyclic purine nucleotide;
organobromine compound		muscle relaxant;
protein kinase G agonist
calcium pyrophosphate[no description available]medium20calcium phosphate
methyl 2,5-dihydroxycinnamate[no description available]medium40cinnamate ester;
hydroquinones;
methyl ester		EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
geroprotector;
human urinary metabolite;
plant metabolite
sphingosine phosphorylcholine[no description available]medium10
muscimol[no description available]medium10alkaloid;
isoxazoles;
primary amino compound		fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug
bay-k-8644[no description available]medium20(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
atrial natriuretic factor[no description available]medium20polypeptide
maitotoxin[no description available]medium10
lipid x[no description available]medium10N-acyl-D-glucosamine 1-phosphateEscherichia coli metabolite
sdz mrl 953[no description available]medium10
sdz 880-431[no description available]medium10
7-hydroxystaurosporine[no description available]medium10
aluminum[no description available]medium60boron group element atom;
elemental aluminium;
metal atom
1,2-dielaidoylphosphatidylethanolamine[no description available]medium10
ag-879[no description available]medium10
gastrin-releasing peptide[no description available]medium30
barium[no description available]medium10alkaline earth metal atom;
elemental barium
cortisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
retinol[no description available]medium30retinol;
vitamin A		human metabolite;
mouse metabolite;
plant metabolite
trichloroacetic acid[no description available]medium20monocarboxylic acid;
organochlorine compound		carcinogenic agent;
metabolite;
mouse metabolite
pindolol[no description available]medium10indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
sta 2[no description available]medium10
guanine[no description available]medium102-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
queuine[no description available]medium10pyrrolopyrimidineEscherichia coli metabolite
ethyl methanesulfonate[no description available]medium10methanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
genotoxin;
mutagen;
teratogenic agent
rubidium[no description available]medium10alkali metal atom
iodine[no description available]medium20halide anion;
monoatomic iodine		human metabolite
phosphocreatine[no description available]medium10phosphagen;
phosphoamino acid		human metabolite;
mouse metabolite
phosphoenolpyruvate[no description available]medium20carboxyalkyl phosphate;
monocarboxylic acid		fundamental metabolite
phenylphosphate[no description available]medium50aryl phosphatemouse metabolite
dimethylformamide[no description available]medium10formamides;
volatile organic compound		geroprotector;
hepatotoxic agent;
polar aprotic solvent
methylene chloride[no description available]medium10chloromethanes;
volatile organic compound		carcinogenic agent;
polar aprotic solvent;
refrigerant
phenylbutazone[no description available]medium10pyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
demecolcine[no description available]medium10alkaloid;
secondary amino compound		antineoplastic agent;
microtubule-destabilising agent
8-((4-chlorophenyl)thio)cyclic-3',5'-amp[no description available]medium103',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
aryl sulfide;
organochlorine compound		protein kinase agonist
gamma-linolenic acid[no description available]medium20linolenic acid;
omega-6 fatty acid		human metabolite;
mouse metabolite;
plant metabolite
8-chloro-cyclic adenosine monophosphate[no description available]medium10
ag 30[no description available]medium10
diiodotyrosine[no description available]medium10diiodotyrosine;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite
dityrosine[no description available]medium40biphenyls;
non-proteinogenic alpha-amino acid;
tyrosine derivative		biomarker
monoiodotyrosine[no description available]medium10amino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid		EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
adrenomedullin[no description available]medium10
asparagine[no description available]medium20amino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
diethylstilbestrol[no description available]medium10olefinic compound;
polyphenol		antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
rg 13022[no description available]medium10
nitrates[no description available]medium60monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
arginine vasopressin[no description available]medium50vasopressincardiovascular drug;
hematologic agent;
mitogen
guanosine 5'-o-(3-thiotriphosphate)[no description available]medium110nucleoside triphosphate analogue
rges peptide[no description available]medium10
fura-2-am[no description available]medium10
zinc chloride[no description available]medium30inorganic chloride;
zinc molecular entity		astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
molybdenum[no description available]medium30chromium group element atommicronutrient
molybdate ion[no description available]medium30divalent inorganic anion;
molybdenum oxoanion		Escherichia coli metabolite
tetramisole[no description available]medium10imidazothiazoleenvironmental contaminant;
xenobiotic
omega-n-methylarginine[no description available]medium20amino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
tetrafluoroaluminate[no description available]medium20
sodium salicylate[no description available]medium10organic molecular entity
butyric acid[no description available]medium50fatty acid 4:0;
straight-chain saturated fatty acid		human urinary metabolite;
Mycoplasma genitalium metabolite
camphor, (+-)-isomer[no description available]medium10bornane monoterpenoid;
cyclic monoterpene ketone		plant metabolite
isosorbide dinitrate[no description available]medium10glucitol derivative;
nitrate ester		nitric oxide donor;
vasodilator agent
potassium cyanide[no description available]medium10cyanide salt;
one-carbon compound;
potassium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
4-aminopyridine[no description available]medium10aminopyridine;
aromatic amine		avicide;
orphan drug;
potassium channel blocker
inositol-1,3,4,5-tetrakisphosphate[no description available]medium10inositol phosphate
mifepristone[no description available]medium203-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound		abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
cytochalasin e[no description available]medium20cytochalasan alkaloidmetabolite
jasplakinolide[no description available]medium30cyclodepsipeptide;
phenols		actin polymerisation inducer;
animal metabolite;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
marine metabolite;
neuroprotective agent
imipramine[no description available]medium20dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
icatibant[no description available]medium10
2-methylthio-atp[no description available]medium10
6-ketoprostaglandin f1 alpha[no description available]medium20prostaglandins Falphahuman metabolite;
mouse metabolite
methanol[no description available]medium20alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
trehalose[no description available]medium10trehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
uranyl acetate[no description available]medium10
phosphoryl chloride[no description available]medium10phosphorus coordination entity
calpeptin[no description available]medium20amino acid amide
substance p, phe(5)-trp(7,9)-leu(11)-[no description available]medium10
neurotensin[no description available]medium10peptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
geranylgeraniol[no description available]medium20geranylgeraniol
flag peptide[no description available]medium20peptide
tosylphenylalanyl chloromethyl ketone[no description available]medium10alpha-chloroketone;
sulfonamide		alkylating agent;
serine proteinase inhibitor
pyruvic acid[no description available]medium102-oxo monocarboxylic acidcofactor;
fundamental metabolite
e-z cinnamic acid[no description available]medium10cinnamic acidplant metabolite
monorden[no description available]medium20cyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols		antifungal agent;
metabolite;
tyrosine kinase inhibitor
farnesol[no description available]medium20farnesolplant metabolite
fti 277[no description available]medium10
spermine[no description available]medium10polyazaalkane;
tetramine		antioxidant;
fundamental metabolite;
immunosuppressive agent
spermidine[no description available]medium20polyazaalkane;
triamine		autophagy inducer;
fundamental metabolite;
geroprotector
formaldehyde[no description available]medium10aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
quinine[no description available]medium10cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
charybdotoxin[no description available]medium10
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc[no description available]medium20amino tetrasaccharide;
glucosamine oligosaccharide		epitope
bepafant[no description available]medium20
aurintricarboxylic acid[no description available]medium20monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid		fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
s-(2,4-dinitrophenyl)glutathione[no description available]medium10glutathione conjugate
naphthyl glucuronide[no description available]medium10
u 73343[no description available]medium10
cyc 202[no description available]medium202,6-diaminopurinesantiviral drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
olomoucine[no description available]medium202,6-diaminopurines;
ethanolamines		EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
kinetin[no description available]medium206-aminopurines;
furans		cytokinin;
geroprotector
peroxynitric acid[no description available]medium50nitrogen oxoacid
calyculin a[no description available]medium60
oxazoles[no description available]medium601,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
selenium[no description available]medium10chalcogen;
nonmetal atom		micronutrient
amyloid beta-peptides[no description available]medium10
ddt[no description available]medium10benzenoid aromatic compound;
chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide		bridged diphenyl acaricide;
carcinogenic agent;
endocrine disruptor;
persistent organic pollutant
diamide[no description available]medium501,1'-azobis(N,N-dimethylformamide)
dinoprost[no description available]medium20monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
s-ethylcysteine[no description available]medium10S-alkyl-L-cysteine zwitterion;
S-alkyl-L-cysteine		antitubercular agent
allopurinol[no description available]medium30nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
xanthine[no description available]medium20xanthineSaccharomyces cerevisiae metabolite
sodium propionate[no description available]medium10organic sodium saltantifungal drug;
food preservative
propionic acid[no description available]medium20saturated fatty acid;
short-chain fatty acid		antifungal drug
beta-endorphin[no description available]medium10
su 4984[no description available]medium10
tiludronic acid[no description available]medium10organochlorine compound
microcystin[no description available]medium10peptide
digitonin[no description available]medium40
corticosterone[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
beta-naphthyl phosphate[no description available]medium10aryl phosphatechromogenic compound
guanosine[no description available]medium10guanosines;
purines D-ribonucleoside		fundamental metabolite
flavin mononucleotide[no description available]medium10
pyridoxal phosphate[no description available]medium10methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
folic acid[no description available]medium20folic acids;
N-acyl-amino acid		human metabolite;
mouse metabolite;
nutrient
rx 821002[no description available]medium10benzodioxine;
cyclic ketal;
imidazolines		alpha-adrenergic antagonist
idazoxan[no description available]medium10benzodioxine;
imidazolines		alpha-adrenergic antagonist
bryostatin 1[no description available]medium10
arachidonyltrifluoromethane[no description available]medium20fatty acid derivative;
ketone;
olefinic compound;
organofluorine compound		EC 3.1.1.4 (phospholipase A2) inhibitor
sq 29548[no description available]medium10
echistatin[no description available]medium30
5-chloro-2-methyl-4-isothiazolin-3-one[no description available]medium101,2-thiazoles;
organochlorine compound		antimicrobial agent;
environmental contaminant;
xenobiotic
foscarnet[no description available]medium10carboxylic acid;
one-carbon compound;
phosphonic acids		antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
catechin[no description available]medium30catechinantioxidant;
plant metabolite
epigallocatechin gallate[no description available]medium30flavans;
gallate ester;
polyphenol		antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
xylose[no description available]medium10D-xylose
ly 311727[no description available]medium10
bumetanide[no description available]medium10amino acid;
benzoic acids;
sulfonamide		diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
chondroitin sulfates[no description available]medium10
glycyl-arginyl-glycyl-aspartyl-seryl-proline[no description available]medium10
methylnitronitrosoguanidine[no description available]medium10nitroso compoundalkylating agent
enkephalin, methionine[no description available]medium10
sb 203580[no description available]medium110imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide		EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
flurazepam[no description available]medium101,4-benzodiazepinone;
monofluorobenzenes;
organochlorine compound;
tertiary amino compound		anticonvulsant;
anxiolytic drug;
GABAA receptor agonist;
sedative
loxtidine[no description available]medium10aromatic ether;
piperidines;
primary alcohol;
triazoles		H2-receptor antagonist
vasoactive intestinal peptide[no description available]medium10
pyrophosphate[no description available]medium20diphosphate ion
4-nitrophenol[no description available]medium104-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide[no description available]medium10aromatic ether;
C-nitro compound;
sulfonamide		antineoplastic agent;
cyclooxygenase 2 inhibitor
dibutyryl cyclic gmp[no description available]medium10
ethacrynic acid[no description available]medium10aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid		EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
ammonium chloride[no description available]medium10ammonium salt;
inorganic chloride		ferroptosis inhibitor
methylamine[no description available]medium30methylamines;
one-carbon compound;
primary aliphatic amine		mouse metabolite
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid[no description available]medium20
dihydro-dids[no description available]medium10
ag 127[no description available]medium30
englitazone[no description available]medium10
galactocerebroside[no description available]medium10
gentamicin[no description available]medium10
galactosyl-(1-3)galactose[no description available]medium10O-acyl carbohydrate
vitamin k semiquinone radical[no description available]medium20
dinitrofluorobenzene[no description available]medium20C-nitro compound;
organofluorine compound		agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
lactoferrin[no description available]medium10
lysophosphatidylinositol[no description available]medium10
resveratrol[no description available]medium10resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
isopropyl thiogalactoside[no description available]medium10S-glycosyl compound
atropine[no description available]medium10
nigericin[no description available]medium10polycyclic etherantibacterial agent;
antimicrobial agent;
bacterial metabolite;
potassium ionophore
gallocatechol[no description available]medium10gallocatechinantioxidant;
metabolite;
radical scavenger
epicatechin gallate[no description available]medium10catechin;
gallate ester;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
fluo-3[no description available]medium10xanthene dyefluorochrome
2,4-dinitrophenol[no description available]medium30dinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
cyclopentane[no description available]medium10cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
glucosamine[no description available]medium40D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
inosine[no description available]medium10inosines;
purines D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
metrizoate[no description available]medium10monocarboxylic acidradioopaque medium
2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid[no description available]medium10aromatic amine
promegestone[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid		antineoplastic agent;
progesterone receptor agonist;
progestin
1-ethyl-3-(3-dimethylaminoethyl)carbodiimide[no description available]medium10
glycerol[no description available]medium10alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
5-iodoacetamidofluorescein[no description available]medium10
(3,4-dihydroxyphenylamino)-2-imidazoline[no description available]medium10
hypoxanthine[no description available]medium10nucleobase analogue;
oxopurine;
purine nucleobase		fundamental metabolite
gadolinium[no description available]medium10f-block element atom;
lanthanoid atom
afimoxifene[no description available]medium10phenols;
tertiary amino compound		antineoplastic agent;
estrogen receptor antagonist;
metabolite
beta-escin[no description available]medium10
diacetyl[no description available]medium10alpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
diacetylmonoxime[no description available]medium10
ml 7[no description available]medium10N-sulfonyldiazepane;
organoiodine compound		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
isotretinoin[no description available]medium10retinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
picryl chloride[no description available]medium10C-nitro compound;
monochlorobenzenes		allergen;
epitope;
explosive;
hapten
pravastatin[no description available]medium103-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)		anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
mevalonic acid[no description available]medium103,5-dihydroxy-3-methylpentanoic acid
jtt 501[no description available]medium10
thyroxine[no description available]medium102-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
ag 183[no description available]medium10
p-methoxy-n-methylphenethylamine[no description available]medium10aromatic ether;
secondary amino compound		metabolite
c.i. fluorescent brightening agent 28[no description available]medium10
web 2086[no description available]medium10organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
camptothecin[no description available]medium20delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
1,10-phenanthroline[no description available]medium10phenanthrolineEC 2.7.1.1 (hexokinase) inhibitor;
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
12-hydroxy-5,8,10,14-eicosatetraenoic acid[no description available]medium10
guanosine tetraphosphate[no description available]medium10guanosine bisphosphateEscherichia coli metabolite;
mouse metabolite
streptomycin[no description available]medium10antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
a-factor (streptomyces)[no description available]medium10butan-4-olide;
primary alcohol		metabolite
sodium bicarbonate[no description available]medium20one-carbon compound;
organic sodium salt		antacid;
food anticaking agent
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid[no description available]medium10stilbenoid
ninhydrin[no description available]medium10aromatic ketone;
beta-diketone;
indanones;
ketone hydrate		colour indicator;
human metabolite
ro 31-9790[no description available]medium10
9,10-dimethyl-1,2-benzanthracene[no description available]medium10ortho-fused polycyclic arene;
tetraphenes		carcinogenic agent
7-nitroindazole[no description available]medium10
strontium[no description available]medium10alkaline earth metal atom
evans blue[no description available]medium10organic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
eicosapentaenoic acid[no description available]medium10icosapentaenoic acid;
omega-3 fatty acid		anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
leupeptin[no description available]medium10aldehyde;
tripeptide		bacterial metabolite;
calpain inhibitor;
cathepsin B inhibitor;
EC 3.4.21.4 (trypsin) inhibitor;
serine protease inhibitor
ubenimex[no description available]medium10
carbobenzoxy-leucyl-leucyl-norvalinal[no description available]medium20peptide
tert-butylhydroperoxide[no description available]medium10alkyl hydroperoxideantibacterial agent;
oxidising agent
13-hydroperoxy-9,11-octadecadienoic acid[no description available]medium10hydroperoxy polyunsaturated fatty acid;
octadecadienoic acid
5-nitro-2-(3-phenylpropylamino)benzoic acid[no description available]medium10nitrobenzoic acid
anisomycin[no description available]medium30monohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
luteolin[no description available]medium103'-hydroxyflavonoid;
tetrahydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
n-hydroxysuccinimide suberic acid ester[no description available]medium10
acetic anhydride[no description available]medium10acyclic carboxylic anhydridemetabolite;
reagent
mtt formazan[no description available]medium10
formazans[no description available]medium10
phorbol[no description available]medium10cyclic ketone;
enone;
tertiary alcohol;
tertiary alpha-hydroxy ketone;
tetracyclic diterpenoid
farnesylthioacetic acid[no description available]medium10
n-acetyl-s-geranylgeranyl-cysteine[no description available]medium10diterpenoid
sri 63-441[no description available]medium10
fluphenazine[no description available]medium10N-alkylpiperazine;
organofluorine compound;
phenothiazines		anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug
tocotrienol, alpha[no description available]medium10tocotrienol;
vitamin E		ferroptosis inhibitor;
human metabolite;
neuroprotective agent;
plant metabolite
d-alpha tocopherol[no description available]medium20alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
plastochromanol 8[no description available]medium10
tocotrienols[no description available]medium10diterpenoid
vanadium pentoxide[no description available]medium10vanadium oxide
phosphatidylinositol 4-phosphate[no description available]medium20
propyl gallate[no description available]medium10trihydroxybenzoic acid
ethylene[no description available]medium10alkene;
gas molecular entity		plant hormone;
refrigerant
vanadyl sulfate[no description available]medium10metal sulfate;
vanadium coordination entity
emetine[no description available]medium20isoquinoline alkaloid;
pyridoisoquinoline		antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
ethanolamine[no description available]medium10ethanolamines;
primary alcohol;
primary amine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
melatonin[no description available]medium10acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
citric acid, anhydrous[no description available]medium20tricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
fascaplysine[no description available]medium10
u 69593[no description available]medium10monocarboxylic acid amide;
N-alkylpyrrolidine;
organic heterobicyclic compound;
oxaspiro compound		anti-inflammatory agent;
diuretic;
kappa-opioid receptor agonist
linsidomine[no description available]medium10morpholines
molsidomine[no description available]medium10ethyl ester;
morpholines;
oxadiazole;
zwitterion		antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
ag 538[no description available]medium10
vitamin b 12[no description available]medium10
lipoteichoic acid[no description available]medium20
pyrrolidonecarboxylic acid[no description available]medium105-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
carbon tetrachloride[no description available]medium10chlorocarbon;
chloromethanes		hepatotoxic agent;
refrigerant
fulvestrant[no description available]medium1017beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide		antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
ponceau s[no description available]medium10organic sodium salt;
organosulfonate salt		fluorochrome;
histological dye
thiourea[no description available]medium10one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
1,3-dimethylthiourea[no description available]medium10
tiopronin[no description available]medium10N-acyl-amino acid
malondialdehyde[no description available]medium10dialdehydebiomarker
allyl isothiocyanate[no description available]medium10alkenyl isothiocyanate;
isothiocyanate		antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lachrymator;
metabolite
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone[no description available]medium10
noc 9[no description available]medium10
n(6)-cyclopentyladenosine[no description available]medium10
tetrodotoxin[no description available]medium10azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid		animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
beta-(5-hydroxy-2-pyridyl)alanine[no description available]medium10
acetohexamide[no description available]medium10
sucrose[no description available]medium10glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
phenol[no description available]medium10phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
fusicoccin[no description available]medium10
glycosides[no description available]medium10
hypochlorous acid[no description available]medium10chlorine oxoacid;
reactive oxygen species		EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
diphenylhexatriene[no description available]medium10alkatrienefluorochrome
alvocidib[no description available]medium10dihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound		antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone[no description available]medium10nitrosamine;
pyridines
ozone[no description available]medium10elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid[no description available]medium10chromanol;
monocarboxylic acid;
phenols		antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
edelfosine[no description available]medium10glycerophosphocholine
pyrrolidine dithiocarbamate[no description available]medium10dithiocarbamic acids;
pyrrolidines		anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
arabinose[no description available]medium10L-arabinoseEscherichia coli metabolite;
mouse metabolite
ammonium hydroxide[no description available]medium10azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
caprolactam[no description available]medium10caprolactamshuman blood serum metabolite
leptomycin b[no description available]medium10
nimodipine[no description available]medium102-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
fructosamine[no description available]medium10
puromycin[no description available]medium10puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
busulfan[no description available]medium10methanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
ebrotidine[no description available]medium10sulfonamide
isradipine[no description available]medium10benzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
arsenic acid[no description available]medium10arsenic oxoacidEscherichia coli metabolite
kemptide[no description available]medium20
angiotensin i[no description available]medium10angiotensin;
peptide zwitterion		human metabolite;
neurotransmitter agent
kt 5926[no description available]medium10gamma-lactam;
hemiaminal;
indolocarbazole;
methyl ester;
organic heterooctacyclic compound;
tertiary alcohol		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
iodoacetic acid[no description available]medium10haloacetic acid;
organoiodine compound		alkylating agent
veratridine[no description available]medium10
dimethyl sulfate[no description available]medium10alkyl sulfatealkylating agent;
immunosuppressive agent
nadp[no description available]medium20
amanitins[no description available]medium10
7-nitrobenz-2-oxa-1,3-diazole-phallacidin[no description available]medium10
tyramine[no description available]medium10monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
quin2[no description available]medium10
thiabendazole[no description available]medium101,3-thiazoles;
benzimidazole fungicide;
benzimidazoles		antifungal agrochemical;
antinematodal drug
plumbagin[no description available]medium10hydroxy-1,4-naphthoquinone;
phenols		anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite
ethylene glycol[no description available]medium10ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
5,5'-dimethyl-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetate[no description available]medium10polyamino carboxylic acidchelator
hexacyanoferrate iii[no description available]medium10
peptide elongation factor 2[no description available]medium10
aphidicolin[no description available]medium10tetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
2-amino-5-phosphonovalerate[no description available]medium10non-proteinogenic alpha-amino acidNMDA receptor antagonist
big gastrin[no description available]medium10
lithium[no description available]medium10alkali metal atom
pilocarpine[no description available]medium10pilocarpineantiglaucoma drug
beta-glycerophosphoric acid[no description available]medium10glycerol monophosphateEscherichia coli metabolite;
plant metabolite
quinone[no description available]medium101,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
w 7[no description available]medium10
o-phthalaldehyde[no description available]medium20benzaldehydes;
dialdehyde		epitope
phenylglyoxal[no description available]medium10phenylacetaldehydes
1-carboxyglutamic acid[no description available]medium10
sodium hydroxide[no description available]medium10alkali metal hydroxide
mannose[no description available]medium10D-aldohexose;
D-mannose;
mannopyranose		metabolite
nitroblue tetrazolium[no description available]medium10organic cation
2-(methylamino)isobutyric acid[no description available]medium10alanine derivative;
alpha-amino acid zwitterion;
non-proteinogenic alpha-amino acid;
secondary amino compound		human urinary metabolite
mannose-6-phosphate[no description available]medium10D-mannopyranose 6-phosphate
isomethyleugenol[no description available]medium100isomethyleugenol
guaifenesin[no description available]medium10methoxybenzenes
cinidon-ethyl[no description available]medium10ethyl ester;
isoindoles;
monochlorobenzenes		herbicide
eye[no description available]medium20
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone[no description available]medium170dichlorobenzene;
differentiation-inducing factor;
monomethoxybenzene;
resorcinols		eukaryotic metabolite;
signalling molecule
bassianolide[no description available]medium10cyclodepsipeptide;
cyclooctadepsipeptide		antineoplastic agent;
fungal metabolite;
insecticide
torpedo[no description available]medium130
apigenin[no description available]medium10trihydroxyflavoneantineoplastic agent;
metabolite
khellin[no description available]medium10furanochromone;
organic heterotricyclic compound;
oxacycle		anti-asthmatic agent;
bronchodilator agent;
cardiovascular drug;
vasodilator agent
trazodone hydrochloride[no description available]medium10hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
isoniazid[no description available]medium10carbohydrazideantitubercular agent;
drug allergen
monoisopropanolamine[no description available]low00amino alcohol;
secondary alcohol		Escherichia coli metabolite
dihydro-3-coumaric acid[no description available]low00monocarboxylic acidEscherichia coli metabolite;
human xenobiotic metabolite
3-mercaptopyruvic acid[no description available]low002-oxo monocarboxylic acid;
thiol		antidote to cyanide poisoning;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
4-aminobutyraldehyde[no description available]low00aminobutanal;
omega-aminoaldehyde		Escherichia coli metabolite;
mouse metabolite
aminolevulinic acid[no description available]low004-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid		antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
5,6,7,8-tetrahydropteridine[no description available]low00pteridinescofactor;
Escherichia coli metabolite
acetyl phosphate[no description available]low00acyl monophosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
agmatine[no description available]low00guanidines;
primary amino compound		Escherichia coli metabolite;
mouse metabolite
allantoin[no description available]low00imidazolidine-2,4-dione;
ureas		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite;
vulnerary
aminoacetone[no description available]low00methyl ketone;
propanones		Escherichia coli metabolite;
mouse metabolite
betaine aldehyde[no description available]low00quaternary ammonium ionAspergillus metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
butyraldehyde[no description available]low00butanalsbiomarker;
Escherichia coli metabolite;
mouse metabolite
carbamic acid[no description available]low00carbon oxoacid;
one-carbon compound;
organonitrogen compound		Escherichia coli metabolite
carbamyl phosphate[no description available]low00acyl monophosphate;
one-carbon compound		Escherichia coli metabolite;
mouse metabolite
ureidosuccinic acid[no description available]low00aspartic acid derivative;
C4-dicarboxylic acid;
N-carbamoyl-amino acid		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
coproporphyrinogen iii[no description available]low00coproporphyrinogenEscherichia coli metabolite;
mouse metabolite
2-aminoacetaldehyde[no description available]low00amino aldehyde;
omega-aminoaldehyde		Escherichia coli metabolite
2,3-diaminopropionic acid[no description available]low00alanine derivative;
amino acid zwitterion;
beta-amino acid;
diamino acid;
non-proteinogenic alpha-amino acid		Escherichia coli metabolite
octanoic acid[no description available]low00medium-chain fatty acid;
straight-chain saturated fatty acid		antibacterial agent;
Escherichia coli metabolite;
human metabolite
hydrogen sulfide[no description available]low00gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
oxaluric acid[no description available]low002-oxo monocarboxylic acid;
ureas		Escherichia coli metabolite
n(1)-acetylspermidine[no description available]low00acetylspermidineEscherichia coli metabolite;
metabolite
propionaldehyde[no description available]low00alpha-CH2-containing aldehyde;
propanals		Escherichia coli metabolite
hydrogen selenide[no description available]low00mononuclear parent hydride;
selenium hydride		Escherichia coli metabolite;
mouse metabolite
3,3-dimethylallyl pyrophosphate[no description available]low00prenol phosphateepitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
dihydrouracil[no description available]low00pyrimidoneEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
dihydroxyacetone phosphate[no description available]low00glycerone phosphates;
primary alpha-hydroxy ketone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
dihydroxyacetone[no description available]low00ketotriose;
primary alpha-hydroxy ketone		antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1,4-dihydroxy-2-naphthoic acid[no description available]low00dihydroxy monocarboxylic acid;
naphthalenediols;
naphthohydroquinone;
naphthoic acid		Escherichia coli metabolite
5,6-dimethylbenzimidazole[no description available]low00dimethylbenzimidazoleEscherichia coli metabolite;
human metabolite
gamma-butyrobetaine[no description available]low00amino-acid betaineEscherichia coli metabolite;
human metabolite
hydrogen cyanide[no description available]low00hydracid;
one-carbon compound		Escherichia coli metabolite;
human metabolite;
poison
toxopyrimidine[no description available]low00aminopyrimidine;
aromatic primary alcohol		Escherichia coli metabolite;
Saccharomyces cerevisiae metabolite
thiocyanic acid[no description available]low00hydracid;
one-carbon compound;
organosulfur compound		Escherichia coli metabolite
hydroquinone[no description available]low00benzenediol;
hydroquinones		antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
hydroxymethylbilane[no description available]low00bilanesEscherichia coli metabolite;
mouse metabolite
iminoaspartic acid[no description available]low00aspartic acid derivative;
C4-dicarboxylic acid;
ketimine		Escherichia coli metabolite
indole[no description available]low00indole;
polycyclic heteroarene		Escherichia coli metabolite
lipoamide[no description available]low00dithiolanes;
monocarboxylic acid amide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
racemethionine[no description available]low00alpha-amino acid;
amino acid zwitterion;
sulfur-containing amino acid		algal metabolite;
Daphnia magna metabolite;
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
pyruvaldehyde[no description available]low002-oxo aldehyde;
propanals		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
niacin[no description available]low00pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
hydroxypyruvic acid[no description available]low002-oxo monocarboxylic acid;
3-hydroxy monocarboxylic acid;
primary alpha-hydroxy ketone		Escherichia coli metabolite;
human metabolite
4-aminobenzoic acid[no description available]low00aminobenzoic acid;
aromatic amino-acid zwitterion		allergen;
Escherichia coli metabolite;
plant metabolite
phenylacetaldehyde[no description available]low00alpha-CH2-containing aldehyde;
phenylacetaldehydes		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
phenylacetic acid[no description available]low00benzenes;
monocarboxylic acid;
phenylacetic acids		allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
phenethylamine[no description available]low00alkaloid;
aralkylamine;
phenylethylamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
porphobilinogen[no description available]low00aralkylamino compound;
dicarboxylic acid;
pyrroles		Escherichia coli metabolite;
metabolite;
mouse metabolite
diphosphoric acid[no description available]low00acyclic phosphorus acid anhydride;
phosphorus oxoacid		Escherichia coli metabolite
prephenic acid[no description available]low00oxo dicarboxylic acidEscherichia coli metabolite;
plant metabolite
pyridoxal[no description available]low00hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyridoxamine[no description available]low00aminoalkylpyridine;
hydroxymethylpyridine;
monohydroxypyridine;
vitamin B6		Escherichia coli metabolite;
human metabolite;
iron chelator;
mouse metabolite;
nephroprotective agent;
plant metabolite;
Saccharomyces cerevisiae metabolite
pyridoxamine phosphate[no description available]low00aminoalkylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6 phosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyridoxine[no description available]low00hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyridoxine 5-phosphate[no description available]low00vitamin B6 phosphateEscherichia coli metabolite;
mouse metabolite
dimethyl sulfide[no description available]low00aliphatic sulfidealgal metabolite;
bacterial xenobiotic metabolite;
EC 3.5.1.4 (amidase) inhibitor;
Escherichia coli metabolite;
marine metabolite
succinic semialdehyde[no description available]low00aldehydic acidEscherichia coli metabolite;
mouse metabolite
sulfur dioxide[no description available]low00sulfur oxideEscherichia coli metabolite;
food bleaching agent;
refrigerant
tartronate semialdehyde[no description available]low002-hydroxy monocarboxylic acid;
3-oxo monocarboxylic acid;
aldehyde		Escherichia coli metabolite;
mouse metabolite
thiamine[no description available]low00primary alcohol;
vitamin B1		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2-(4-methyl-1,3-thiazol-5-yl)ethanol[no description available]low001,3-thiazoles;
primary alcohol		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
trimethyloxamine[no description available]low00tertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte
trimethylamine[no description available]low00methylamines;
tertiary amine		Escherichia coli metabolite;
human xenobiotic metabolite
uracil[no description available]low00pyrimidine nucleobase;
pyrimidone		allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
uroporphyrinogen iii[no description available]low00uroporphyrinogenEscherichia coli metabolite;
mouse metabolite
isopentenyl pyrophosphate[no description available]low00prenol phosphateantigen;
antioxidant;
epitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
4-cresol[no description available]low00cresolEscherichia coli metabolite;
human metabolite;
uremic toxin
4-aminobenzoic acid[no description available]low00aminobenzoate;
aromatic amino-acid anion		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
chloramphenicol[no description available]low00C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
uridine diphosphate[no description available]low00pyrimidine ribonucleoside 5'-diphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
cytidine diphosphate[no description available]low00cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-diphosphate		Escherichia coli metabolite;
mouse metabolite
cytidine[no description available]low00cytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
cytidine triphosphate[no description available]low00cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite
methanesulfonic acid[no description available]low00alkanesulfonic acid;
one-carbon compound		Escherichia coli metabolite
phosphoribosyl pyrophosphate[no description available]low005-O-phosphono-D-ribofuranosyl diphosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
acetol[no description available]low00methyl ketone;
primary alcohol;
primary alpha-hydroxy ketone;
propanones		Escherichia coli metabolite;
human metabolite;
mouse metabolite
framycetin[no description available]low00aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
shikimic acid[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
citrulline[no description available]low00amino acid zwitterion;
citrulline		Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
phosphoadenosine phosphosulfate[no description available]low00acyl sulfate;
adenosine bisphosphate;
purine ribonucleoside bisphosphate		Escherichia coli metabolite;
mouse metabolite
adenosine phosphosulfate[no description available]low00acyl monophosphate;
acyl sulfate;
adenosine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
pyridoxamine dihydrochloride[no description available]low00hydrochloride;
vitamin B6		Escherichia coli metabolite;
human metabolite;
iron chelator;
mouse metabolite;
nephroprotective agent;
plant metabolite;
Saccharomyces cerevisiae metabolite
galactitol[no description available]low00hexitolEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
chorismic acid[no description available]low005-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acidEscherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
deoxycytidine[no description available]low00pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
deoxyuridine[no description available]low00pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2'-deoxyadenosine[no description available]low00purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
deoxycytidine monophosphate[no description available]low002'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
mouse metabolite
nicotinamide mononucleotide[no description available]low00nicotinamide mononucleotideEscherichia coli metabolite;
mouse metabolite
2'-deoxyadenosine triphosphate[no description available]low002'-deoxyadenosine 5'-phosphate;
purine 2'-deoxyribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite
1,3,4-butanetriol[no description available]low00triolbacterial xenobiotic metabolite;
Escherichia coli metabolite
diadenosine tetraphosphate[no description available]low00diadenosyl tetraphosphateEscherichia coli metabolite;
mouse metabolite
d-glutamate[no description available]low00D-alpha-amino acid;
glutamic acid		Escherichia coli metabolite;
mouse metabolite
silver[no description available]low00copper group element atom;
elemental silver		Escherichia coli metabolite
myrmicacin[no description available]low003-hydroxy fatty acid;
medium-chain fatty acid		antimitotic;
Escherichia coli metabolite
phosphopantothenic acid[no description available]low00amidoalkyl phosphateEscherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
d-lactic acid[no description available]low002-hydroxypropanoic acidEscherichia coli metabolite;
human metabolite
xanthosine[no description available]low00purines D-ribonucleoside;
xanthosines		Escherichia coli metabolite;
human metabolite;
mouse metabolite
thymidine 5'-triphosphate[no description available]low00pyrimidine 2'-deoxyribonucleoside 5'-triphosphate;
thymidine phosphate		Escherichia coli metabolite;
mouse metabolite
2'-deoxyuridylic acid[no description available]low00deoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
deoxyuridine triphosphate[no description available]low00deoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate		Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
2'-deoxycytidine 5'-triphosphate[no description available]low002'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
n-(3-aminopropyl)cadaverine[no description available]low00polyazaalkane;
triamine		Escherichia coli metabolite
3'-cmp[no description available]low00cytidine 3'-phosphate;
pyrimidine ribonucleoside 3'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
hydracrylic acid[no description available]low003-hydroxy monocarboxylic acid;
omega-hydroxy-short-chain fatty acid		Escherichia coli metabolite;
human metabolite
plasmenylserine[no description available]low00O-phosphoserineEC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor;
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
cifostodine[no description available]low002',3'-cyclic pyrimidine nucleotideEscherichia coli metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
ubiquinone-o[no description available]low00ubiquinonesEscherichia coli metabolite;
human metabolite
D-serine[no description available]low00D-alpha-amino acid;
serine zwitterion;
serine		Escherichia coli metabolite;
human metabolite;
NMDA receptor agonist
D-alanine[no description available]low00alanine zwitterion;
alanine;
D-alpha-amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
Escherichia coli metabolite;
human metabolite
D-tyrosine[no description available]low00D-alpha-amino acid zwitterion;
D-alpha-amino acid;
tyrosine		Escherichia coli metabolite
xanthosine 5'-triphosphate[no description available]low00purine ribonucleoside 5'-monophosphate;
xanthosine 5'-phosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
glucose-1,6-bisphosphate[no description available]low00D-glucose 1,6-bisphosphateEscherichia coli metabolite;
human metabolite
coenzyme a[no description available]low00adenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
succinyl-coenzyme a[no description available]low00omega-carboxyacyl-CoAEscherichia coli metabolite;
inhibitor;
mouse metabolite
L-2-aminoadipic acid[no description available]low002-aminoadipic acidEscherichia coli metabolite;
human metabolite
acetoacetyl coa[no description available]low003-oxo-fatty acyl-CoAEscherichia coli metabolite;
mouse metabolite
propionyl-coenzyme a[no description available]low00acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
stearoyl-coenzyme a[no description available]low0011,12-saturated fatty acyl-CoA;
long-chain fatty acyl-CoA		Escherichia coli metabolite;
mouse metabolite
3'-uridylic acid[no description available]low00pyrimidine ribonucleoside 3'-monophosphate;
uridine phosphate		Escherichia coli metabolite
2',3'-cyclic amp[no description available]low002',3'-cyclic purine nucleotideEscherichia coli metabolite
2,5-diketogluconic acid[no description available]low00diketoaldonic acidEscherichia coli metabolite
l-lactic acid[no description available]low00(2S)-2-hydroxy monocarboxylic acid;
2-hydroxypropanoic acid		Escherichia coli metabolite;
human metabolite
selenodiglutathione[no description available]low00glutathione derivative;
thioselenide		Escherichia coli metabolite;
metabolite
2-deoxyglucose-6-phosphate[no description available]low00deoxyaldohexose phosphateEscherichia coli metabolite;
Mycoplasma genitalium metabolite
3,4-dihydroxyphenylacetaldehyde[no description available]low00alpha-CH2-containing aldehyde;
catechols;
phenylacetaldehydes		Escherichia coli metabolite;
human metabolite;
mouse metabolite
protoporphyrinogen[no description available]low00porphyrinogensEscherichia coli metabolite;
mouse metabolite
thymidine diphosphate-l-rhamnose[no description available]low00dTDP-L-rhamnoseEscherichia coli metabolite
butyryl-coenzyme a[no description available]low00butanoyl-CoAsEscherichia coli metabolite;
mouse metabolite
trehalose-6-phosphate[no description available]low00trehalose phosphateEscherichia coli metabolite
erythrose 4-phosphate[no description available]low00erythrose phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
ribulose-1,5 diphosphate[no description available]low00ribulose phosphateEscherichia coli metabolite;
plant metabolite
n(8)-acetylspermidine[no description available]low00acetylspermidineEscherichia coli metabolite;
human metabolite
aerobactin[no description available]low00L-lysine derivativeEscherichia coli metabolite;
siderophore;
virulence factor
galactose-1-phosphate[no description available]low00alpha-D-hexose 1-phosphate;
D-galactopyranose 1-phosphate		Escherichia coli metabolite;
mouse metabolite
gamma-glutamylcysteine[no description available]low00gamma-glutamylcysteineEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
glutamate-1-semialdehyde[no description available]low005-oxo monocarboxylic acid;
amino acid zwitterion;
gamma-amino acid;
glutamic semialdehyde		Escherichia coli metabolite
mannitol-1-phosphate[no description available]low00alditol 1-phosphate;
hexitol phosphate		Escherichia coli metabolite;
human metabolite
2'-deoxycytidine diphosphate[no description available]low002'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-diphosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
o-phosphohomoserine[no description available]low00O-phosphorylhomoserineEscherichia coli metabolite
ribulose[no description available]low00ribuloseEscherichia coli metabolite;
human metabolite
2,3-dihydroxybenzoylserine[no description available]low00L-serine derivativeEscherichia coli metabolite
sorbitol 6-phosphate[no description available]low00alditol 6-phosphate;
glucitol phosphate		Escherichia coli metabolite;
mouse metabolite
beta-aspartyl phosphate[no description available]medium00aminoacyl phosphate;
L-aspartic acid derivative;
non-proteinogenic L-alpha-amino acid		Escherichia coli metabolite
adenosine 3'-phosphate-5'-phosphate[no description available]low00adenosine bisphosphateEscherichia coli metabolite;
mouse metabolite
alpha-ribazole[no description available]low001-ribosylbenzimidazole;
dimethylbenzimidazole		Escherichia coli metabolite;
mouse metabolite
abrine[no description available]low00L-tryptophan derivative;
N-methyl-L-alpha-amino acid zwitterion;
N-methyl-L-alpha-amino acid		Escherichia coli metabolite
orotidylic acid[no description available]low00pyrimidine ribonucleoside 5'-monophosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
3-deoxy-d-arabino-heptulosonate-7-phosphate[no description available]low00ketoaldonic acid phosphateEscherichia coli metabolite
saicar[no description available]low001-(phosphoribosyl)imidazolecarboxamideEscherichia coli metabolite;
mouse metabolite
n(6)-(n-threonylcarbonyl)adenosine[no description available]low00L-threonine derivative;
N-(adenosin-N(6)-ylcarbonyl)threonine		Escherichia coli metabolite;
human metabolite
thymidine 5'-diphosphate[no description available]low00pyrimidine 2'-deoxyribonucleoside 5'-diphosphate;
thymidine phosphate		Escherichia coli metabolite;
mouse metabolite
sedoheptulose 1,7-bisphosphate[no description available]low00ketoheptose phosphate;
sedoheptulose derivative		Escherichia coli metabolite;
mouse metabolite
sedoheptulose 7-phosphate[no description available]low00ketoheptose phosphate;
sedoheptulose derivative		Escherichia coli metabolite;
human metabolite;
mouse metabolite
histidinol[no description available]low00amino alcohol;
imidazoles		EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
carboxyaminoimidazole ribotide[no description available]low001-(phosphoribosyl)imidazole;
aminoimidazole;
imidazole-4-carboxylic acid		Escherichia coli metabolite;
mouse metabolite
lauroyl-coenzyme a[no description available]low00medium-chain fatty acyl-CoAEscherichia coli metabolite;
mouse metabolite
nicotinic acid adenine dinucleotide[no description available]low00nicotinic acid dinucleotideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
phenylacetyl-coenzyme a[no description available]low00acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
5-formamidoimidazole-4-carboxamide ribotide[no description available]low001-(phosphoribosyl)imidazolecarboxamideEscherichia coli metabolite;
mouse metabolite
6,7-dimethyl-8-ribityllumazine, (d)-isomer[no description available]low00pteridinescofactor;
Escherichia coli metabolite
glucosamine 1-phosphate[no description available]low00glucosamine phosphateEscherichia coli metabolite
2'-deoxyadenosine triphosphate[no description available]low002'-deoxyadenosine 5'-phosphate;
purine 2'-deoxyribonucleoside 5'-diphosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
9-mercaptodethiobiotin[no description available]low00imidazolidinone;
monocarboxylic acid;
thiol;
ureas		Escherichia coli metabolite
idonic acid[no description available]low00idonic acidEscherichia coli metabolite
gamma-glutamyl phosphate[no description available]low00gamma-glutamyl phosphateEscherichia coli metabolite;
mouse metabolite
5-amino-6-ribitylamino-2,4-(1h,3h)pyrimidinedione[no description available]low00aminouracil;
hydroxypyrimidine		Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
hydroxythreonine[no description available]medium00amino acid zwitterion;
hydroxy-amino acid;
L-threonine derivative;
non-proteinogenic L-alpha-amino acid		Escherichia coli metabolite;
Saccharomyces cerevisiae metabolite
n(1)-((5'-phosphoribulosyl)formimino)-5-aminoimidazo-4-carboxamide ribonucleotide[no description available]low001-(phosphoribosyl)imidazolecarboxamideEscherichia coli metabolite
2-oxo-3-deoxygalactonic acid[no description available]low00hexonic acid;
ketoaldonic acid		Escherichia coli metabolite
5'-deoxyadenosine[no description available]low005'-deoxyribonucleoside;
adenosines		Escherichia coli metabolite;
human metabolite;
mouse metabolite
xylulose-5-phosphate, (d)-isomer[no description available]low00xylulose 5-phosphateEscherichia coli metabolite;
mouse metabolite
glycerate 1,3-biphosphate[no description available]low002,3-bisphosphoglyceric acid;
acyl monophosphate		Escherichia coli metabolite;
mouse metabolite
ribose 1-phosphate[no description available]low00D-ribose 1-phosphateEscherichia coli metabolite
diaminopimelic acid[no description available]low002,6-diaminopimelic acid;
amino acid zwitterion		Escherichia coli metabolite
xanthosine 5'-triphosphate[no description available]low00purine ribonucleoside 5'-triphosphate;
xanthosine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
3-dehydroquinic acid[no description available]low002-hydroxy monocarboxylic acid;
4-hydroxy monocarboxylic acid;
4-oxo monocarboxylic acid;
5-hydroxy monocarboxylic acid;
secondary alpha-hydroxy ketone		Escherichia coli metabolite
o-succinylhomoserine[no description available]low00hemisuccinate;
o-succinylhomoserine		Escherichia coli metabolite;
Saccharomyces cerevisiae metabolite
s-adenosyl-3-methylthiopropylamine[no description available]low00adenosines;
sulfonium compound		Escherichia coli metabolite;
human urinary metabolite;
mouse metabolite;
rat metabolite
6-phosphonoglucono-delta-lactone[no description available]low00aldonolactone phosphateEscherichia coli metabolite;
mouse metabolite
cysteinylglycine[no description available]low00dipeptide zwitterion;
dipeptide		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
tartaric acid[no description available]low00tartaric acidEscherichia coli metabolite
s-ribosyl-l-homocysteine[no description available]low00S-(5-deoxy-D-ribos-5-yl)-L-homocysteineEscherichia coli metabolite
4-hydroxyphenylacetaldehyde[no description available]low00alpha-CH2-containing aldehyde;
phenylacetaldehydes		Escherichia coli metabolite;
human metabolite;
mouse metabolite
nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)[no description available]low00diadenosyl pentaphosphateEscherichia coli metabolite;
vasoconstrictor agent
n-acetylglucosamine-1-phosphate[no description available]low00N-acetyl-D-glucosamine 1-phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
pantothenylcysteine 4'-phosphate[no description available]low00L-cysteine derivativeEscherichia coli metabolite;
mouse metabolite
glutathionylspermidine[no description available]low00glutathione derivativeEscherichia coli metabolite
arbutin[no description available]low00beta-D-glucoside;
monosaccharide derivative		Escherichia coli metabolite;
plant metabolite
2-c-methylerythritol 4-phosphate[no description available]low00tetritol phosphateEscherichia coli metabolite
1-deoxy-d-xylulose 5-phosphate[no description available]low00xylulose phosphateEscherichia coli metabolite
c(alpha)-formylglycine[no description available]medium003-oxoalanine;
amino acid zwitterion;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid		Escherichia coli metabolite
dephosphocoenzyme a[no description available]low00adenosine 5'-phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
n(1)-(5-phosphoribosyl)-5,6-dimethylbenzimidazole[no description available]low001-ribosylbenzimidazole;
dimethylbenzimidazole;
ribose monophosphate		Escherichia coli metabolite;
mouse metabolite
ribothymidine[no description available]low00methyluridineantigen;
Escherichia coli metabolite;
human metabolite
palmitoleic acid[no description available]low00hexadec-9-enoic acidalgal metabolite;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
human blood serum metabolite
farnesyl pyrophosphate[no description available]low00farnesyl diphosphateEscherichia coli metabolite;
mouse metabolite
geranyl pyrophosphate[no description available]low00polyprenyl diphosphateEscherichia coli metabolite;
mouse metabolite
1,5-dihydro-fad[no description available]low00flavin adenine dinucleotideEscherichia coli metabolite;
mouse metabolite
s-hydroxymethylglutathione[no description available]low00S-substituted glutathioneEscherichia coli metabolite;
mouse metabolite
hexanoyl-coenzyme a[no description available]low00medium-chain fatty acyl-CoAEscherichia coli metabolite;
human metabolite;
mouse metabolite
4-phosphoerythronate[no description available]low004-phosphoerythronic acidEscherichia coli metabolite;
mouse metabolite
riboflavin[no description available]low00flavin;
vitamin B2		anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
flavin-adenine dinucleotide[no description available]low00flavin adenine dinucleotide;
vitamin B2		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
malonyl coenzyme a[no description available]low00malonyl-CoAsEC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor;
Escherichia coli metabolite;
metabolite;
mouse metabolite
sucrose-6-phosphate[no description available]low00disaccharide phosphateEscherichia coli metabolite
palmitoyl coenzyme a[no description available]low0011,12-saturated fatty acyl-CoA;
3-substituted propionyl-CoA;
long-chain fatty acyl-CoA;
palmitoyl bioconjugate		Escherichia coli metabolite;
mouse metabolite
glycerylphosphorylcholine[no description available]low00phosphocholines;
sn-glycerol 3-phosphates		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neuroprotective agent;
parasympatholytic;
Saccharomyces cerevisiae metabolite
cysteine sulfinic acid[no description available]low00organosulfinic acid;
S-substituted L-cysteine		Escherichia coli metabolite;
human metabolite;
metabotropic glutamate receptor agonist;
mouse metabolite
fusidic acid[no description available]low0011alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester		EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
iminoglycine[no description available]low00dehydroamino acid;
imine;
zwitterion		Escherichia coli metabolite
2-keto-3-deoxy-6-phosphogluconate[no description available]low00ketoaldonic acid phosphateEscherichia coli metabolite
formyl-coenzyme a[no description available]low00acyl-CoAEscherichia coli metabolite
3-deoxy-2-octulosonic acid(2)-lipid iv(a)[no description available]low00lipid AsEscherichia coli metabolite
maleamic acid[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
dicarboxylic acid monoamide		bacterial xenobiotic metabolite;
Escherichia coli metabolite
retinol palmitate[no description available]low00all-trans-retinyl ester;
retinyl palmitate		antioxidant;
Escherichia coli metabolite;
human xenobiotic metabolite
canthaxanthin[no description available]low00carotenonebiological pigment;
Escherichia coli metabolite;
food colouring;
fungal metabolite
(e)-4-hydroxy-3-methylbut-2-enyl diphosphate[no description available]low00prenol phosphateepitope;
Escherichia coli metabolite;
phosphoantigen
menaquinone 7[no description available]low00menaquinonebone density conservation agent;
cofactor;
Escherichia coli metabolite;
human blood serum metabolite;
Mycoplasma genitalium metabolite
xylulose[no description available]low00xyluloseEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
vitamin mk 8[no description available]low00menaquinoneEscherichia coli metabolite;
human metabolite
5-ketogluconic acid[no description available]low00hexonic acid;
ketoaldonic acid		Escherichia coli metabolite
oleoyl-coenzyme a[no description available]low00octadecenoyl-CoAEscherichia coli metabolite;
mouse metabolite
menaquinone 9[no description available]low00menaquinoneEscherichia coli metabolite
allolactose[no description available]low00glycosylglucoseEscherichia coli metabolite
fuculose[no description available]low00deoxyketohexoseEscherichia coli metabolite;
human metabolite
1-deoxy-2-pentulose[no description available]low00deoxypentoseEscherichia coli metabolite
fructosyl-lysine[no description available]low00fructosamine;
glyco-amino acid		Escherichia coli metabolite
methionine sulfoxide[no description available]low00amino acid zwitterion;
L-methionine S-oxide		Escherichia coli metabolite
(S)-4,5-dihydroxypentane-2,3-dione[no description available]low00alpha-diketone;
secondary alpha-hydroxy ketone		Escherichia coli metabolite
kdo2-lipid a[no description available]low00dodecanoate ester;
lipid As;
tetradecanoate ester		Escherichia coli metabolite
oxalyl-coenzyme a[no description available]low00omega-carboxyacyl-CoAEscherichia coli metabolite
s-tetradecanoyl-coenzyme a[no description available]low0011,12-saturated fatty acyl-CoA;
long-chain fatty acyl-CoA		Escherichia coli metabolite;
mouse metabolite
novobiocin[no description available]low00carbamate ester;
ether;
hexoside;
hydroxycoumarin;
monocarboxylic acid amide;
monosaccharide derivative;
phenols		antibacterial agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Escherichia coli metabolite;
hepatoprotective agent
diguanosine tetraphosphate[no description available]low00guanosine 5'-phosphate;
purine ribonucleoside 5'-tetraphosphate		Escherichia coli metabolite;
mouse metabolite
deoxyguanosine[no description available]low00purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
deoxyinosine[no description available]low00purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2'-deoxyguanosine 5'-phosphate[no description available]low00deoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
mouse metabolite
deoxyguanosine triphosphate[no description available]low00deoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-triphosphate		Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
7,8-dihydroneopterin[no description available]low00dihydropterin;
neopterins		Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
dihydrofolate[no description available]low00dihydrofolic acidsEscherichia coli metabolite;
mouse metabolite
dihydroneopterin triphosphate[no description available]low00dihydropterin;
neopterins;
pterin phosphate		Escherichia coli metabolite;
mouse metabolite
deoxyinosine monophosphate[no description available]low00deoxyinosine phosphate;
purine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
2'-deoxyinosine triphosphate[no description available]low00deoxyinosine phosphate;
purine 2'-deoxyribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite
gdp-4-keto-6-deoxymannose[no description available]low00GDP-sugarEscherichia coli metabolite;
mouse metabolite
guanosine diphosphate mannose[no description available]low00GDP-D-mannoseEscherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
guanosine pentaphosphate[no description available]low00guanosine 5'-phosphate;
guanosine bisphosphate		Escherichia coli metabolite;
mouse metabolite
inosinic acid[no description available]low00inosine phosphate;
purine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
inosine triphosphate[no description available]low00inosine phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
3'-guanylic acid[no description available]low00guanosine 3'-phosphate;
purine ribonucleoside 3'-monophosphate		Escherichia coli metabolite
2',3'-cyclic gmp[no description available]low002',3'-cyclic purine nucleotideEscherichia coli metabolite
rifampin[no description available]low00cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
leucovorin[no description available]low00formyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
5,10-methenyltetrahydrofolate[no description available]low00methylenetetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
10-formyltetrahydrofolate[no description available]low00formyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
colibactin[no description available]low001,3-thiazoles;
azaspiro compound;
polyketide;
pyrroline;
secondary carboxamide		alkylating agent;
carcinogenic agent;
Escherichia coli metabolite;
genotoxin
levodopa[no description available]low00amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
3-methoxytyrosine[no description available]low00aromatic L-alpha-amino acid zwitterion;
L-tyrosine derivative;
monomethoxybenzene;
non-proteinogenic L-alpha-amino acid		human metabolite
ethyl n-alpha-acetyl-tyrosinate[no description available]low00acetamides;
ethyl ester;
L-tyrosine derivative;
phenols
methyldopa[no description available]low00L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
benzoyltyrosine ethyl ester[no description available]low00benzamides;
ethyl ester;
L-tyrosine derivative;
phenols		chromogenic compound
droxidopa[no description available]low00catechols;
L-tyrosine derivative		antihypertensive agent;
prodrug;
vasoconstrictor agent
3-chloro-L-tyrosine[no description available]low00chloroamino acid;
L-alpha-amino acid zwitterion;
L-tyrosine derivative;
monochlorobenzenes;
non-proteinogenic L-alpha-amino acid		biomarker;
human metabolite
tyrosinamide[no description available]low00amino acid amide;
L-tyrosine derivative
methyl-3-tyrosine[no description available]low00amino acid zwitterion;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
2-s-cysteinyldopa[no description available]low00amino dicarboxylic acid;
aryl sulfide;
catechols;
diamine;
L-tyrosine derivative;
S-conjugate;
S-organyl-L-cysteine		human urinary metabolite
n-hydroxytyrosine[no description available]low00L-tyrosine derivative;
N-hydroxy-alpha-amino-acid
metyrosine[no description available]low00L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		antihypertensive agent;
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
lysine tyrosylquinone[no description available]low001,2-benzoquinones;
L-lysine derivative;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
ornithine[no description available]low00non-proteinogenic L-alpha-amino acid;
ornithine		algal metabolite;
hepatoprotective agent;
mouse metabolite
homoarginine[no description available]low00homoarginine;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid		biomarker;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
human metabolite;
rat metabolite;
xenobiotic metabolite
diazooxonorleucine[no description available]low00amino acid zwitterion;
diazo compound;
ketone;
non-proteinogenic L-alpha-amino acid		analgesic;
antibacterial agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
bacterial metabolite;
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor;
EC 3.5.1.2 (glutaminase) inhibitor;
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor;
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor;
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor;
glutamine antagonist
norleucine[no description available]low002-aminohexanoic acid;
L-alpha-amino acid zwitterion;
non-proteinogenic L-alpha-amino acid
3-methylhistidine[no description available]low00L-histidine derivative;
non-proteinogenic L-alpha-amino acid;
zwitterion		human metabolite;
Saccharomyces cerevisiae metabolite
homocitrulline[no description available]low00amino acid zwitterion;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid;
ureas		human metabolite;
mouse metabolite
cystine[no description available]low00cystine zwitterion;
cystine;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
djenkolic acid[no description available]low00dithioacetal;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid		plant metabolite;
toxin
furanomycin[no description available]low00dihydrofuran;
non-proteinogenic L-alpha-amino acid		antibacterial agent;
antimicrobial agent;
bacterial metabolite
biocytin[no description available]low00azabicycloalkane;
L-alpha-amino acid zwitterion;
L-lysine derivative;
monocarboxylic acid amide;
non-proteinogenic L-alpha-amino acid;
thiabicycloalkane;
ureas		mouse metabolite
o-methylserine[no description available]low00L-serine derivative;
non-proteinogenic L-alpha-amino acid		metabolite
methionine sulfoximine[no description available]low00L-alpha-amino acid zwitterion;
L-methionine derivative;
methionine sulfoximine;
non-proteinogenic L-alpha-amino acid		EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor;
geroprotector
1-methylhistidine[no description available]low00L-histidine derivative;
non-proteinogenic L-alpha-amino acid;
zwitterion		human metabolite
albizziin[no description available]low00non-proteinogenic L-alpha-amino acid
s-2-aminoethyl cysteine[no description available]low00L-cysteine thioether;
non-proteinogenic L-alpha-amino acid		EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor;
metabolite;
protein synthesis inhibitor
beta-n-methylamino-l-alanine[no description available]low00diamino acid;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid;
secondary amino compound		bacterial metabolite;
neurotoxin
4-ketoproline[no description available]low004-oxoproline;
amino acid zwitterion;
L-proline derivative;
non-proteinogenic L-alpha-amino acid
s-methylthiocitrulline[no description available]low00imidothiocarbamic ester;
L-arginine derivative;
L-ornithine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
neuroprotective agent
indospicine[no description available]low00carboxamidine;
non-proteinogenic L-alpha-amino acid		hepatotoxic agent;
plant metabolite
coprine[no description available]low00cyclopropanes;
dicarboxylic acid monoamide;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite;
mycotoxin
tabtoxinine beta-lactam[no description available]low00beta-lactam antibiotic;
monobactam;
non-proteinogenic L-alpha-amino acid;
tertiary alpha-hydroxy ketone		apoptosis inducer;
bacterial metabolite;
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor
pentosidine[no description available]low00imidazopyridine;
non-proteinogenic L-alpha-amino acid		biomarker;
cross-linking reagent
mannopine[no description available]low00amino acid opine;
dicarboxylic acid monoamide;
hexitol derivative;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid;
secondary amino compound		plant metabolite
dansyllysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid;
sulfonamide		epitope
deoxyhypusine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid		human metabolite
2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine[no description available]low00L-lysine derivative;
N-substituted pyrraline;
non-proteinogenic L-alpha-amino acid
n(6)-carboxymethyllysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid		antigen
n,n-dimethylarginine[no description available]low00dimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor
5-fluorowillardiine[no description available]low00L-alanine derivative;
non-proteinogenic L-alpha-amino acid;
organofluorine compound		AMPA receptor agonist
4-fluorothreonine[no description available]low00amino acid zwitterion;
fluoroamino acid;
L-threonine derivative;
non-proteinogenic L-alpha-amino acid
ovothiol a[no description available]low00aryl thiol;
L-alpha-amino acid zwitterion;
L-histidine derivative;
non-proteinogenic L-alpha-amino acid		antioxidant;
marine metabolite;
radical scavenger
selenomethylselenocysteine[no description available]low00amino acid zwitterion;
L-selenocysteine derivative;
non-proteinogenic L-alpha-amino acid;
Se-methylselenocysteine		antineoplastic agent
vinylglycine[no description available]low00glycine derivative;
L-alpha-amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor
i-677[no description available]low00L-serine derivative;
non-proteinogenic L-alpha-amino acid		antimetabolite;
antimicrobial agent;
antineoplastic agent;
metabolite
allysine[no description available]low00allysine;
amino acid zwitterion;
aminoadipate semialdehyde;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
kynurenine[no description available]low00amino acid zwitterion;
kynurenine;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
n(5)-hydroxy-l-arginine[no description available]low00hydroxy-L-arginine;
non-proteinogenic L-alpha-amino acid
felinine[no description available]low00L-cysteine thioether;
non-proteinogenic L-alpha-amino acid;
S-alkyl-L-cysteine zwitterion		mammalian metabolite;
pheromone
serine o-sulfate[no description available]low00L-serine derivative;
non-proteinogenic L-alpha-amino acid;
O-sulfoamino acid
epsilon-n-methyllysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid
trifluoromethionine[no description available]low00L-methionine derivative;
non-proteinogenic L-alpha-amino acid;
organofluorine compound
cysteinesulfenic acid[no description available]low00L-cysteine derivative;
non-proteinogenic L-alpha-amino acid
symmetric dimethylarginine[no description available]low00amino acid zwitterion;
dimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor
delta-n-methylarginine[no description available]low00guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
2-amino-4-phosphonobutyric acid[no description available]low00non-proteinogenic L-alpha-amino acid;
phosphonic acids		metabotropic glutamate receptor agonist
epsilon n-dimethyllysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid
carbocysteine[no description available]low00L-cysteine thioether;
non-proteinogenic L-alpha-amino acid		mucolytic
acivicin[no description available]low00isoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
canavanine[no description available]low00amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		phytogenic insecticide;
plant metabolite
5-hydroxytryptophan[no description available]low005-hydroxytryptophan;
amino acid zwitterion;
hydroxy-L-tryptophan;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite;
plant metabolite
agaritine[no description available]low00amino acid zwitterion;
benzyl alcohols;
carbohydrazide;
L-glutamic acid derivative;
non-proteinogenic L-alpha-amino acid
n'-formylkynurenine[no description available]low00amino acid zwitterion;
N-formylkynurenine;
non-proteinogenic amino acid derivative;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
3,5-dichlorotyrosine[no description available]low00chloroamino acid;
dichlorobenzene;
dihalogenated L-tyrosine;
non-proteinogenic L-alpha-amino acid
nitroarginine[no description available]low00guanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
willardiine[no description available]low00amino acid zwitterion;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid
mimosine[no description available]low004-pyridones;
amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		EC 1.14.18.1 (tyrosinase) inhibitor;
plant metabolite
canaline[no description available]low00amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		antimetabolite;
antineoplastic agent;
phytogenic insecticide;
plant metabolite
2,5-dihydrophenylalanine[no description available]low00non-proteinogenic L-alpha-amino acid
3,5-dihydroxyphenylglycine[no description available]low00amino acid zwitterion;
non-proteinogenic L-alpha-amino acid;
resorcinols
methionine sulfone[no description available]low00L-alpha-amino acid zwitterion;
L-methionine derivative;
methionine sulfone;
non-proteinogenic L-alpha-amino acid		animal metabolite
(S)-ATPA[no description available]low00isoxazoles;
non-proteinogenic L-alpha-amino acid		metabolite
azaserine[no description available]low00carboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite
4-fluorophenyl-L-alanine[no description available]low004-fluorophenylalanine;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid
o-methyl threonine[no description available]low00ether;
L-threonine derivative;
non-proteinogenic L-alpha-amino acid		antibacterial agent;
bleaching agent
n(6)-(1-iminoethyl)lysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid
glycerophosphoserine[no description available]low00glycerol 1-phosphodiester;
L-serine derivative;
non-proteinogenic L-alpha-amino acid
7-chlorotryptophan[no description available]low007-chlorotryptophan;
amino acid zwitterion;
L-tryptophan derivative;
non-proteinogenic L-alpha-amino acid
leukotriene e4[no description available]low00amino dicarboxylic acid;
L-cysteine thioether;
leukotriene;
non-proteinogenic L-alpha-amino acid;
secondary alcohol
domoic acid[no description available]low00L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid;
tricarboxylic acid		algal metabolite;
hapten;
marine metabolite;
neuromuscular agent;
neurotoxin
4-chlorothreonine[no description available]low00chloroamino acid;
L-threonine derivative;
non-proteinogenic L-alpha-amino acid
cilastatin[no description available]low00carboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide		EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
3-tyrosine[no description available]low00hydroxyphenylalanine;
L-alpha-amino acid zwitterion;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
phenols		plant metabolite
(S)-2-amino-6-boronohexanoic acid[no description available]low00non-proteinogenic L-alpha-amino acid;
organoboron compound
6-bromotryptophan[no description available]low00aromatic L-alpha-amino acid zwitterion;
bromoamino acid;
bromoindole;
L-alpha-amino acid zwitterion;
L-tryptophan derivative;
non-proteinogenic L-alpha-amino acid
6-chlorotryptophan[no description available]low00L-alpha-amino acid zwitterion;
L-tryptophan derivative;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
anticapsin[no description available]low00alicyclic ketone;
epoxide;
L-alanine derivative;
L-alpha-amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		antimetabolite;
antimicrobial agent;
bacterial metabolite;
EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitor
n(6)-(1-carboxyethyl)lysine[no description available]low00L-lysine derivative;
non-proteinogenic L-alpha-amino acid
ConditionIndicatedRelationship StrengthStudiesTrials
(pPNET) Peripheral Primitive Neuroectodermal Tumors0low10
47,XX,+210low30
47,XY,+210low30
Abnormalities, Autosome0low10
Abnormalities, Chromosomal0low10
Abnormalities, Chromosome0low10
Abnormalities, Multiple0low10
Absence Seizure0low40
Absence Seizures0low40
Achondroplasia0low10
Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans0low10
Acidosis0low10
Acoustic Neurinoma, Bilateral0low10
Acoustic Neuroma0low10
Acoustic Neuroma, Cerebellopontine Angle0low10
Acoustic Schwannomas, Bilateral0low10
Acoustic Tumor0low10
Acquired Immune Deficiency Syndrome0low30
Acquired Immuno-Deficiency Syndrome0low30
Acquired Immunodeficiency Syndrome0low30
Acrocephalosyndactylia0low10
Acrocephalosyndactyly (Apert)0low10
Acrocephalosyndactyly III0low10
Acrocephalosyndactyly, Type 10low10
Acrocephalosyndactyly, Type 30low10
Acrocephalosyndactyly, Type I0low10
Acrocephalosyndactyly, Type II0low10
Acrocephalosyndactyly, Type III0low10
Acrocephalosyndactyly, Type V0low10
Acrocephaly, Skull Asymmetry, and Mild Syndactyly0low10
Acute Confusional Senile Dementia0low270
Acute Coronary Syndrome0low10
Acute Disease0low100
Acute Edematous Pancreatitis0low10
Acute Kidney Failure0low10
Acute Kidney Injury0low10
Acute Kidney Insufficiency0low10
Acute Liver Injury, Drug-Induced0low10
Acute Lung Injury0low20
Acute Lymphoid Leukemia0low70
Acute Myelogenous Leukemia0medium221
Acute Myeloid Leukemia0medium221
Acute Myeloid Leukemia with Maturation0medium221
Acute Myeloid Leukemia without Maturation0medium221
Acute Pancreatitis0low10
Acute Promyelocytic Leukemia0low80
Acute Renal Failure0low10
Acute Renal Injury0low10
Acute Renal Insufficiency0low10
Acute-Phase Reaction0low20
Acute-Phase State0low20
Addiction, Opioid0low10
Addison Disease and Cerebral Sclerosis0low10
Adenocarcinoma0low180
Adenocarcinoma Of Kidney0low40
Adenocarcinoma of Lung0low10
Adenocarcinoma, Basal Cell0low180
Adenocarcinoma, Granular Cell0low180
Adenocarcinoma, Oxyphilic0low180
Adenocarcinoma, Renal0low40
Adenocarcinoma, Renal Cell0low40
Adenocarcinoma, Tubular0low180
Adenoma0low30
Adenoma, Basal Cell0low30
Adenoma, beta-Cell0low30
Adenoma, Follicular0low30
Adenoma, Malignant0low180
Adenoma, Microcystic0low30
Adenoma, Monomorphic0low30
Adenoma, Papillary0low30
Adenoma, Pleomorphic0low10
Adenoma, Prostatic0low20
Adenoma, Trabecular0low30
Adenomatosis, Ovine Pulmonary0low10
Adenomatosis, Pulmonary, Ovine0low10
Adenomatous Polyposis Coli0low20
Adenomatous Polyposis Coli, Familial0low20
Adenomatous Polyposis of the Colon0low20
Adjuvant Arthritis0low20
ADPKD0low10
Adrenal Cancer0low170
Adrenal Gland Cancer0low170
Adrenal Gland Neoplasms0low170
Adrenal Neoplasm0low170
Adrenoleukodystrophy0low10
Adrenoleukodystrophy, Autosomal Neonatal Form0low10
Adrenoleukodystrophy, Autosomal, Neonatal Form0low10
Adrenoleukodystrophy, Neonatal0low10
Adrenomyeloneuropathy0low10
Adult Polycystic Kidney Disease0low10
Adult Polycystic Kidney Disease Type 10low10
Adult Polycystic Kidney Disease Type 20low10
Adult Premature Aging Syndrome0low10
Adult Progeria0low10
African Lymphoma0low90
Agammaglobulinemia0low40
Aganglionic Megacolon0low10
Aganglionosis, Colonic0low10
Aganglionosis, Rectosigmoid Colon0low10
Aganglionosis, Total Colonic0low10
Age-Related Memory Disorders0low20
Agenesis of Hemidiaphragm0low20
Aging0low220
AIDS0low30
AIDS Seroconversion0low10
AIDS Seropositivity0low10
AIDS, Murine0low10
Akinetic-Rigid Variant of Huntington Disease0low30
Alcohol Related Neurodevelopmental Disorder0low10
Alcohol-Related Birth Defects0low10
ALD (Adrenoleukodystrophy)0low10
Aldrich Syndrome0low30
Alexander Disease0low10
Alexander's Disease0low10
ALL, Childhood0low70
Allergic Contact Dermatitis0low10
Allergic Encephalomyelitis0low10
Allergic Encephalomyelitis, Experimental0low10
Allergic Reaction0low40
Allergy0low40
Alloxan Diabetes0low130
alpha 1-Antitrypsin Deficiency0low10
ALS - Amyotrophic Lateral Sclerosis0low10
Alzheimer Dementia0low270
Alzheimer Disease0low270
Alzheimer Disease, Early Onset0low270
Alzheimer Disease, Late Onset0low270
Alzheimer Sclerosis0low270
Alzheimer Syndrome0low270
Alzheimer Type Senile Dementia0low270
Alzheimer-Type Dementia (ATD)0low270
Alzheimer's Disease0low270
Alzheimer's Disease, Focal Onset0low270
Alzheimer's Diseases0low270
AML M30low80
Amyloid Deposits0low10
Amyloid Plaques0low10
Amyotrophic Lateral Sclerosis0low10
Amyotrophic Lateral Sclerosis With Dementia0low10
Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 10low10
Amyotrophic Lateral Sclerosis, Guam Form0low10
Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam0low10
Anaplastic Astrocytoma0low70
Anaplastic Large-Cell Lymphoma0low10
Anasarca0low10
Androgen-Independent Prostatic Cancer0low10
Androgen-Independent Prostatic Neoplasms0low10
Androgen-Insensitive Prostatic Cancer0low10
Androgen-Insensitive Prostatic Neoplasms0low10
Androgen-Resistant Prostatic Cancer0low10
Androgen-Resistant Prostatic Neoplasms0low10
Anemia0low20
Anemia, Cooley's0low20
Anemia, Erythroblastic0low20
Anemia, Mediterranean0low20
Anemia, Sickle Cell0low40
Aneuploid0low10
Aneuploid Cell0low10
Aneuploidy0low10
Angioblastic Meningioma0low20
Angiogenesis, Pathologic0low130
Angiogenesis, Pathological0low130
Angiomatosis, Bacillary0low10
Angiomatosis, Bacillary Epithelioid0low10
Angiomatosis, Epithelioid0low10
Angiomatous Meningioma0low20
Angiosarcoma0low10
Angle Tumor0low10
Animal Mammary Carcinoma0low50
ANLL0medium221
Anoxemia0low50
Anoxia0low50
Anoxia, Fetal0low10
Anterior Circulation Transient Ischemic Attack0low140
Anti-HIV Positivity0low10
Antibody Deficiency Syndrome0low30
Apert Syndrome0low10
Apert-Crouzon Disease0low10
Apoplexy0low20
Arachnoidal Cerebellar Sarcoma, Circumscribed0low10
Arteriosclerosis0low10
Arthritides, Bacterial0low10
Arthritis, Adjuvant0low20
Arthritis, Adjuvant-Induced0low20
Arthritis, Bacterial0low10
Arthritis, Collagen-Induced0low20
Arthritis, Experimental0low20
Arthritis, Infectious0low10
Arthritis, Rheumatoid0low50
Arthritis, Septic0low10
Arthritis, Suppurative0low10
Arthritis, Viral0low10
Asphyxia0low10
Asphyxia Neonatorum0low20
Asthma0low60
Asthma, Bronchial0low60
Astrocytoma0low70
Astrocytoma, Grade I0low70
Astrocytoma, Grade II0low70
Astrocytoma, Grade III0low70
Astrocytoma, Grade IV0low270
Astrocytoma, Protoplasmic0low70
Astrocytoma, Subependymal Giant Cell0low70
Astrocytosis0low30
Astroglioma0low70
Astrogliosis0low30
Asystole0low30
Ataxia Telangiectasia0low10
Ataxia Telangiectasia Syndrome0low10
Ataxia-Telangiectasia0low10
Atherogenesis0low10
Atherosclerosis0low10
ATLL0low70
Atonic Absence Seizure0low40
Atonic Absence Seizures0low40
Atonic Seizure0low40
Atonic Seizures0low40
Atrophy0low20
Atypical Ductal Hyperplasia0low10
Autoimmune Diabetes0low90
Autoimmune Disease0low10
Autoimmune Diseases0low10
Autoimmune Encephalomyelitis, Experimental0low10
Autoimmune Experimental Encephalomyelitis0low10
Autoimmune Thrombocytopenia0low10
Autoimmune Thrombocytopenic Purpura0low10
Autoimmune Thyroiditis0low10
Autosomal Chromosome Disorders0low10
Autosomal Dominant Cerebellar Ataxia, Type II0low10
Autosomal Dominant Polycystic Kidney0low10
Autosome Abnormalities0low10
Avian Sarcoma0low20
Axonotmesis0low10
B Virus Infection0low30
B-Cell Chronic Lymphocytic Leukemia0low100
B-Cell Leukemia0low40
B-Cell Leukemia, Chronic0low100
B-Cell Lymphoma0low140
B-Cell Malignancy, Low-Grade0low100
B-Lymphocytic Leukemia0low40
B-Lymphocytic Leukemia, Chronic0low100
B16 Melanoma0low100
Bacillary Angiomatosis0low10
Bacillary Peliosis0low10
Bacteremia0low10
Bacterial Arthritides0low10
Bacterial Arthritis0low10
Bacterial Infections, Gram-Negative0low10
Bacterial Infections, Gram-Positive0low10
Bare Lymphocyte Syndrome0low40
Bartonella bacilliformis Infection0low10
Bartonella Infections0low10
Bartonellosis0low10
Basophilic Leukemia, Acute0low290
Benign Cerebellar Neoplasms0low10
Benign Meningeal Neoplasms0low10
Benign Meningioma0low20
Benign Neoplasms0low580
Benign Neoplasms, Brain0low140
Benign Prostatic Hyperplasia0low20
beta Thalassemia0low20
beta-Cell Tumor0low30
beta-Thalassemia0low20
Bilateral Acoustic Neurofibromatosis0low10
Bilateral Wilms Tumor0low10
Bile Duct Cancer0low10
Bile Duct Neoplasms0low10
Black Fever0low10
Bladder Cancer0medium41
Bladder Neoplasms0medium41
Bladder Tumors0medium41
Blast Crisis0low50
Blast Phase0low50
Bleeding0low10
Blood Clot0low30
Blood Diseases0low10
Blood Poisoning0low30
Blood Pressure, High0low40
Blood Pressure, Low0low10
Blood Vessel Tumors0low10
Bloodstream Infection0low30
BLV Infections0low10
Bochdalek Hernia0low20
Bochdalek Hernias0low20
Body Weight0low150
Bone Cancer0low40
Bone Diseases0low10
Bone Loss, Osteoclastic0low90
Bone Neoplasms0low40
Bone Resorption0low90
Bovine Diseases0low10
Brain Cancer0low140
Brain Ischemia0low50
Brain Metastases0low140
Brain Neoplasm, Primary0low140
Brain Neoplasms0low140
Brain Neoplasms, Benign0low140
Brain Neoplasms, Malignant0low140
Brain Neoplasms, Malignant, Primary0low140
Brain Neoplasms, Primary Malignant0low140
Brain Stem Ischemia, Transient0low140
Brain Stem Transient Ischemic Attack0low140
Brain TIA0low140
Brain Tumor, Primary0low140
Brain Tumor, Recurrent0low140
Brain Tumors0low140
Brainstem Ischemia, Transient0low140
Brainstem Transient Ischemic Attack0low140
Branch Vein Occlusion0low10
Breast Cancer0medium1261
Breast Carcinoma0medium1261
Breast Neoplasms0medium1261
Breast Tumors0medium1261
Bright Disease0low10
Bronchial Asthma0low60
Bronchitis0low10
Bronze Schilder Disease0low10
Buckley Syndrome0low20
Burkitt Cell Leukemia0low90
Burkitt Leukemia0low90
Burkitt Lymphoma0low90
Burkitt Tumor0low90
Burkitt's Leukemia0low90
Burkitt's Lymphoma0low90
Burkitt's Tumor0low90
Burns0low40
Burns, Chemical0low10
Cachexia0low10
Cafe-au-Lait Spots with Pulmonic Stenosis0low10
Cancer0low580
Cancer of Bile Duct0low10
Cancer of Bladder0medium41
Cancer of Bone0low40
Cancer of Brain0low140
Cancer of Breast0medium1261
Cancer of Cervix0low30
Cancer of Colon0low220
Cancer of Duodenum0low10
Cancer of Endometrium0low20
Cancer of Esophagus0low50
Cancer of Eye0low10
Cancer of Gallbladder0low10
Cancer of Gastrointestinal Tract0low30
Cancer of Head0low70
Cancer of Head and Neck0low70
Cancer of Intestines0low10
Cancer of Kidney0low50
Cancer of Larynx0low10
Cancer of Liver0low350
Cancer of Lung0low420
Cancer of Mediastinum0low10
Cancer of Mouth0low20
Cancer of Nasopharynx0low20
Cancer of Neck0low70
Cancer of Ovary0low160
Cancer of Pancreas0low150
Cancer of Parotid0low20
Cancer of Pituitary0low40
Cancer of Prostate0low300
Cancer of Skin0low110
Cancer of Spleen0low10
Cancer of Stomach0low190
Cancer of Testis0low10
Cancer of the Adrenal Gland0low170
Cancer of the Bile Duct0low10
Cancer of the Bladder0medium41
Cancer of the Bone0low40
Cancer of the Brain0low140
Cancer of the Breast0medium1261
Cancer of the Cervix0low30
Cancer of the Colon0low220
Cancer of the Duodenum0low10
Cancer of the Endometrium0low20
Cancer of the Esophagus0low50
Cancer of the Eye0low10
Cancer of the Gallbladder0low10
Cancer of the Gastrointestinal Tract0low30
Cancer of the Head0low70
Cancer of the Head and Neck0low70
Cancer of the Intestines0low10
Cancer of the Kidney0low50
Cancer of the Larynx0low10
Cancer of the Liver0low350
Cancer of the Lung0low420
Cancer of the Mediastinum0low10
Cancer of the Mouth0low20
Cancer of the Nasopharynx0low20
Cancer of the Neck0low70
Cancer of the Ovary0low160
Cancer of the Pancreas0low150
Cancer of the Parotid0low20
Cancer of the Pituitary0low40
Cancer of the Prostate0low300
Cancer of the Retina0low10
Cancer of the Skin0low110
Cancer of the Spleen0low10
Cancer of the Stomach0low190
Cancer of the Testes0low10
Cancer of the Testis0low10
Cancer of the Thymus0low50
Cancer of the Thyroid0low40
Cancer of the Tongue0low10
Cancer of the Uterine Cervix0low30
Cancer of the Uterus0low10
Cancer of the Vulva0low10
Cancer of Thymus0low50
Cancer of Thyroid0low40
Cancer of Tongue0low10
Cancer of Uterus0low10
Cancer of Vulva0low10
Cancer, Hepatocellular0low350
Cancer, Retinal0low10
Canine Diseases0low20
Carcinogenesis0low80
Carcinoma0low240
Carcinoma in Situ0low10
Carcinoma of Endometrium0low20
Carcinoma, Anaplastic0low240
Carcinoma, Bronchial0low10
Carcinoma, Bronchogenic0low10
Carcinoma, Cribriform0low180
Carcinoma, Ductal, Breast0low50
Carcinoma, Ductal, Pancreatic0low30
Carcinoma, Ehrlich Tumor0low30
Carcinoma, Embryonal0low20
Carcinoma, Epidermoid0low460
Carcinoma, Granular Cell0low180
Carcinoma, Hepatocellular0low300
Carcinoma, Hypernephroid0low40
Carcinoma, Infiltrating Duct0low50
Carcinoma, Intraductal0low10
Carcinoma, Intraductal, Noninfiltrating0low10
Carcinoma, Intraepithelial0low10
Carcinoma, Invasive Ductal, Breast0low50
Carcinoma, Lewis Lung0low50
Carcinoma, Lobular0low20
Carcinoma, Mammary Ductal0low50
Carcinoma, Non-Small Cell Lung0low80
Carcinoma, Non-Small-Cell Lung0low80
Carcinoma, Oat Cell0low70
Carcinoma, Ovine Pulmonary0low10
Carcinoma, Pancreatic Ductal0low30
Carcinoma, Papillary0low40
Carcinoma, Planocellular0low460
Carcinoma, Preinvasive0low10
Carcinoma, Renal Cell0low40
Carcinoma, Small Cell0low70
Carcinoma, Spindle-Cell0low240
Carcinoma, Squamous0low460
Carcinoma, Squamous Cell0low460
Carcinoma, Squamous Cell of Head and Neck0low10
Carcinoma, Thymic0low50
Carcinoma, Tubular0low180
Carcinoma, Undifferentiated0low240
Carcinomatosis0low240
Cardiac Arrest0low30
Cardiac Diseases0low10
Cardiac Disorders0low10
Cardiac Hypertrophy0low40
Cardiomegaly0low40
Cardiomyopathy, Congestive0low10
Cardiomyopathy, Dilated0low10
Cardiomyopathy, Dilated, 1a0low10
Cardiomyopathy, Dilated, Autosomal Recessive0low10
Cardiomyopathy, Dilated, CMD1A0low10
Cardiomyopathy, Dilated, LMNA0low10
Cardiomyopathy, Dilated, With Conduction Defect 10low10
Cardiomyopathy, Dilated, with Conduction Deffect10low10
Cardiomyopathy, Familial Idiopathic0low10
Cardiomyopathy, Idiopathic Dilated0low10
Cardiopulmonary Arrest0low30
Carotid Circulation Transient Ischemic Attack0low140
Carrion Disease0low10
Carrion's Disease0low10
Castration-Resistant Prostatic Cancer0low10
Castration-Resistant Prostatic Neoplasms0low10
Cattle Diseases0low10
CD30-Positive Anaplastic Large-Cell Lymphoma0low10
CD30+ Anaplastic Large-Cell Lymphoma0low10
CD4-Positive T-Lymphocytopenia, Idiopathic0low10
CD4+ T-Lymphocytopenia0low10
CD4+ T-Lymphocytopenia, Idiopathic0low10
Celiac Disease0low30
Celiac Sprue0low30
Cell Transformation, Neoplastic0low1650
Cell Transformation, Viral0low1110
Central Nervous System Neoplasm0low10
Central Nervous System Neoplasms0low10
Central Nervous System Neoplasms, Primary0low10
Central Nervous System Tumor0low10
Central Nervous System Tumors0low10
Central Neurofibromatosis0low10
Central Retinal Vein Occlusion0low10
Cerebellar Cancer0low10
Cerebellar Degeneration with Slow Eye Movements0low10
Cerebellar Neoplasms0low10
Cerebellar Neoplasms, Benign0low10
Cerebellar Neoplasms, Malignant0low10
Cerebellar Neoplasms, Primary0low10
Cerebellar Tumors0low10
Cerebelloparenchymal Disorder I0low10
Cerebellopontine Angle Acoustic Neuroma0low10
Cerebellopontine Angle Tumor0low10
Cerebral Astrocytoma0low70
Cerebral Convexity Meningioma0low20
Cerebral Infarction, Middle Cerebral Artery0low10
Cerebral Ischemia0low50
Cerebral Ischemia, Transient0low140
Cerebral Stroke0low20
Cerebro-Hepato-Renal Syndrome0low10
Cerebrohepatorenal Syndrome0low10
Cerebrovascular Accident0low20
Cerebrovascular Accident, Acute0low20
Cerebrovascular Apoplexy0low20
Cerebrovascular Stroke0low20
Cervical Cancer0low30
Cervical Neoplasms0low30
Cervix Cancer0low30
Cervix Neoplasms0low30
Chancroid0low10
Charcot Disease0low10
Chemical and Drug Induced Liver Injury0low10
Chemical Burns0low10
Chemically-Induced Liver Toxicity0low10
Childhood Cerebral Astrocytoma0low70
Chlamydia Infections0low20
Cholangiocarcinoma0low10
Cholangiocellular Carcinoma0low10
Cholera Infantum0low20
Chondrosarcoma0low10
Chorea, Chronic Progressive Hereditary (Huntington)0low30
Choriocarcinoma0low10
Chotzen Syndrome0low10
Chromophil Renal Cell Carcinoma0low40
Chromophobe Renal Cell Carcinoma0low40
Chromosomal Aberrations0low10
Chromosomal Disorders0low10
Chromosomal Translocation0low60
Chromosomal Triplication0low10
Chromosome Aberrations0low10
Chromosome Abnormalities0low10
Chromosome Abnormality Disorders0low10
Chromosome Deletion0low50
Chromosome Disorders0low10
Chromosome Inversion0low20
Chronic Hepatitis C0low10
Chronic Kidney Failure0low10
Chronic Lymphocytic Leukemia0low100
Chronic Lymphocytic Thyroiditis0low10
Chronic Progressive Hereditary Chorea (Huntington)0low30
Cicatrix, Hypertrophic0low10
Circulatory Collapse0low10
Circulatory Failure0low10
Cirrhosis0low20
Cirrhosis, Liver0low20
Clear Cell Meningioma0low20
Clear Cell Renal Carcinoma0low40
Clear Cell Renal Cell Carcinoma0low40
Clonic Seizure0low40
Clonic Seizures0low40
CNS Neoplasm0low10
CNS Neoplasms0low10
Cognition Disorders0low20
Colitis0low20
Colitis Gravis0low10
Colitis, Ulcerative0low10
Collagen Arthritis0low20
Collagen Diseases0low10
Collecting Duct Carcinoma0low40
Collecting Duct Carcinoma (Kidney)0low40
Collecting Duct Carcinoma of the Kidney0low40
Colon Cancer0low220
Colon Neoplasms0low220
Colonic Aganglionosis0low10
Colonic Cancer0low220
Colonic Neoplasms0low220
Colorectal Cancer0low190
Colorectal Carcinoma0low190
Colorectal Neoplasms0low190
Colorectal Tumors0low190
Compensatory Hyperinsulinemia0low40
Complex Partial Seizure0low40
Complex Partial Seizures0low40
Complication, Postoperative0low10
Complications, Pregnancy0low10
Condition, Preneoplastic0low30
Conditions, Preneoplastic0low30
Congenital Diaphragmatic Defect0low20
Congenital Diaphragmatic Hernia0low20
Congenital Diaphragmatic Hernias0low20
Congenital Intestinal Aganglionosis0low10
Congenital Megacolon0low10
Congenital Myasthenia0low10
Congenital Myasthenia Gravis0low10
Congenital Myasthenic Syndrome0low10
Congenital Myasthenic Syndromes0low10
Congenital Myasthenic Syndromes, Postsynaptic0low10
Congenital Myasthenic Syndromes, Presynaptic0low10
Congenital Myotonic Dystrophy0low20
Congenital Slow-Channel Myasthenic Syndrome0low10
Congenital Slow-Channel Myasthenic Syndromes0low10
Congestive Cardiomyopathy0low10
Contact Dermatitis0low30
Convulsion0low40
Convulsion, Non-Epileptic0low40
Convulsions0low40
Convulsive Seizure0low40
Convulsive Seizures0low40
Coronary Restenosis0low10
Craniocervical Injuries0low10
Craniofacial-Skeletal-Dermatologic Dysplasia0low10
Crescendo Transient Ischemic Attacks0low140
Cronobacter Infections0low10
Cryptogenic Fibrosing Alveolitis0low10
Cryptosporidiosis0low10
Cryptosporidium Infection0low10
Curling Ulcer0low10
Curling's Ulcer0low10
Cutaneous T-Cell Lymphoma0low10
CVA (Cerebrovascular Accident)0low20
Cyst0low10
Cysts0low10
Cytogenetic Aberrations0low10
Cytogenetic Abnormalities0low10
Cytomegalic Inclusion Disease0low10
Cytomegalovirus0low50
Cytomegalovirus Infections0low10
DCIS0low10
Deficiency of GP 2b 3a Complex0low50
Deficiency Syndrome, Immunologic0low30
Deficiency Syndromes, Antibody0low30
Deficiency Syndromes, Immunologic0low30
Deficiency, Oxygen0low50
Deficiency, Protein0low10
Degenerative Diseases, Central Nervous System0low10
Degenerative Diseases, Nervous System0low10
Degenerative Diseases, Neurologic0low10
Degenerative Diseases, Spinal Cord0low10
Degenerative Neurologic Diseases0low10
Degenerative Neurologic Disorders0low10
Delayed Effects, Prenatal Exposure0low10
Delayed Hypersensitivity0low20
Delayed Puberty0low10
Deltaretrovirus Infections0low10
Dementia With Amyotrophic Lateral Sclerosis0low10
Dementia, Alzheimer Type0low270
Dementia, Presenile0low270
Dementia, Primary Senile Degenerative0low270
Dementia, Senile0low270
Dementias, Transmissible0low10
Demyelinogenic Leukodystrophy0low10
Dependence, Opioid0low10
Depression, Involutional0low10
Depressive Disorder, Major0low10
Dermatitis Venenata0low30
Dermatitis, Allergic Contact0low10
Dermatitis, Allergic Eczematous0low10
Dermatitis, Contact0low30
Dermatitis, Contact, Allergic0low10
Di Guglielmo Disease0low240
Di Guglielmo's Disease0low240
Diabetes Mellitus0low60
Diabetes Mellitus, Adult-Onset0low230
Diabetes Mellitus, Brittle0low90
Diabetes Mellitus, Experimental0low130
Diabetes Mellitus, Gestational0low20
Diabetes Mellitus, Insulin-Dependent0low90
Diabetes Mellitus, Insulin-Dependent, 10low90
Diabetes Mellitus, Juvenile-Onset0low90
Diabetes Mellitus, Ketosis-Prone0low90
Diabetes Mellitus, Ketosis-Resistant0low230
Diabetes Mellitus, Maturity-Onset0low230
Diabetes Mellitus, Non Insulin Dependent0low230
Diabetes Mellitus, Non-Insulin-Dependent0low230
Diabetes Mellitus, Noninsulin Dependent0low230
Diabetes Mellitus, Noninsulin-Dependent0low230
Diabetes Mellitus, Slow-Onset0low230
Diabetes Mellitus, Stable0low230
Diabetes Mellitus, Sudden-Onset0low90
Diabetes Mellitus, Type 10low90
Diabetes Mellitus, Type 20low230
Diabetes Mellitus, Type I0low90
Diabetes Mellitus, Type II0low230
Diabetes, Autoimmune0low90
Diabetes, Gestational0low20
Diabetes, Pregnancy-Induced0low20
Diabetic Glomerulosclerosis0low10
Diabetic Kidney Disease0low10
Diabetic Nephropathies0low10
Diabetic Nephropathy0low10
Diabetic Retinopathy0low40
Diaphragmatic Hernia0low20
Diarrhea0low30
Diffuse Large B-Cell Lymphoma0low50
Diffuse Large-Cell Lymphoma0low50
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated0low20
Diffuse Mixed Small and Large Cell Lymphoma0low20
Diffuse Mixed-Cell Lymphoma0low20
Diffuse Small Cleaved-Cell Lymphoma0low20
Diffuse Undifferentiated Lymphoma0low20
Diffuse Well-Differentiated Lymphocytic Lymphoma0low100
Diffuse, Large B-Cell, Lymphoma0low50
Dilated Cardiomyopathy0low10
Disease0low10
Disease Exacerbation0medium161
Disease Models, Animal0low350
Disease Progression0medium161
Disease Resistance0low10
Disease, Pulmonary0low20
Diseases of Immune System0low10
Diseases, Pulmonary0low20
Disrupted In B-Cell Malignancy0low100
Dog Diseases0low20
Dominantly-Inherited Spinocerebellar Ataxias0low10
Down Syndrome0low30
Down Syndrome, Partial Trisomy 210low30
Down's Syndrome0low30
Dropsy0low10
Drug-Induced Acute Liver Injury0low10
Drug-Induced Liver Disease0low10
Drug-Induced Liver Injury0low10
Duct-Cell Carcinoma of the Pancreas0low30
Duct-Cell Carcinoma, Pancreas0low30
Ductal Carcinoma In Situ0low10
Ductal Carcinoma of the Pancreas0low30
Duncan Disease0low40
Duncan's Syndrome0low40
Duodenal Cancer0low10
Duodenal Neoplasms0low10
Duodenal Ulcer0low10
Dwarfism, Thanatophoric0low10
Dysmyelinogenic Leukodystrophy0low10
Dysostosis Craniofacialis with Hypertelorism0low10
Dystrophia Myotonica0low20
Dystrophia Myotonica 10low20
Dystrophia Myotonica 20low20
E coli Infections0low30
E. coli Infection0low30
Early Onset Alzheimer Disease0low270
EBV Infections0low20
Eczema-Thrombocytopenia-Immunodeficiency Syndrome0low30
Eczema, Contact0low30
Edema0low10
Edema-Proteinuria-Hypertension Gestosis0low20
Edema, Pulmonary0low10
Edemas, Pulmonary0low10
Ehrlich Ascites Tumor0low30
EHS Tumor0low20
Elevated Cholesterol0low40
Embolic Infarction, Middle Cerebral Artery0low10
Embolus, Middle Cerebral Artery0low10
Encephalitis, Japanese0low10
Encephalitis, Japanese B0low10
Encephalomyelitis, Allergic0low10
Encephalomyelitis, Autoimmune, Experimental0low10
Encephalomyelitis, Experimental Autoimmune0low10
Encephalopathies, Spongiform, Transmissible0low10
Encephalopathy, Ischemic0low50
End-Stage Kidney Disease0low10
End-Stage Renal Disease0low10
Endogenous Hyperinsulinism0low40
Endometrial Cancer0low20
Endometrial Carcinoma0low20
Endometrial Diseases0low10
Endometrial Neoplasms0low20
Endometrioma0low10
Endometriosis0low10
Endometrium Cancer0low20
Endotoxemia0low10
Endotoxin Shock0low10
Enlarged Heart0low40
Enterobacteriaceae Infections0low10
Enterobacterial Infections0low10
Eosinophilia0low10
Eosinophilia, Tropical0low10
EPH Complex0low20
EPH Gestosis0low20
EPH Toxemias0low20
Epileptic Seizure0low40
Epileptic Seizures0low40
Epithelial Neoplasms, Malignant0low240
Epithelial Tumors, Malignant0low240
Epithelioma0low240
Epstein-Barr Virus Infection0low20
Epstein-Barr Virus Infection, Familial Fatal0low40
Epstein-Barr Virus Infections0low20
Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males0low40
ER-Negative PR-Negative HER2-Negative Breast Cancer0low10
ER-Negative PR-Negative HER2-Negative Breast Neoplasms0low10
Erythremia0low40
Erythremic Myelosis0low240
Erythroblastic Anemia0low20
Erythroblastic Leukemia, Acute0low240
Erythroleukemia0low240
Escherichia coli Infections0low30
Esophageal Cancer0low50
Esophageal Neoplasms0low50
Esophageal Squamous Cell Carcinoma0low10
Esophagus Cancer0low50
Esophagus Neoplasm0low50
ESRD0low10
Ewing Sarcoma0low20
Ewing Tumor0low20
Ewing's Sarcoma0low20
Ewing's Tumor0low20
Exertional Heat Illness0low10
Exertional Heat Stress0low10
Exogenous Hyperinsulinism0low40
Experimental Allergic Encephalomyelitis0low10
Experimental Autoimmune Encephalomyelitis0low10
Experimental Diabetes Mellitus0low130
Experimental Hepatoma0low330
Experimental Hepatomas0low330
Experimental Leukemia0low70
Experimental Leukemias0low70
Experimental Liver Neoplasms0low330
Experimental Mammary Neoplasms0low110
Experimental Melanoma0low100
Experimental Melanomas0low100
Experimental Neoplasms0low170
Experimental Sarcoma0low20
Experimental Sarcomas0low20
Extracranial Primitive Neuroectodermal Tumor0low10
Extrahepatic Cholangiocarcinoma0low10
Extravascular Hemolysis0low20
Eye Cancer0low10
Eye Cancer, Retinoblastoma0low30
Eye Neoplasms0low10
FAE (Fetal Alcohol Effects)0low10
Familial Acoustic Neuromas0low10
Familial Adenomatous Polyposis0low20
Familial Adenomatous Polyposis Coli0low20
Familial Adenomatous Polyposis of the Colon0low20
Familial Alzheimer Disease (FAD)0low270
Familial Fatal Epstein-Barr Infection0low40
Familial Idiopathic Pulmonary Fibrosis0low10
Familial Intestinal Polyposis0low20
Familial Multiple Polyposi0low20
Familial Multiple Polyposis0low20
Familial Multiple Polyposis Syndrome0low20
Familial Polyposis Coli0low20
Familial Polyposis of the Colon0low20
Familial Polyposis Syndrome0low20
Familial Retinoblastoma0low30
Far East Scarlet-like Fever0low10
FASD0low10
Fasting Hypoglycemia0low20
Fatty Liver, Nonalcoholic0low10
Fetal Alcohol Spectrum Disorder0low10
Fetal Alcohol Spectrum Disorders0low10
Fetal Alcohol Syndrome0low10
Fetal Anoxia0low10
Fetal Growth Restriction0low10
Fetal Growth Retardation0low10
Fetal Hypoxia0low10
Fibrillary Astrocytoma0low70
Fibrinoid Degeneration of Astrocytes0low10
Fibroadenoma0low10
Fibrocystic Pulmonary Dysplasia0low10
Fibroid0low10
Fibroid Tumor0low10
Fibroid Uterus0low10
Fibroids, Uterine0low10
Fibroma0low20
Fibroma, Shope0low10
Fibroma, Uterine0low10
Fibromatosis0low20
Fibromyoma0low10
Fibromyxoma0low20
Fibrosarcoma0low70
Fibrosing Alveolitis, Cryptogenic0low10
Fibrosis0low20
Fibrosis, Liver0low20
Fibrous Meningioma0low20
Focal Onset Alzheimer's Disease0low270
Foot Dermatoses0low10
Foot Dermatosis0low10
Fra(X) Syndrome0low10
Fragile X Mental Retardation Syndrome0low10
Fragile X Syndrome0low10
Fragile X-F Mental Retardation Syndrome0low10
FRAXA Syndrome0low10
FRAXE Syndrome0low10
Friedreich Ataxia0low10
Friedreich Disease0low10
Friedreich Familial Ataxia0low10
Friedreich Hereditary Ataxia0low10
Friedreich Hereditary Spinal Ataxia0low10
Friedreich Spinocerebellar Ataxia0low10
Friedreich's Ataxia0low10
Friedreich's Disease0low10
Friedreich's Familial Ataxia0low10
Friedreich's Hereditary Ataxia0low10
Friedreich's Hereditary Spinal Ataxia0low10
Functional Gastrointestinal Disorders0low20
Gall Bladder Cancer0low10
Gallbladder Cancer0low10
Gallbladder Neoplasms0low10
Gastric Cancer0low190
Gastric Cancer, Familial Diffuse0low190
Gastric Neoplasms0low190
Gastric Ulcer0low10
Gastritis0low10
Gastroduodenal Ulcer0low10
Gastrointestinal Cancer0low30
Gastrointestinal Diseases0low20
Gastrointestinal Disorders0low20
Gastrointestinal Disorders, Functional0low20
Gastrointestinal Neoplasms0low30
Gehrig's Disease0low10
Gemistocytic Astrocytoma0low70
Generalized Absence Seizure0low40
Generalized Absence Seizures0low40
Generalized Tonic-Clonic Seizures0low40
Genetic Predisposition0low30
Genetic Predisposition to Disease0low30
Genetic Susceptibility0low30
Germinoblastoma0low90
Gestational Diabetes0low20
Gestosis, EPH0low20
Giant Cell Glioblastoma0low270
Glanzmann Thrombasthenia0low50
Glanzmann Thrombasthenia, Type A0low50
Glaucoma0low10
Glial Cell Tumors0low220
Glial Scar0low30
Glioblastoma0low270
Glioblastoma Multiforme0low270
Glioblastoma, Retinal0low30
Glioma0low220
Glioma, Astrocytic0low70
Glioma, Retinal0low30
Gliosis0low30
Glomerulonephritis0low10
Glomerulonephritis, Lupus0low10
Glomerulosclerosis, Diabetic0low10
Glucose Intolerance0low50
Gluten Enteropathy0low30
Gluten-Sensitive Enteropathy0low30
Glycoprotein Complex IIb-IIIa, Deficiency Of0low50
Gout0low10
GP IIb-IIIa Complex, Deficiency Of0low50
Gram-Negative Bacterial Infections0low10
Gram-Positive Bacterial Infections0low10
Granular Cell Myoblastoma0low10
Granular Cell Tumor0low10
Granulocytic Leukemia0low250
Granulocytic Leukemia, Chronic0low420
Granulocytic Leukemia, Chronic, Stable Phase0low10
Granulocytic Leukemia, Chronic, Stable-Phase0low10
Granuloma, Hodgkin0low10
Granuloma, Hodgkin's0low10
Granuloma, Hodgkins0low10
Granuloma, Malignant0low10
Granulomatous Slack Skin0low10
Grawitz Tumor0low40
Growth Disorders0low10
Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction0low10
Growth Retardation, Intrauterine0low10
Guam Disease0low10
Guam Form of Amyotrophic Lateral Sclerosis0low10
Haemolysis0low20
Hand Dermatoses0low10
Hand Dermatosis0low10
Harding Passey Melanoma0low100
Hashimoto Disease0low10
Hashimoto Struma0low10
Hashimoto Thyroiditis0low10
Hashimoto's Disease0low10
Hashimoto's Struma0low10
Hashimoto's Syndrome0low10
HbS Disease0low40
Head and Neck Cancer0low70
Head and Neck Neoplasm0low70
Head and Neck Neoplasms0low70
Head and Neck Squamous Cell Carcinoma0low10
Head And Neck Squamous Cell Carcinomas0low10
Head Cancer0low70
Head Neoplasm0low70
Head Neoplasms0low70
Head, Neck Neoplasms0low70
Heart Arrest0low30
Heart Disease, Ischemic0low10
Heart Diseases0low10
Heart Disorders0low10
Heart Enlargement0low40
Heart Hypertrophy0low40
Heat Cramps0low10
Heat Fatigue0low10
Heat Illness0low10
Heat Stress Disorders0low10
Heat Stress Syndromes0low10
Heat Syncope0low10
Helicobacter Infections0low100
Hemangioblastic Meningioma0low20
Hemangiopericytic Meningioma0low20
Hemangiosarcoma0low10
Hematologic Diseases0low10
Hematologic Malignancies0low10
Hematologic Malignancy0low10
Hematologic Neoplasms0low10
Hematological Diseases0low10
Hematological Malignancies0low10
Hematological Neoplasms0low10
Hematopoietic Malignancies0low10
Hematopoietic Neoplasms0low10
Hemoglobin F Disease0low20
Hemoglobin S Disease0low40
Hemoglobin SC Disease0low10
Hemoglobinopathies0low10
Hemolysis0low20
Hemorrhage0low10
Hemorrhage, Subarachnoid0low20
Hemorrhagic Diathesis0low10
Hemorrhagic Disorders0low10
Hepatic Cancer0low350
Hepatic Cirrhosis0low20
Hepatic Neoplasms0low350
Hepatitis C, Chronic0low10
Hepatitis, Drug-Induced0low10
Hepatitis, Toxic0low10
Hepatitis, Viral, Animal0low10
Hepatoblastoma0low10
Hepatocellular Cancer0low350
Hepatocellular Carcinoma0low300
Hepatoma0low300
Hepatoma, Experimental0low330
Hepatoma, Morris0low330
Hepatoma, Novikoff0low330
Hepatomas, Experimental0low330
Hereditary Polyposis Coli0low20
Hereditary Retinoblastoma0low30
Hereditary Spinal Ataxia, Friedreich0low10
Hereditary Spinal Ataxia, Friedreich's0low10
Hereditary Spinal Sclerosis0low10
Hernia, Diaphragmatic0low20
Hernias, Diaphragmatic, Congenital0low20
Herpes Simplex0low10
Herpes Simplex Keratitis0low10
Herpes Simplex Virus Infection0low10
Herpes Simplex, Ocular0low10
Herpesviridae Infections0low30
Herpesvirus 4 Infections, Human0low20
Herpesvirus Infections0low30
HIE Syndrome0low20
HIES, Autosomal Dominant0low20
HIES, Autosomal Recessive0low20
High Cholesterol Levels0low40
Hirschsprung Disease0low10
Hirschsprung's Disease0low10
Histiocytic Lymphoma0low50
Histiocytic Lymphoma, Diffuse0low50
HIV0low40
HIV Antibody Positivity0low10
HIV Coinfection0low50
HIV Infections0low50
HIV Seroconversion0low10
HIV Seropositivity0low10
HNSCC0low10
Hodgkin Disease0low10
Hodgkin Lymphoma0low10
Hodgkin Lymphoma, Adult0low10
Hodgkin's Disease0low10
Hodgkin's Lymphoma0low10
Hodgkins Disease0low10
Hormone Refractory Prostatic Cancer0low10
Hormone Refractory Prostatic Neoplasms0low10
HTLV I Associated T Cell Leukemia Lymphoma0low70
HTLV Infections0low10
HTLV-Associated Leukemia-Lymphoma0low70
HTLV-BLV Infections0low10
HTLV-I Infections0low20
HTLV-I-Associated T-Cell Leukemia-Lymphoma0low70
HTLV-III Infections0low50
HTLV-III Seroconversion0low10
HTLV-III Seropositivity0low10
HTLV-III-LAV Infections0low50
Human Herpes Virus 4 Infections0low20
Human Herpesvirus 4 Infections0low20
Human Mammary Carcinoma0medium1261
Human T Lymphotropic Virus Associated Leukemia Lymphoma0low70
Human T Lymphotropic Virus-Associated Leukemia-Lymphoma0low70
Human T-Cell Leukemia-Lymphoma0low70
Human T-lymphotropic Virus 1 Infection0low20
Human T-lymphotropic Virus 1 Infections0low20
Human Transmissible Spongiform Encephalopathies, Inherited0low10
Huntington Chorea0low30
Huntington Chronic Progressive Hereditary Chorea0low30
Huntington Disease0low30
Huntington Disease, Akinetic-Rigid Variant0low30
Huntington Disease, Juvenile0low30
Huntington Disease, Juvenile-Onset0low30
Huntington Disease, Late Onset0low30
Huntington's Chorea0low30
Huntington's Disease0low30
Hydrops0low10
Hyper-IgE Recurrent Infection Syndrome, Autosomal Recessive0low20
Hyper-IgE Syndrome0low20
Hyper-IgE Syndrome, Autosomal Dominant0low20
Hyper-IgE Syndrome, Autosomal Recessive0low20
Hyper-Immunoglobulin E Syndrome, Autosomal Dominant0low20
Hyper-Immunoglobulin E Syndrome, Autosomal Recessive0low20
Hypercholesteremia0low40
Hypercholesterolemia0low40
Hyperglycemia0low30
Hyperglycemia, Postprandial0low30
Hypergonadotropic Hypogonadism0low10
Hyperhomocysteinemia0low10
Hyperimmunoglobulin E-Recurrent Infection Syndrome0low20
Hyperimmunoglobulin E, Recurrent Infection Syndrome0low20
Hyperimmunoglobulinemia E Syndrome0low20
Hyperinsulinemia0low40
Hyperinsulinism0low40
Hypernephroma0low40
Hyperoxia0low20
Hyperpipecolatemia0low10
Hyperpipecolic Acidemia0low10
Hyperplasia0low40
Hypersensitivity0low40
Hypersensitivity, Contact0low30
Hypersensitivity, Delayed0low20
Hypersensitivity, Tuberculin-Type0low20
Hypersensitivity, Type IV0low20
Hypertension0low40
Hypertension-Edema-Proteinuria Gestosis0low20
Hypertension, Pulmonary0low20
Hypertriglyceridemia0low10
Hypertrophy0low10
Hypogammaglobulinemia0low40
Hypoglycemia0low20
Hypogonadism0low10
Hypogonadism, Isolated Hypogonadotropic0low10
Hypogonadotropic Hypogonadism0low10
Hypopharyngeal Squamous Cell Carcinoma0low10
Hypospermatogenesis0low10
Hypotension0low10
Hypotension, Vascular0low10
Hypovolemic Shock0low10
Hypoxemia0low50
Hypoxia0low50
IDDM0low90
Idiopathic CD4 Positive T-Lymphocytopenia0low10
Idiopathic CD4-Positive T-Lymphocytopenia0low10
Idiopathic CD4+ T-Lymphocytopenia0low10
Idiopathic Fibrosing Alveolitis, Chronic Form0low10
Idiopathic Parkinson Disease0low10
Idiopathic Parkinson's Disease0low10
Idiopathic Proctocolitis0low10
Idiopathic Pulmonary Fibrosis0low10
Idiopathic Pulmonary Fibrosis, Familial0low10
Idiopathic Thrombocytopenic Purpura0low10
Imd20low30
Immune Diseases0low10
Immune Disorders0low10
Immune System Diseases0low10
Immune System Disorders0low10
Immune Thrombocytopenia0low10
Immune Thrombocytopenic Purpura0low10
Immunodeficiency 20low30
Immunodeficiency 50low40
Immunodeficiency Syndrome, Acquired0low30
Immunodeficiency Syndrome, Severe Combined0low40
Immunodeficiency, Severe Combined0low40
Immunodeficiency, X-Linked Progressive Combined Variable0low40
Immunologic Deficiency Syndrome0low30
Immunologic Deficiency Syndrome, Acquired0low30
Immunologic Deficiency Syndromes0low30
Immunologic Deficiency, Severe Combined0low40
Immunologic Diseases0low10
Immunological Deficiency Syndromes0low30
Immunological Diseases0low10
Impaired Glucose Tolerance0low50
Inadequate Sleep0low10
Inclusion Disease0low10
Infarction, Middle Cerebral Artery0low10
Infection0low10
Infection and Infestation0low10
Infections0low10
Infections and Infestations0low10
Infections, Bartonella0low10
Infections, Chlamydia0low20
Infections, Cytomegalovirus0low10
Infections, E coli0low30
Infections, EBV0low20
Infections, Enterobacteriaceae0low10
Infections, Enterobacterial0low10
Infections, Epstein-Barr Virus0low20
Infections, Escherichia coli0low30
Infections, Gram-Negative Bacterial0low10
Infections, Gram-Positive Bacterial0low10
Infections, Helicobacter0low100
Infections, Herpesviridae0low30
Infections, Herpesvirus0low30
Infections, HTLV-I0low20
Infections, Legionella pneumophila0low10
Infections, Listeria0low10
Infections, Plasmodium0low10
Infections, Reoviridae0low10
Infections, Respiratory Syncytial Virus0low10
Infections, Rochalimaea0low10
Infections, Salmonella0low10
Infections, Staphylococcal0low10
Infections, Taenia0low10
Infections, Tumor Virus0low10
Infections, Yersinia0low10
Infections, Yersinia pseudotuberculosis0low10
Infectious Arthritis0low10
Infertility0low20
Infertility, Male0low20
Inflammation0low250
Inflammatory Bowel Disease, Ulcerative Colitis Type0low10
Inherited Human Transmissible Spongiform Encephalopathies0low10
Injuries0low20
Injuries and Wounds0low20
Injuries, Nervous System0low10
Injuries, Wounds0low20
Injury, Ischemia-Reperfusion0low60
Injury, Reperfusion0low60
Innate Inflammatory Response0low250
Insufficient Sleep0low10
Insufficient Sleep Syndrome0low10
Insulin Resistance0low550
Insulin Sensitivity0low550
Insulin-Dependent Diabetes Mellitus 10low90
Insulinoma0low30
Insuloma0low30
Interstitial Cell Tumor0low10
Interstitial Pneumonitis, Usual0low10
Intestinal Cancer0low10
Intestinal Neoplasms0low10
Intestinal Polyps0low10
Intestines Cancer0low10
Intestines Neoplasms0low10
Intracapillary Glomerulosclerosis0low10
Intracranial Astrocytoma0low70
Intracranial Meningeal Neoplasms0low10
Intracranial Meningioma0low20
Intracranial Neoplasms0low140
Intraductal Carcinoma, Noninfiltrating0low10
Intraepithelial Neoplasms0low10
Intraepithelial Prostatic Neoplasia0low10
Intrahepatic Cholangiocarcinoma0low10
Intraocular Pressure0low10
Intraorbital Meningioma0low20
Intrauterine Growth Restriction0low10
Intrauterine Growth Retardation0low10
Intravascular Hemolysis0low20
Intraventricular Meningioma0low20
Invasive Ductal Carcinoma, Breast0low50
Invasiveness, Neoplasm0low500
Inversion, Chromosomal0low20
Inversion, Chromosome0low20
Ischemia0low50
Ischemia-Reperfusion Injury0low60
Ischemia, Cerebral0low50
Ischemia, Myocardial0low10
Ischemic Attack, Transient0low140
Ischemic Encephalopathy0low50
Ischemic Heart Disease0low10
Jaagsiekte0low10
Jacksonian Seizure0low40
Japanese B Encephalitis0low10
Japanese B Viral Encephalitis0low10
Japanese Encephalitis0low10
Job Syndrome0low20
Job-Buckley Syndrome0low20
Job's Syndrome0low20
Juvenile Huntington Disease0low30
Juvenile Pilocytic Astrocytoma0low70
Juvenile-Onset Diabetes0low90
Juvenile-Onset Huntington Disease0low30
Kahler Disease0low120
Kala-Azar0low10
Kaposi Sarcoma0low40
Kaposi's Sarcoma0low40
Keloid0low10
Keratitis, Herpetic0low10
Ki-1 Lymphoma0low10
Kidney Cancer0low50
Kidney Failure, Acute0low10
Kidney Failure, Chronic0low10
Kidney Insufficiency, Acute0low10
Kidney Neoplasms0low50
Kidney Scarring0low10
Kidney, Polycystic, Autosomal Dominant0low10
Kimmelstiel-Wilson Disease0low10
Kimmelstiel-Wilson Syndrome0low10
Koch's Disease0low20
Kochs Disease0low20
Kurczynski Casperson Syndrome0low10
Large Lymphoid Lymphoma, Diffuse0low50
Large-Cell Lymphoma, Diffuse0low50
Laryngeal Cancer0low10
Laryngeal Neoplasms0low10
Laryngeal Squamous Cell Carcinoma0low10
Larynx Cancer0low10
Larynx Neoplasms0low10
Late Effects, Prenatal Exposure0low10
Late Onset Alzheimer Disease0low270
Late-Onset Huntington Disease0low30
Left Middle Cerebral Artery Infarction0low10
Legionella pneumophila Infections0low10
Legionnaire Disease0low10
Legionnaires' Disease0low10
Leiomyoma0low10
Leiomyoma, Uterine0low10
Leishmania Infection0low10
Leishmaniasis0low10
Leishmaniasis, Visceral0low10
Leptomeningeal Neoplasms0low10
Lesion of Sciatic Nerve0low10
Leucocythaemia0low190
Leucocythemia0low190
Leukemia0low190
Leukemia L 12100low50
Leukemia L12100low50
Leukemia L51780low10
Leukemia Lymphoma, Adult T Cell0low70
Leukemia Lymphoma, T Cell, Acute, HTLV I Associated0low70
Leukemia Model, Animal0low70
Leukemia P3880low10
Leukemia-Lymphoma, Adult T-Cell0low70
Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated0low70
Leukemia, Acute Lymphoblastic0low70
Leukemia, Acute Monocytic0low10
Leukemia, Acute Myelogenous0medium221
Leukemia, Acute Myeloid0medium221
Leukemia, Acute Promyelocytic0low80
Leukemia, Adult T-Cell0low70
Leukemia, B Cell, Chronic0low100
Leukemia, B-Cell0low40
Leukemia, B-Cell, Chronic0low100
Leukemia, Basophilic, Acute0low290
Leukemia, Chronic Lymphatic0low100
Leukemia, Chronic Lymphocytic0low100
Leukemia, Chronic Lymphocytic, B-Cell0low100
Leukemia, Chronic Myelogenous0low420
Leukemia, Chronic Myeloid0low420
Leukemia, Erythroblastic, Acute0low240
Leukemia, Experimental0low70
Leukemia, Granulocytic0low250
Leukemia, Granulocytic, Chronic0low420
Leukemia, Granulocytic, Chronic Phase0low10
Leukemia, Granulocytic, Chronic-Phase0low10
Leukemia, Lymphoblastic0low70
Leukemia, Lymphoblastic, Acute0low70
Leukemia, Lymphoblastic, Acute, L10low70
Leukemia, Lymphoblastic, Acute, L20low70
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0low70
Leukemia, Lymphoblastic, Burkitt-Type0low90
Leukemia, Lymphoblastic, Chronic0low100
Leukemia, Lymphocytic0low10
Leukemia, Lymphocytic, Acute0low70
Leukemia, Lymphocytic, Acute, L10low70
Leukemia, Lymphocytic, Acute, L20low70
Leukemia, Lymphocytic, B Cell0low40
Leukemia, Lymphocytic, B-Cell0low40
Leukemia, Lymphocytic, Chronic0low100
Leukemia, Lymphocytic, Chronic, B Cell0low100
Leukemia, Lymphocytic, Chronic, B-Cell0low100
Leukemia, Lymphocytic, L30low90
Leukemia, Lymphocytic, T Cell0low100
Leukemia, Lymphocytic, T-Cell0low100
Leukemia, Lymphoid0low10
Leukemia, Lymphoid, Acute0low70
Leukemia, Mast-Cell0low20
Leukemia, Megakaryoblastic, Acute0low70
Leukemia, Megakaryocytic0low70
Leukemia, Megakaryocytic, Acute0low70
Leukemia, Monoblastic, Acute0low10
Leukemia, Monocytic, Acute0low10
Leukemia, Monocytic, Chronic0low250
Leukemia, Myeloblastic, Acute0medium221
Leukemia, Myelocytic0low250
Leukemia, Myelocytic, Acute0medium221
Leukemia, Myelocytic, Chronic0low420
Leukemia, Myelogenous0low250
Leukemia, Myelogenous, Acute0medium221
Leukemia, Myelogenous, Chronic0low420
Leukemia, Myelogenous, Chronic Phase0low10
Leukemia, Myelogenous, Chronic-Phase0low10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive0low420
Leukemia, Myelogenous, Ph1 Positive0low420
Leukemia, Myelogenous, Ph1-Positive0low420
Leukemia, Myeloid0low250
Leukemia, Myeloid, Acute0medium221
Leukemia, Myeloid, Acute, M10medium221
Leukemia, Myeloid, Acute, M20medium221
Leukemia, Myeloid, Acute, M30low80
Leukemia, Myeloid, Acute, M40low10
Leukemia, Myeloid, Acute, M50low10
Leukemia, Myeloid, Acute, M60low240
Leukemia, Myeloid, Acute, M70low70
Leukemia, Myeloid, Chronic0low420
Leukemia, Myeloid, Chronic Phase0low10
Leukemia, Myeloid, Chronic-Phase0low10
Leukemia, Myeloid, Naegeli-Type0low10
Leukemia, Myeloid, Ph1 Positive0low420
Leukemia, Myeloid, Ph1-Positive0low420
Leukemia, Myeloid, Philadelphia Positive0low420
Leukemia, Myeloid, Philadelphia-Positive0low420
Leukemia, Myeloid, Schilling Type0low10
Leukemia, Myeloid, Schilling-Type0low10
Leukemia, Myeloid, Stable Phase0low10
Leukemia, Myeloid, Stable-Phase0low10
Leukemia, Myelomonocytic, Acute0low10
Leukemia, Myelomonocytic, Chronic0low10
Leukemia, Nonlymphoblastic, Acute0medium221
Leukemia, Nonlymphocytic, Acute0medium221
Leukemia, Pre-B-Cell0low30
Leukemia, Progranulocytic0low80
Leukemia, Prolymphocytic0low10
Leukemia, Promyelocytic, Acute0low80
Leukemia, T-Cell0low100
Leukemias, Experimental0low70
Leukocytosis0low10
Leukodystrophy with Rosenthal Fibers0low10
Lewy Body Parkinson Disease0low10
Lewy Body Parkinson's Disease0low10
Leydig Cell Tumor0low10
Libman-Sacks Disease0low110
Listeria Infections0low10
Listeriosis0low10
Liver Cancer0low350
Liver Cancer, Adult0low300
Liver Cell Carcinoma0low300
Liver Cell Carcinoma, Adult0low300
Liver Cirrhosis0low20
Liver Diseases0low20
Liver Dysfunction0low20
Liver Fibrosis0low20
Liver Injury, Drug-Induced0low10
Liver Injury, Drug-Induced, Acute0low10
Liver Neoplasms0low350
Liver Neoplasms, Experimental0low330
Lou Gehrig Disease0low10
Lou Gehrig's Disease0low10
Lou-Gehrigs Disease0low10
Louis-Bar Syndrome0low10
Low Blood Pressure0low10
Low Sperm Count0low10
Lung Adenocarcinoma0low10
Lung Cancer0low420
Lung Diseases0low20
Lung Injury, Acute0low20
Lung Neoplasms0low420
Lupus Erythematosus Disseminatus0low110
Lupus Erythematosus, Systemic0low110
Lupus Glomerulonephritis0low10
Lupus Nephritis0low10
Lymph Node Metastasis0low40
Lymphatic Metastasis0low40
Lymphatic Sarcoma0low20
Lymphoblastic Leukemia0low70
Lymphoblastic Leukemia, Acute0low70
Lymphoblastic Leukemia, Acute, Adult0low70
Lymphoblastic Leukemia, Acute, Childhood0low70
Lymphoblastic Leukemia, Acute, L10low70
Lymphoblastic Leukemia, Acute, L20low70
Lymphoblastic Leukemia, Chronic0low100
Lymphoblastic Lymphoma0low70
Lymphocyte Depletion Hodgkin's Lymphoma0low10
Lymphocyte-Rich Classical Hodgkin's Lymphoma0low10
Lymphocytic Leukemia0low10
Lymphocytic Leukemia, Acute0low70
Lymphocytic Leukemia, B-Cell0low40
Lymphocytic Leukemia, Chronic0low100
Lymphocytic Leukemia, Chronic, B Cell0low100
Lymphocytic Leukemia, Chronic, B-Cell0low100
Lymphocytic Leukemia, L10low70
Lymphocytic Leukemia, L20low70
Lymphocytic Leukemia, L30low90
Lymphocytic Leukemia, T-Cell0low100
Lymphocytic Lymphoma0low100
Lymphocytic Lymphoma, Diffuse, Poorly Differentiated0low20
Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated0low20
Lymphocytic Lymphoma, Diffuse, Well Differentiated0low100
Lymphocytic Lymphoma, Diffuse, Well-Differentiated0low100
Lymphocytic Lymphoma, Well Differentiated0low100
Lymphocytic Lymphoma, Well-Differentiated0low100
Lymphogranuloma, Malignant0low10
Lymphoid Leukemia0low10
Lymphoma0low90
Lymphoma L51780low10
Lymphoma, Atypical Diffuse Small Lymphoid0low20
Lymphoma, B-Cell0low140
Lymphoma, Burkitt0low90
Lymphoma, Centrocytic Small-Cell0low20
Lymphoma, Diffuse0low20
Lymphoma, Diffuse Large-Cell0low50
Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, High-Grade0low20
Lymphoma, Histiocytic0low50
Lymphoma, Histiocytic, Diffuse0low50
Lymphoma, Intermediate-Grade0low20
Lymphoma, Large B-Cell, Diffuse0low50
Lymphoma, Large Cell, Diffuse0low50
Lymphoma, Large Lymphoid, Diffuse0low50
Lymphoma, Large-Cell, Anaplastic0low10
Lymphoma, Large-Cell, Diffuse0low50
Lymphoma, Large-Cell, Ki-10low10
Lymphoma, Low-Grade0low20
Lymphoma, Lymphoblastic0low70
Lymphoma, Lymphocytic0low100
Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated0low20
Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated0low20
Lymphoma, Lymphocytic, Diffuse, Well Differentiated0low100
Lymphoma, Lymphocytic, Diffuse, Well-Differentiated0low100
Lymphoma, Lymphocytic, Intermediate0low20
Lymphoma, Lymphocytic, Well Differentiated0low100
Lymphoma, Lymphocytic, Well-Differentiated0low100
Lymphoma, Lymphoplasmacytoid, CLL0low100
Lymphoma, Malignant0low90
Lymphoma, Mantle-Cell0low20
Lymphoma, Mixed0low20
Lymphoma, Mixed Cell, Diffuse0low20
Lymphoma, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, Mixed Small and Large Cell, Diffuse0low20
Lymphoma, Mixed-Cell0low20
Lymphoma, Mixed-Cell, Diffuse0low20
Lymphoma, Non-Hodgkin0low20
Lymphoma, Non-Hodgkin, Familial0low20
Lymphoma, Non-Hodgkin's0low20
Lymphoma, Non-Hodgkins0low20
Lymphoma, Nonhodgkin's0low20
Lymphoma, Nonhodgkins0low20
Lymphoma, Pleomorphic0low20
Lymphoma, Small and Large Cleaved-Cell, Diffuse0low20
Lymphoma, Small Cleaved Cell, Diffuse0low20
Lymphoma, Small Cleaved-Cell, Diffuse0low20
Lymphoma, Small Lymphocytic0low100
Lymphoma, Small Lymphocytic, Plasmacytoid0low100
Lymphoma, Small Non-Cleaved-Cell0low20
Lymphoma, Small Noncleaved-Cell0low20
Lymphoma, Small-Cell0low100
Lymphoma, Small-Cell, Centrocytic0low20
Lymphoma, T Cell, Cutaneous0low10
Lymphoma, T-Cell0low90
Lymphoma, T-Cell, Cutaneous0low10
Lymphoma, Undifferentiated0low20
Lymphoma, Undifferentiated, Diffuse0low20
Lymphomatoid Papulosis0low10
Lymphoplasmacytoid Lymphoma, CLL0low100
Lymphoproliferative Disease, X-Linked0low40
Lymphoproliferative Disorders0low40
Lymphoproliferative Syndrome, X-Linked, 10low40
Lymphosarcoma0low20
M3 ANLL0low80
Macular Holes0low10
MAIDS0low10
Major Depressive Disorder0low10
Malaria0low10
Malaria, Falciparum0low10
Malignancies, Hematologic0low10
Malignancy0low580
Malignancy, Hematologic0low10
Malignant Cerebellar Neoplasms0low10
Malignant Epithelial Neoplasms0low240
Malignant Glioma0low220
Malignant Melanoma0low220
Malignant Meningeal Neoplasms0low10
Malignant Meningioma0low20
Malignant Neoplasm of Breast0medium1261
Malignant Neoplasms0low580
Malignant Neoplasms, Brain0low140
Malignant Primary Brain Neoplasms0low140
Malignant Primary Brain Tumors0low140
Malignant Tumor of Breast0medium1261
Malignant Tumor of Urinary Bladder0medium41
Mammary Cancer0medium1261
Mammary Carcinoma, Animal0low50
Mammary Carcinoma, Human0medium1261
Mammary Ductal Carcinoma0low50
Mammary Neoplasm, Human0medium1261
Mammary Neoplasms0low50
Mammary Neoplasms, Animal0low50
Mammary Neoplasms, Experimental0low110
Mammary Neoplasms, Human0medium1261
Mantle-Cell Lymphoma0low20
Mantle-Zone Lymphoma0low20
Mar (X) Syndrome0low10
Marginal Ulcer0low10
Marker X Syndrome0low10
Marsh Fever0low10
Martin-Bell Syndrome0low10
Mast Cell Activation Disease0low10
Mast Cell Activation Syndrome0low10
Mast Cell Activation Syndromes0low10
Mast Cell Disease0low10
Mast-Cell Disease0low10
Mast-Cell Leukemia0low20
Mast-Cell Sarcoma0low60
Mastocytoma, Malignant0low60
Mastocytosis0low10
Maturity-Onset Diabetes0low230
Maturity-Onset Diabetes Mellitus0low230
MCA Infarct0low10
MCA Infarction0low10
MEA 2a0low40
MEA 2b0low10
MEA II0low40
MEA IIa0low40
MEA IIb0low10
Mediastinal Cancer0low10
Mediastinal Neoplasms0low10
Mediastinum Cancer0low10
Mediastinum Neoplasms0low10
Mediterranean Anemia0low20
Medulloblastoma0low10
Medulloblastoma, Adult0low10
Medulloblastoma, Childhood0low10
Medulloblastoma, Desmoplastic0low10
Medullomyoblastoma0low10
Megacolon, Aganglionic0low10
Megacolon, Congenital0low10
Megakaryoblastic Leukemia, Acute0low70
Megakaryocytic Leukemia0low70
Megakaryocytic Leukemia, Acute0low70
Melancholia, Involutional0low10
Melanocytic Medulloblastoma0low10
Melanocytic Vestibular Schwannoma0low10
Melanodermic Leukodystrophy0low10
Melanoma0low220
Melanoma, B160low100
Melanoma, Cloudman S910low100
Melanoma, Experimental0low100
Melanoma, Harding-Passey0low100
Melanomas, Experimental0low100
Memory Deficits0low20
Memory Disorder, Semantic0low20
Memory Disorder, Spatial0low20
Memory Disorders0low20
Memory Disorders, Age-Related0low20
Memory Loss0low20
MEN 20low40
MEN 2a0low40
MEN 2b0low10
MEN 30low10
MEN II0low40
MEN IIa0low40
MEN IIb0low10
MEN III0low10
MEN-2A Syndrome0low40
MEN2a0low40
MEN2b0low10
Meningeal Cancer0low10
Meningeal Neoplasms0low10
Meningeal Neoplasms, Benign0low10
Meningeal Neoplasms, Intracranial0low10
Meningeal Neoplasms, Malignant0low10
Meningeal Tumors0low10
Meningioma0low20
Meningiomas, Multiple0low20
Meningiomatosis0low20
Meningotheliomatous Meningioma0low20
Mental Retardation, X-Linked, Associated With Fragile Site Fraxe0low10
Mental Retardation, X-Linked, Associated With Marxq280low10
Menzel Type OPCA0low10
Mesothelioma0low10
Metabolic Acidosis0low10
Metaplasia0low10
Metastase0medium341
Metastases, Neoplasm0medium341
Metastasis0medium341
Metastasis, Neoplasm0medium341
Microcystic Meningioma0low20
Microcytemia, beta Type0low20
Middle Cerebral Artery Circulation Infarction0low10
Middle Cerebral Artery Embolic Infarction0low10
Middle Cerebral Artery Embolus0low10
Middle Cerebral Artery Infarction0low10
Middle Cerebral Artery Occlusion0low10
Middle Cerebral Artery Stroke0low10
Middle Cerebral Artery Syndrome0low10
Middle Cerebral Artery Thrombosis0low10
Middle Cerebral Artery Thrombotic Infarction0low10
Mixed Cellularity Hodgkin's Lymphoma0low10
Mixed Glioma0low220
Mixed Salivary Gland Tumor0low10
Mixed Small and Large Cell Lymphoma, Diffuse0low20
Mixed-Cell Lymphoma0low20
Mixed-Cell Lymphoma, Diffuse0low20
MODY0low230
Molluscum Fibrosum0low10
Mongolism0low30
Monoblastic Leukemia, Acute0low10
Monocytic Leukemia, Acute0low10
Monocytic Leukemia, Chronic0low250
Monosomy, Partial0low50
Morgagni Hernia0low20
Morgagni Hernias0low20
Morgagni's Hernia0low20
Morgagni's Hernias0low20
Morphine Abuse0low10
Morphine Addiction0low10
Morphine Dependence0low10
Motor Neuron Disease, Amyotrophic Lateral Sclerosis0low10
Mouth Cancer0low20
Mouth Neoplasms0low20
Mucosal Neuroma Syndrome0low10
Multiple Abnormalities0low10
Multiple Endocrine Neoplasia Type 20low40
Multiple Endocrine Neoplasia Type 2a0low40
Multiple Endocrine Neoplasia Type 2b0low10
Multiple Endocrine Neoplasia, Type 2b0low10
Multiple Endocrine Neoplasia, Type IIa0low40
Multiple Endocrine Neoplasia, Type IIb0low10
Multiple Endocrine Neoplasms Type 2a0low40
Multiple Endocrine Neoplasms Type 2b0low10
Multiple Idiopathic Pigmented Hemangiosarcoma0low40
Multiple Myeloma0low120
Multiple Neurofibromas0low10
Murine Acquired Immune Deficiency Syndrome0low10
Murine Acquired Immuno-Deficiency Syndrome0low10
Murine Acquired Immunodeficiency Syndrome0low10
Murine AIDS0low10
Muscle Contraction0low140
Muscle Disorders0low10
Muscle Relaxation0low30
Muscular Diseases0low10
Muscular Dystrophies0low10
Muscular Dystrophy0low10
Myasthenia Gravis, Congenital0low10
Myasthenic Syndrome, Congenital, Slow-Channel0low10
Myasthenic Syndromes, Congenital0low10
Myasthenic Syndromes, Congenital, Slow Channel0low10
Mycobacterium tuberculosis Infection0low20
Myeloblastic Leukemia, Acute0medium221
Myelocytic Leukemia0low250
Myelocytic Leukemia, Acute0medium221
Myelocytic Leukemia, Chronic0low420
Myelogenous Leukemia0low250
Myelogenous Leukemia, Acute0medium221
Myelogenous Leukemia, Chronic0low420
Myelogenous Leukemia, Chronic, Chronic Phase0low10
Myelogenous Leukemia, Chronic, Chronic-Phase0low10
Myelogenous Leukemia, Ph1-Positive0low420
Myeloid Leukemia0low250
Myeloid Leukemia, Acute0medium221
Myeloid Leukemia, Acute, M10medium221
Myeloid Leukemia, Acute, M20medium221
Myeloid Leukemia, Acute, M30low80
Myeloid Leukemia, Acute, M40low10
Myeloid Leukemia, Acute, M50low10
Myeloid Leukemia, Acute, M60low240
Myeloid Leukemia, Acute, M70low70
Myeloid Leukemia, Chronic0low420
Myeloid Leukemia, Chronic, Chronic Phase0low10
Myeloid Leukemia, Chronic, Chronic-Phase0low10
Myeloid Leukemia, Chronic, Stable-Phase0low10
Myeloid Leukemia, Naegeli-Type0low10
Myeloid Leukemia, Ph1-Positive0low420
Myeloid Leukemia, Philadelphia-Positive0low420
Myeloid Leukemia, Schilling-Type0low10
Myeloma-Multiple0low120
Myeloma, Multiple0low120
Myeloma, Plasma-Cell0low120
Myelomatosis0low120
Myelomonocytic Leukemia, Acute0low10
Myelomonocytic Leukemia, Chronic0low10
Myeloproliferative Disorders0low40
Myh-Associated Polyposis0low20
Myoblastoma, Granular Cell0low10
Myocardial Ischemia0low10
Myoclonic Seizure0low40
Myoclonic Seizures0low40
Myodystrophica0low10
Myodystrophy0low10
Myopathic Conditions0low10
Myopathies0low10
Myotonia Atrophica0low20
Myotonia Dystrophica0low20
Myotonic Dystrophy0low20
Myotonic Dystrophy 10low20
Myotonic Dystrophy 20low20
Myotonic Dystrophy, Congenital0low20
Myotonic Myopathy, Proximal0low20
Myxofibroma0low20
NAFLD0low10
Nasal Catarrh0low10
Nasal Polyps0low10
Nasopharyngeal Cancer0low20
Nasopharyngeal Neoplasms0low20
Nasopharynx Cancer0low20
Nasopharynx Neoplasms0low20
Neck Cancer0low70
Neck Neoplasm0low70
Neck Neoplasms0low70
Necrosis0low40
Neonatal Adrenoleukodystrophy0low10
Neoplasia0low580
Neoplasia, Multiple Endocrine Type 2a0low40
Neoplasia, Multiple Endocrine Type 2b0low10
Neoplasia, Prostatic Intraepithelial0low10
Neoplasm0low580
Neoplasm Invasion0low500
Neoplasm Invasiveness0low500
Neoplasm Metastases0medium341
Neoplasm Metastasis0medium341
Neoplasms0low580
Neoplasms, Adrenal Gland0low170
Neoplasms, Benign0low580
Neoplasms, Bile Duct0low10
Neoplasms, Bladder0medium41
Neoplasms, Bone0low40
Neoplasms, Brain0low140
Neoplasms, Brain, Benign0low140
Neoplasms, Brain, Malignant0low140
Neoplasms, Brain, Primary0low140
Neoplasms, Breast0medium1261
Neoplasms, Central Nervous System0low10
Neoplasms, Cerebellar0low10
Neoplasms, Cerebellar, Benign0low10
Neoplasms, Cerebellar, Malignant0low10
Neoplasms, Cerebellar, Primary0low10
Neoplasms, Cervical0low30
Neoplasms, Cervix0low30
Neoplasms, Colonic0low220
Neoplasms, Colorectal0low190
Neoplasms, Endometrial0low20
Neoplasms, Esophageal0low50
Neoplasms, Experimental0low170
Neoplasms, Experimental Liver0low330
Neoplasms, Experimental Mammary0low110
Neoplasms, Eye0low10
Neoplasms, Gallbladder0low10
Neoplasms, Gastric0low190
Neoplasms, Gastrointestinal0low30
Neoplasms, Head0low70
Neoplasms, Head and Neck0low70
Neoplasms, Hematologic0low10
Neoplasms, Hematopoietic0low10
Neoplasms, Hepatic0low350
Neoplasms, Intestinal0low10
Neoplasms, Intracranial0low140
Neoplasms, Intraepithelial0low10
Neoplasms, Kidney0low50
Neoplasms, Laryngeal0low10
Neoplasms, Leptomeningeal0low10
Neoplasms, Liver0low350
Neoplasms, Lung0low420
Neoplasms, Malignant Epithelial0low240
Neoplasms, Mammary0low50
Neoplasms, Mediastinal0low10
Neoplasms, Meningeal0low10
Neoplasms, Mouth0low20
Neoplasms, Multiple Endocrine Type 2a0low40
Neoplasms, Multiple Endocrine Type 2b0low10
Neoplasms, Nasopharyngeal0low20
Neoplasms, Neck0low70
Neoplasms, Nerve Sheath0low10
Neoplasms, Oral0low20
Neoplasms, Ovarian0low160
Neoplasms, Pancreatic0low150
Neoplasms, Parotid0low20
Neoplasms, Prostate0low300
Neoplasms, Prostatic0low300
Neoplasms, Pulmonary0low420
Neoplasms, Retinal0low10
Neoplasms, Skin0low110
Neoplasms, Splenic0low10
Neoplasms, Squamous Cell0low10
Neoplasms, Stomach0low190
Neoplasms, Testicular0low10
Neoplasms, Testis0low10
Neoplasms, Thymic0low50
Neoplasms, Thymus0low50
Neoplasms, Thyroid0low40
Neoplasms, Tongue0low10
Neoplasms, Upper Aerodigestive Tract0low70
Neoplasms, Uterine0low10
Neoplasms, Uterus0low10
Neoplasms, Vascular Tissue0low10
Neoplasms, Vulvar0low10
Neoplastic Cell Transformation0low1650
Neoplastic Transformation, Cell0low1650
Neovascularization, Pathologic0low130
Neovascularization, Pathological0low130
Nephritis, Lupus0low10
Nephroblastoma0low10
Nephroid Carcinoma0low40
Nephrotic Syndrome0low10
Nerve Degeneration0low50
Nerve Sheath Neoplasm0low10
Nerve Sheath Neoplasms0low10
Nerve Sheath Tumor0low10
Nerve Sheath Tumors0low10
Nerve Sheath Tumors, Peripheral0low10
Nervous System Degenerative Diseases0low10
Nervous System Diseases0low10
Nervous System Disorders0low10
Nervous System Injuries0low10
Neuralgia-Neuritis, Sciatic Nerve0low10
Neuralgia, Postherpetic0low10
Neurilemmoma0low20
Neurilemmoma, Acoustic0low10
Neurilemoma0low20
Neurilemoma, Acoustic0low10
Neurinoma0low20
Neurinoma of the Acoustic Nerve0low10
Neurinoma, Acoustic0low10
Neuritic Plaques0low10
Neuroblastoma0low340
Neuroblastoma, Retinal0low30
Neurodegenerative Diseases0low10
Neurodegenerative Disorders0low10
Neuroectodermal Neoplasm, Peripheral Primitive0low10
Neuroectodermal Tumor, Peripheral0low10
Neuroectodermal Tumor, Peripheral Primitive0low10
Neuroectodermal Tumors, Primitive, Peripheral0low10
Neuroepithelioma, Peripheral0low10
Neurofibroma0low10
Neurofibromatoses0low10
Neurofibromatosis0low10
Neurofibromatosis 10low10
Neurofibromatosis 20low10
Neurofibromatosis 30low10
Neurofibromatosis I0low10
Neurofibromatosis II0low10
Neurofibromatosis Syndrome0low10
Neurofibromatosis Type 10low10
Neurofibromatosis Type 20low10
Neurofibromatosis Type 30low10
Neurofibromatosis Type I0low10
Neurofibromatosis Type II0low10
Neurofibromatosis, Acoustic, Bilateral0low10
Neurofibromatosis, Central NF20low10
Neurofibromatosis, central type0low10
Neurofibromatosis, Central, NF 20low10
Neurofibromatosis, Central, NF20low10
Neurofibromatosis, Peripheral Type0low10
Neurofibromatosis, Peripheral, NF 10low10
Neurofibromatosis, Peripheral, NF10low10
Neurofibromatosis, Type 10low10
Neurofibromatosis, Type 20low10
Neurofibromatosis, Type I0low10
Neurofibromatosis, Type II0low10
Neurologic Degenerative Conditions0low10
Neurologic Degenerative Diseases0low10
Neurologic Diseases, Degenerative0low10
Neurologic Disorders0low10
Neurological Disorders0low10
Neuroma0low10
Neuroma, Acoustic0low10
Neuroma, Acoustic, Bilateral0low10
Neuroma, Acoustic, Unilateral0low10
Neuromata, Mucosal, With Endocrine Tumors0low10
Neuron Degeneration0low50
Neurotmesis0low10
Neutropenia0low20
NF1 (Neurofibromatosis 1)0low10
NF2 (Neurofibromatosis 2)0low10
NIDDM0low230
Noack Syndrome0low10
Nodular Glomerulosclerosis0low10
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma0low10
Nodular Sclerosing Hodgkin's Lymphoma0low10
Non-alcoholic Fatty Liver Disease0low10
Non-Epileptic Seizure0low40
Non-Epileptic Seizures0low40
Non-Hodgkin Lymphoma0low20
Non-Hodgkin's Lymphoma0low20
Non-Small Cell Lung Cancer0low80
Non-Small Cell Lung Carcinoma0low80
Non-Small-Cell Lung Carcinoma0low80
Nonalcoholic Fatty Liver Disease0low10
Nonalcoholic Steatohepatitis0low10
Nonepileptic Seizure0low40
Nonepileptic Seizures0low40
Noninsulin-Dependent Diabetes Mellitus0low230
Nonlymphoblastic Leukemia, Acute0medium221
Nonlymphocytic Leukemia, Acute0medium221
Nonsmall Cell Lung Cancer0low80
Oat Cell Carcinoma0low70
Obesity0low220
Occlusion, Middle Cerebral Artery0low10
Ocular Herpes Simplex0low10
Oesophageal Squamous Cell Carcinoma0low10
Olfactory Groove Meningioma0low20
Oligoasthenoteratozoospermia0low10
Oligoastrocytoma, Mixed0low70
Oligospermia0low10
Oligozoospermia0low10
Olivopontocerebellar Atrophy 20low10
Olivopontocerebellar Atrophy I0low10
Olivopontocerebellar Atrophy II0low10
Olivopontocerebellar Atrophy III0low10
Olivopontocerebellar Atrophy IV0low10
Olivopontocerebellar Atrophy, Holguin Type0low10
Omenn Syndrome0low40
Omenn's Syndrome0low40
Oncogenesis0low80
OPCA with Macular Degeneration and External Ophthalmoplegia0low10
OPCA with Retinal Degeneration0low10
Opiate Abuse0low10
Opiate Addiction0low10
Opiate Dependence0low10
Opioid Abuse0low10
Opioid Addiction0low10
Opioid Dependence0low10
Opioid Misuse0low10
Opioid Use Disorder0low10
Opioid-Related Disorders0low10
Oral Cancer0low20
Oral Cavity Squamous Cell Carcinoma0low10
Oral Neoplasms0low20
Oral Squamous Cell Carcinoma0low10
Oral Squamous Cell Carcinomas0low10
Oral Tongue Squamous Cell Carcinoma0low10
Oropharyngeal Squamous Cell Carcinoma0low10
Oroya Fever0low10
Osler-Vaquez Disease0low40
Osteoclastic Bone Loss0low90
Osteogenic Sarcoma0low110
Osteosarcoma0low110
Osteosarcoma Tumor0low110
Ovarian Cancer0low160
Ovarian Neoplasms0low160
Ovary Cancer0low160
Ovary Neoplasms0low160
Overinclusion0low20
Ovine Pulmonary Adenomatosis0low10
Ovine Pulmonary Carcinoma0low10
Oxygen Deficiency0low50
P388D(1) Leukemia0low10
Palmoplantaris Pustulosis0low30
Paludism0low10
Pancreas Cancer0low150
Pancreas Neoplasms0low150
Pancreatic Cancer0low150
Pancreatic Duct Cell Carcinoma0low30
Pancreatic Ductal Carcinoma0low30
Pancreatic Neoplasms0low150
Pancreatic Parenchyma with Edema0low10
Pancreatic Parenchymal Edema0low10
Pancreatitis0low10
Pancreatitis, Acute0low10
Pancreatitis, Acute Edematous0low10
Papillary Meningioma0low20
Papillary Renal Cell Carcinoma0low40
Papilloma0low10
Papilloma, Shope0low10
Papilloma, Squamous Cell0low10
Papillomatosis0low10
Paralysis Agitans0low10
Paraphrenia, Involutional0low10
Parasagittal Meningioma0low20
Parasitemia0low10
Parkinson Disease0low10
Parkinson Disease, Idiopathic0low10
Parkinson's Disease0low10
Parkinson's Disease, Idiopathic0low10
Parkinson's Disease, Lewy Body0low10
Parotid Cancer0low20
Parotid Neoplasms0low20
Partial Fetal Alcohol Syndrome0low10
Partial Monosomy0low50
Partial Seizure0low40
Partial Seizures0low40
Partial Trisomy0low10
Partial Trisomy 21 Down Syndrome0low30
Pathologic Angiogenesis0low130
Pathologic Neovascularization0low130
PBD, ZSS0low10
Peptic Ulcer0low10
Perinatal Subarachnoid Hemorrhage0low20
Perineurioma0low10
Peripancreatic Fat Necrosis0low10
Peripheral Nerve Injuries0low10
Peripheral Nerve Injury0low10
Peripheral Nerve Neoplasms0low10
Peripheral Nerve Neoplasms, Benign0low10
Peripheral Nerve Neoplasms, Malignant0low10
Peripheral Nerve Neoplastic Infiltration0low10
Peripheral Nerve Sheath Tumor0low10
Peripheral Nerve Sheath Tumors0low10
Peripheral Nerve Tumors0low10
Peripheral Nervous System Benign Neoplasms0low10
Peripheral Nervous System Malignant Neoplasms0low10
Peripheral Nervous System Neoplasms0low10
Peripheral Neurofibromatosis0low10
Peripheral Primitive Neuroectodermal Neoplasm0low10
Peripheral Primitive Neuroectodermal Tumor0low10
Peripheral Primitive Neuroectodermal Tumors0low10
Peritoneal Carcinomatosis0low20
Peritoneal Neoplasms0low20
Peritoneal Surface Malignancy0low20
Peroxisomal Disorders0low10
Peroxisomal Dysfunction, General0low10
Peroxisomal Dysfunction, Multiple0low10
Peroxisomal Dysfunction, Single0low10
Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum0low10
Petit Mal Convulsion0low40
Pfeiffer Syndrome0low10
Ph 1 Chromosome0low30
Ph1 Chromosome0low30
Pheochromocytoma0low160
Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma0low40
Pheochromocytoma, Extra-Adrenal0low160
Philadelphia Chromosome0low30
Pilocytic Astrocytoma0low70
Pituitary Adenoma0low40
Pituitary Cancer0low40
Pituitary Carcinoma0low40
Pituitary Neoplasms0low40
Pituitary Tumors0low40
Placenta Accreta0low10
Placenta Increta0low10
Placenta Percreta0low10
Placenta Praevia0low10
Placenta Previa0low10
Plaque, Amyloid0low10
Plaques, Amyloid0low10
Plasma Cell Myeloma0low120
Plasma Cell Tumor0low20
Plasmacytoma0low20
Plasmocytoma0low20
Plasmodium falciparum Malaria0low10
Plasmodium Infections0low10
Platelet Fibrinogen Receptor, Deficiency of0low50
Platelet Glycoprotein 2b-3a Deficiency0low50
Platelet Glycoprotein IIb-IIIa Deficiency0low50
Pleocytosis0low10
Pleural Effusion0low10
Poisoning, Blood0low30
Polycystic Kidney Disease 20low10
Polycystic Kidney Disease, Adult0low10
Polycystic Kidney Disease, Adult Type 20low10
Polycystic Kidney Disease, Adult, Type II0low10
Polycystic Kidney Disease, Autosomal Dominant0low10
Polycystic Kidney Disease, Type 20low10
Polycystic Kidney, Autosomal Dominant0low10
Polycystic Kidney, Type 1 Autosomal Dominant Disease0low10
Polycystic Kidney, Type 2 Autosomal Dominant Disease0low10
Polycystic Ovarian Syndrome0low10
Polycystic Ovary Syndrome0low10
Polycystic Ovary Syndrome 10low10
Polycythemia Ruba Vera0low40
Polycythemia Rubra Vera0low40
Polycythemia Vera0low40
Polyploid0low10
Polyploid Cell0low10
Polyploidy0low10
Polyposis Coli0low20
Polyposis Coli, Familial0low20
Polyposis Syndrome, Familial0low20
Polyposis, Adenomatous Intestinal0low20
Pontiac Fever0low10
Postabsorptive Hypoglycemia0low20
Posterior Circulation Transient Ischemic Attack0low140
Posterior Fossa Meningioma0low20
Postherpetic Neuralgia0low10
Postoperative Complications0low10
Postprandial Hyperglycemia0low30
Postprandial Hypoglycemia0low20
Postsynaptic Congenital Myasthenic Syndrome0low10
Postsynaptic Congenital Myasthenic Syndromes0low10
Pre B-ALL0low30
Pre-B ALL0low30
Pre-B-Cell Leukemia0low30
Pre-Eclampsia0low20
Precancerous Conditions0low30
Precursor B-Cell Lymphoblastic Leukemia0low30
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma0low30
Precursor B-Cell Lymphoblastic Lymphoma0low30
Precursor Cell Lymphoblastic Leukemia-Lymphoma0low70
Prediabetes0low10
Prediabetic State0low10
Predisposition, Genetic0low30
Preeclampsia0low20
Preeclampsia Eclampsia 10low20
Pregnancy0low390
Pregnancy Complications0low10
Pregnancy in Diabetes0low10
Pregnancy in Diabetics0low10
Pregnancy Toxemias0low20
Prenatal Exposure Delayed Effects0low10
Preneoplastic Condition0low30
Preneoplastic Conditions0low30
Prescription Opioid Abuse0low10
Prescription Opioid Misuse0low10
Presenile Alzheimer Dementia0low270
Presynaptic Congenital Myasthenic Syndrome0low10
Presynaptic Congenital Myasthenic Syndromes0low10
Primary Brain Neoplasms0low140
Primary Central Nervous System Neoplasm0low10
Primary Central Nervous System Neoplasms0low10
Primary Malignant Brain Neoplasms0low140
Primary Malignant Brain Tumors0low140
Primary Neoplasms, Cerebellum0low10
Primary Parkinsonism0low10
Primary Polycythemia0low40
Primary Senile Degenerative Dementia0low270
Primitive Neuroectodermal Tumor, Extracranial0low10
Prion Disease0low10
Prion Diseases0low10
Prion Protein Diseases0low10
Prion-Associated Disorders0low10
Prion-Induced Disorder0low10
Prion-Induced Disorders0low10
Progeria, Adult0low10
Progranulocytic Leukemia0low80
Progressive Chorea, Chronic Hereditary (Huntington)0low30
Progressive Chorea, Hereditary, Chronic (Huntington)0low30
Proliferative Vitreoretinopathy0low10
Prolymphocytic Leukemia0low10
PROMM (Proximal Myotonic Myopathy)0low20
Promyelocytic Leukemia, Acute0low80
Prostate Cancer0low300
Prostate Neoplasms0low300
Prostatic Adenoma0low20
Prostatic Cancer0low300
Prostatic Cancer, Androgen-Independent0low10
Prostatic Cancer, Androgen-Insensitive0low10
Prostatic Cancer, Androgen-Resistant0low10
Prostatic Cancer, Castration-Resistant0low10
Prostatic Cancer, Hormone Refractory0low10
Prostatic Hyperplasia0low20
Prostatic Hyperplasia, Benign0low20
Prostatic Hypertrophy0low20
Prostatic Hypertrophy, Benign0low20
Prostatic Intraepithelial Neoplasia0low10
Prostatic Intraepithelial Neoplasms0low10
Prostatic Neoplasms0low300
Prostatic Neoplasms, Androgen-Independent0low10
Prostatic Neoplasms, Androgen-Insensitive0low10
Prostatic Neoplasms, Androgen-Resistant0low10
Prostatic Neoplasms, Castration-Resistant0low10
Prostatic Neoplasms, Hormone Refractory0low10
Protein Deficiency0low10
Proteinuria-Edema-Hypertension Gestosis0low20
Proximal Myotonic Myopathy0low20
Psammomatous Meningioma0low20
Pseudotuberculosis, Pasteurella0low10
Psoriasis0low30
Psychosis, Involutional0low10
Puberty, Delayed0low10
Pulmonary Adenomatosis, Ovine0low10
Pulmonary Arterial Remodeling0low10
Pulmonary Cancer0low420
Pulmonary Disease0low20
Pulmonary Diseases0low20
Pulmonary Edema0low10
Pulmonary Edemas0low10
Pulmonary Fibrosis, Idiopathic0low10
Pulmonary Hypertension0low20
Pulmonary Neoplasms0low420
Pulmonary Ovine Adenomatosis0low10
Pulmonic Stenosis with Cafe-au-Lait Spots0low10
Purpura, Thrombocytopenic, Autoimmune0low10
Purpura, Thrombocytopenic, Idiopathic0low10
Purtilo Syndrome0low40
Pustular Psoriasis of Palms and Soles0low30
Pustulosis of Palms and Soles0low30
Pustulosis Palmaris et Plantaris0low30
Pyaemia0low30
Pyemia0low30
Pyohemia0low30
Reaction, Acute-Phase0low20
Reactive Hypoglycemia0low20
Recklinghausen Disease of Nerve0low10
Recklinghausen Disease, Nerve0low10
Recklinghausen's Disease of Nerve0low10
Recklinghausens Disease of Nerve0low10
Recrudescence0low10
Rectosigmoid Aganglionosis0low10
Recurrence0low10
Relapse0low10
REM Sleep Deprivation0low10
Remittent Fever0low10
Renal Cancer0low50
Renal Carcinoma0low40
Renal Cell Cancer0low40
Renal Cell Carcinoma0low40
Renal Cell Carcinoma, Papillary0low40
Renal Collecting Duct Carcinoma0low40
Renal Disease, End-Stage0low10
Renal Failure, Acute0low10
Renal Failure, Chronic0low10
Renal Failure, End-Stage0low10
Renal Insufficiency, Acute0low10
Renal Neoplasms0low50
Reoviridae Infections0low10
Reovirus Infections0low10
Reperfusion Damage0low60
Reperfusion Injury0low60
Reproductive Sterility0low20
Research-Related Injuries0low20
Resistance, Disease0low10
Respiratory Syncytial Virus Infection0low10
Respiratory Syncytial Virus Infections0low10
Response, Acute-Phase0low20
Retention Disorders, Cognitive0low20
Reticuloendotheliosis, Familial0low40
Reticulolymphosarcoma0low90
Reticulosarcoma0low20
Reticulum Cell Sarcoma0low20
Reticulum-Cell Sarcoma0low20
Retinal Branch Vein Occlusion0low10
Retinal Breaks0low10
Retinal Cancer0low10
Retinal Degeneration0low20
Retinal Detachment0low10
Retinal Dialyses0low10
Retinal Diseases0low10
Retinal Holes0low10
Retinal Neoplasms0low10
Retinal Perforations0low10
Retinal Pigment Epithelial Detachment0low10
Retinal Tears0low10
Retinal Tumors0low10
Retinal Vein Occlusion0low10
Retinal Vein Thrombosis0low10
Retinoblastoma0low30
Rheumatoid Arthritis0low50
Rhinitis0low10
Ricker Syndrome0low20
Rida0low20
Right Middle Cerebral Artery Infarction0low10
Rochalimaea Infections0low10
Rous Sarcoma0low20
SADDAN0low10
SADDAN Dysplasia0low10
Saethre-Chotzen Syndrome0low10
SAH (Subarachnoid Hemorrhage)0low20
Salivary Gland Tumor, Mixed0low10
Salivary Gland Virus Disease0low10
Salmonella Infections0low10
Salmonellosis0low10
Sarcoma0low30
Sarcoma, Avian0low20
Sarcoma, Cerebellar, Circumscribed Arachnoidal0low10
Sarcoma, Engelbreth-Holm-Swarm0low20
Sarcoma, Epithelioid0low30
Sarcoma, Ewing0low20
Sarcoma, Ewing's0low20
Sarcoma, Experimental0low20
Sarcoma, Germinoblastic0low90
Sarcoma, Jensen0low20
Sarcoma, Kaposi0low40
Sarcoma, Lymphatic0low20
Sarcoma, Mast-Cell0low60
Sarcoma, Osteogenic0low110
Sarcoma, Reticulum-Cell0low20
Sarcoma, Rous0low20
Sarcoma, Soft Tissue0low30
Sarcoma, Spindle Cell0low30
Sarcomas, Experimental0low20
Sarcomatoid Renal Cell Carcinoma0low40
SC Disease0low10
SCA10low10
Scars, Hypertrophic0low10
Schilder-Addison Complex0low10
Schut-Haymaker Type OPCA0low10
Schwannoma0low20
Schwannoma, Acoustic0low10
Schwannoma, Acoustic, Bilateral0low10
Schwannoma, Vestibular0low10
Schwannomatosis, Plexiform0low20
Sciatic Nerve Diseases0low10
Sciatic Nerve Palsy0low10
Sciatic Neuritis0low10
Sciatic Neuropathy0low10
Sclerocystic Ovarian Degeneration0low10
Sclerocystic Ovaries0low10
Sclerocystic Ovary Syndrome0low10
Sclerosis, Hereditary Spinal0low10
Scrapie0low20
Secretory Meningioma0low20
Seizure0low40
Seizures0low40
Seizures, Auditory0low40
Seizures, Clonic0low40
Seizures, Convulsive0low40
Seizures, Epileptic0low40
Seizures, Focal0low40
Seizures, Generalized0low40
Seizures, Gustatory0low40
Seizures, Motor0low40
Seizures, Olfactory0low40
Seizures, Sensory0low40
Seizures, Somatosensory0low40
Seizures, Tonic0low40
Seizures, Tonic-Clonic0low40
Seizures, Vertiginous0low40
Seizures, Vestibular0low40
Seizures, Visual0low40
Semantic Memory Disorder0low20
Senile Dementia, Acute Confusional0low270
Senile Dementia, Alzheimer Type0low270
Senile Plaques0low10
Sensitivity and Specificity0low340
Sensitivity, Contact0low30
Sepsis0low30
Septic Shock0low10
Septicemia0low30
Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans0low10
Severe Combined Immune Deficiency0low40
Severe Combined Immunodeficiency0low40
Severe Combined Immunodeficiency Syndrome0low40
Severe Combined Immunologic Deficiency0low40
Severe Sepsis0low30
Shock0low10
Shock, Endotoxic0low10
Shock, Septic0low10
Shock, Toxic0low10
Sickle Cell Anemia0low40
Sickle Cell Disease0low40
Sickle Cell Disorders0low40
Sickle Cell Hemoglobin C Disease0low10
Sickle Cell Trait0low10
Sickling Disorder Due to Hemoglobin S0low40
Siemerling-Creutzfeldt Disease0low10
Single Seizure0low40
Sipple Syndrome0low40
Skeleton-Skin-Brain Syndrome0low10
Skin Cancer0low110
Skin Neoplasms0low110
Sleep Debt0low10
Sleep Deprivation0low10
Sleep Fragmentation0low10
Sleep Insufficiency0low10
Slow-Channel Congenital Myasthenic Syndrome0low10
Slow-Channel Congenital Myasthenic Syndromes0low10
Small Cell Carcinoma0low70
Small Cleaved-Cell Lymphoma, Diffuse0low20
Small Non-Cleaved-Cell Lymphoma0low20
Small Noncleaved-Cell Lymphoma0low20
Small-Cell Lymphoma0low100
Soft Tissue Neoplasms0low10
Spasmophilia0low10
Spatial Memory Disorder0low20
Sphenoid Wing Meningioma0low20
Spinal Meningeal Neoplasms0low10
Spinal Meningioma0low20
Spinocerebellar Ataxia 10low10
Spinocerebellar Ataxia 20low10
Spinocerebellar Ataxia 40low10
Spinocerebellar Ataxia 50low10
Spinocerebellar Ataxia 60low10
Spinocerebellar Ataxia 70low10
Spinocerebellar Ataxia Type 10low10
Spinocerebellar Ataxia Type 20low10
Spinocerebellar Ataxia Type 40low10
Spinocerebellar Ataxia Type 50low10
Spinocerebellar Ataxia Type 60low10
Spinocerebellar Ataxia Type 70low10
Spinocerebellar Ataxia with Slow Eye Movements0low10
Spinocerebellar Ataxia-10low10
Spinocerebellar Ataxia-20low10
Spinocerebellar Ataxia-40low10
Spinocerebellar Ataxia-50low10
Spinocerebellar Ataxia-60low10
Spinocerebellar Ataxia-70low10
Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy0low10
Spinocerebellar Ataxia, Cuban Type0low10
Spinocerebellar Ataxias0low10
Spinocerebellar Ataxias, Dominantly-Inherited0low10
Spinocerebellar Atrophies0low10
Spinocerebellar Atrophy 20low10
Spinocerebellar Atrophy I0low10
Spinocerebellar Atrophy II0low10
Spinocerebellar Degeneration with Slow Eye Movements0low10
Spleen Cancer0low10
Spleen Neoplasms0low10
Splenic Cancer0low10
Splenic Neoplasms0low10
Spongiform Encephalopathies, Transmissible0low10
Sporadic Retinoblastoma0low30
Sprue0low30
Sprue, Celiac0low30
Sprue, Nontropical0low30
Squamous Cell Cancer0low10
Squamous Cell Carcinoma0low460
Squamous Cell Carcinoma of Head and Neck0low10
Squamous Cell Carcinoma of Larynx0low10
Squamous Cell Carcinoma of the Head and Neck0low10
Squamous Cell Carcinoma of the Larynx0low10
Squamous Cell Carcinoma of the Mouth0low10
Squamous Cell Carcinoma of the Nasal Cavity0low10
Squamous Cell Carcinoma, Head And Neck0low10
Squamous Cell Neoplasms0low10
Staphylococcal Infections0low10
Staphylococcus aureus Infection0low10
Starvation0low20
Stein-Leventhal Syndrome0low10
Steinert Disease0low20
Steinert Myotonic Dystrophy0low20
Steinert's Disease0low20
Sterility0low20
Sterility, Male0low20
Sterility, Reproductive0low20
Stomach Cancer0low190
Stomach Neoplasms0low190
Stomach Ulcer0low10
Streptozocin Diabetes0low130
Streptozotocin Diabetes0low130
Stress Disorders, Heat0low10
Stroke0low20
Stroke, Acute0low20
Stroke, Middle Cerebral Artery0low10
Stunted Growth0low10
Stunting0low10
Sub-Fertility0low20
Sub-Fertility, Male0low20
Subarachnoid Hemorrhage0low20
Subarachnoid Hemorrhage, Aneurysmal0low20
Subarachnoid Hemorrhage, Intracranial0low20
Subarachnoid Hemorrhage, Spontaneous0low20
Subependymal Giant Cell Astrocytoma0low70
Subfertility0low20
Subfertility, Male0low20
Suffocation0low10
Suppurative Arthritis0low10
Susceptibility, Genetic0low30
Symptom Cluster0low20
Syndactylic Oxycephaly0low10
Syndrome0low20
Syringoma, Chondroid0low10
Systemic Anaplastic Large-Cell Lymphoma0low10
Systemic Lupus Erythematosus0low110
T Cell Leukemia Lymphoma, HTLV I Associated0low70
T Cell Leukemia, Adult0low70
T Lymphocytic Leukemia0low100
T-Cell Leukemia0low100
T-Cell Leukemia-Lymphoma, Adult0low70
T-Cell Leukemia-Lymphoma, HTLV-I-Associated0low70
T-Cell Leukemia, Adult0low70
T-Cell Lymphoma0low90
T-Cell Lymphoma, Cutaneous0low10
T-Lymphocytic Leukemia0low100
T-Lymphocytopenia, Idiopathic CD4-Positive0low10
T-Lymphocytopenia, Idiopathic CD4+0low10
T-Lymphotropic Virus Type III Infections, Human0low50
Taenia brauni Infection0low10
Taenia glomeratus Infection0low10
Taenia Infections0low10
Taenia multiceps Infection0low10
Taenia serialis Infection0low10
Taenia solium Infection0low10
Taeniasis0low10
Telangiectasia, Cerebello-Oculocutaneous0low10
Testicular Cancer0low10
Testicular Neoplasm0low10
Testicular Neoplasms0low10
Testicular Tumor0low10
Testicular Tumors0low10
Testis Cancer0low10
Testis Neoplasms0low10
Tetanilla0low10
Tetany0low10
Tetany, Neonatal0low10
Thalassemia Intermedia0low20
Thalassemia Major0low20
Thalassemia Major (beta-Thalassemia Major)0low20
Thalassemia Minor0low20
Thalassemia Minor (beta-Thalassemia Minor)0low20
Thalassemia, beta Type0low20
Thanatophoric Dwarfism0low10
Thanatophoric Dysplasia0low10
Thanatophoric Short Stature0low10
Thrombasthenia0low50
Thrombasthenia of Glanzmann and Naegeli0low50
Thrombocythemia0low20
Thrombocytopenic Purpura, Autoimmune0low10
Thrombocytosis0low20
Thrombosis0low30
Thrombosis, Middle Cerebral Artery0low10
Thrombosis, Retinal Vein0low10
Thrombotic Infarction, Middle Cerebral Artery0low10
Thrombus0low30
Thymic Cancer0low50
Thymic Neoplasms0low50
Thymic Tumors0low50
Thymoma0low50
Thymus Cancer0low50
Thymus Neoplasms0low50
Thymus Tumors0low50
Thyroid Adenoma0low40
Thyroid Cancer0low40
Thyroid Carcinoma0low40
Thyroid Neoplasms0low40
Thyroiditis, Autoimmune0low10
Thyroiditis, Lymphocytic0low10
Thyroiditis, Lymphomatous0low10
TIA (Transient Ischemic Attack)0low140
Tongue Cancer0low10
Tongue Neoplasms0low10
Tonic Clonic Seizure0low40
Tonic Seizure0low40
Tonic Seizures0low40
Tonic-Clonic Seizure0low40
Tonic-Clonic Seizures0low40
Total Colonic Aganglionosis0low10
Toxemia Of Pregnancy0low20
Toxemias, Pregnancy0low20
Toxic Hepatitis0low10
Toxic Shock0low10
Toxic Shock Syndrome0low10
Transformation, Neoplastic Cell0low1650
Transformation, Viral Cell0low1110
Transient Ischemic Attack0low140
Transient Ischemic Attack, Anterior Circulation0low140
Transient Ischemic Attack, Brain Stem0low140
Transient Ischemic Attack, Brainstem0low140
Transient Ischemic Attack, Carotid Circulation0low140
Transient Ischemic Attack, Posterior Circulation0low140
Transient Ischemic Attack, Vertebrobasilar Circulation0low140
Transient Ischemic Attacks, Crescendo0low140
Transitional Meningioma0low20
Translocation, Chromosomal0low60
Translocation, Genetic0low60
Transmissible Dementias0low10
Transmissible Spongiform Encephalopathies0low10
Trauma0low20
Trauma, Nervous System0low10
Triple Negative Breast Cancer0low10
Triple Negative Breast Neoplasms0low10
Triple-Negative Breast Cancer0low10
Triple-Negative Breast Neoplasm0low10
Trisomy0low10
Trisomy 210low30
Trisomy 21, Meiotic Nondisjunction0low30
Trisomy 21, Mitotic Nondisjunction0low30
Trisomy G0low30
Tropical Eosinophilia0low10
Tuberculin-Type Hypersensitivity0low20
Tuberculosis0low20
Tumor of Rete Testis0low10
Tumor Virus Infections0low10
Tumorigenesis0low80
Tumorigenic Transformation0low1650
Tumors0low580
Tumors of the Nerve Sheath0low10
Tumors, Breast0medium1261
Tumors, Central Nervous System0low10
Tumors, Retinal0low10
Type 1 Diabetes0low90
Type 1 Diabetes Mellitus0low90
Type 1 Spinocerebellar Ataxia0low10
Type 2 Diabetes0low230
Type 2 Diabetes Mellitus0low230
Type 2 Spinocerebellar Ataxia0low10
Type 4 Spinocerebellar Ataxia0low10
Type 5 Spinocerebellar Ataxia0low10
Type 6 Spinocerebellar Ataxia0low10
Type 7 Spinocerebellar Ataxia0low10
Type IV Hypersensitivity0low20
UADT Neoplasm0low70
UADT Neoplasms0low70
Ulcerative Colitis0low10
Undifferentiated Lymphoma0low20
Unilateral Agenesis of Diaphragm0low20
Upper Aerodigestive Tract Neoplasm0low70
Upper Aerodigestive Tract Neoplasms0low70
Urinary Bladder Cancer0medium41
Urinary Bladder Neoplasms0medium41
Usual Interstitial Pneumonia0low10
Uterine Cancer0low10
Uterine Cervical Cancer0low30
Uterine Cervical Neoplasms0low30
Uterine Diseases0low10
Uterine Neoplasms0low10
Uterus Cancer0low10
Uterus Neoplasms0low10
Vascular Accident, Brain0low20
Vascular Diseases0low10
Vascular Hypotension0low10
Vascular Malformations0low10
Vascular Remodeling0low10
Vascular Tissue Neoplasms0low10
Verruga Peruana0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low140
Vestibular Schwannoma0low10
Viral Cell Transformation0low1110
Viral Encephalitis, Japanese B0low10
Viral Hepatitis, Animal0low10
Vitreoretinopathy Neovascular Inflammatory0low10
Vitreoretinopathy, Proliferative0low10
von Recklinghausen Disease0low10
von Recklinghausen's Disease0low10
Vulva Cancer0low10
Vulva Neoplasms0low10
Vulvar Cancer0low10
Vulvar Neoplasms0low10
Wadia Swami Syndrome0low10
Wadia-Swami Syndrome0low10
Wagenmann-Froboese Syndrome0low10
Wallerian Degeneration0low20
Watson Syndrome0low10
Weight Gain0low20
Werlhof Disease0low10
Werlhof's Disease0low10
Werner Syndrome0low10
Werner's Syndrome0low10
Werners Syndrome0low10
Wet Lung0low10
Wilms Tumor0low10
Wilms Tumor 10low10
Wilms' Tumor0low10
Wiskott Syndrome0low30
Wiskott-Aldrich Syndrome0low30
Wounds0low20
Wounds and Injuries0low20
Wounds and Injury0low20
Wounds, Injury0low20
X-ALD0low10
X-ALD (X-Linked Adrenoleukodystrophy)0low10
X-Linked Adrenoleukodystrophy0low10
X-Linked Lymphoproliferative Disease0low40
X-Linked Lymphoproliferative Disorder0low40
X-Linked Lymphoproliferative Syndrome0low40
X-Linked Mental Retardation and Macroorchidism0low10
Xanthomatous Meningioma0low20
Yersinia enterocolitica Infection0low10
Yersinia Infection0low10
Yersinia Infections0low10
Yersinia pseudotuberculosis Infections0low10
Yersiniosis0low10
Zellweger Disease0low10
Zellweger Spectrum0low10
Zellweger Syndrome0low10
Zellweger Syndrome Spectrum0low10
Zellweger-Like Syndrome0low10
Zellweger's Syndrome0low10

Research Highlights

Safety/Toxicity (12)

ArticleYear
The radioprotector ortho-phospho-L-tyrosine (pTyr) attenuates the side effects of fractionated irradiation in retinoblastoma mouse models but also decreases the local tumour control.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Volume: 124, Issue: 3		2017
Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells.
Nanomedicine (London, England), Volume: 5, Issue: 8		2010
The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
Molecular immunology, Volume: 45, Issue: 12		2008
L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: Involvement of src family kinases.
Journal of neuroscience research, Volume: 85, Issue: 12		2007
Binding of sialyl Lewis X antigen to lectin-like receptors on NK cells induces cytotoxicity and tyrosine phosphorylation of a 17-kDa protein.
Biochimica et biophysica acta, Volume: 1760, Issue: 9		2006
Tyrosine kinase inhibitors attenuate Japanese encephalitis virus-induced neurotoxicity.
Biochemical and biophysical research communications, Feb-11, Volume: 327, Issue: 2		2005
The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity.
European journal of immunology, Volume: 31, Issue: 7		2001
Active-oxygen involvement in canine NK-mediated cytotoxicity.
The Journal of veterinary medical science, Volume: 62, Issue: 4		2000
Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.
Journal of neuro-oncology, Volume: 41, Issue: 3		1999
Transforming growth factor-beta 1 induction of novel extracellular matrix proteins that trigger resistance to tumor necrosis factor cytotoxicity in murine L929 fibroblasts.
The Journal of biological chemistry, Mar-31, Volume: 270, Issue: 13		1995
HER4 expression correlates with cytotoxicity directed by a heregulin-toxin fusion protein.
The Journal of biological chemistry, Mar-31, Volume: 270, Issue: 13		1995
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing.
Journal of immunology (Baltimore, Md. : 1950), Jan-01, Volume: 146, Issue: 1		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (3)

ArticleYear
Proteomic analysis of phosphotyrosyl proteins in the rat brain: effect of butorphanol dependence.
Journal of neuroscience research, Sep-15, Volume: 77, Issue: 6		2004
Insulin-mediated cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes.
Endocrinology, Volume: 141, Issue: 12		2000
Alterations in the subcellular distribution of p21ras-GTPase activating protein in proliferating rat acinar cells.
Biochemical and biophysical research communications, Sep-16, Volume: 187, Issue: 2		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (5)

ArticleYear
Myosin light chain kinase and Src control membrane dynamics in volume recovery from cell swelling.
Molecular biology of the cell, Mar-01, Volume: 22, Issue: 5		2011
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.
Molecular cancer therapeutics, Volume: 6, Issue: 8		2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
Molecular cancer therapeutics, Volume: 6, Issue: 7		2007
High tidal volume mechanical ventilation with hyperoxia alters alveolar type II cell adhesion.
American journal of physiology. Lung cellular and molecular physiology, Volume: 293, Issue: 3		2007
Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase.
The Journal of biological chemistry, Jul-30, Volume: 274, Issue: 31		1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (9)

ArticleYear
Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis.
PloS one, Volume: 7, Issue: 8		2012
Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia.
Journal of cellular physiology, Volume: 215, Issue: 1		2008
Sodium orthovanadate induced tyrosine phosphorylation of platelet nitric oxide synthase negatively regulates enzyme activity.
Biochimica et biophysica acta, Volume: 1760, Issue: 9		2006
Phosphate isosteres in medicinal chemistry.
Current medicinal chemistry, Volume: 12, Issue: 26		2005
Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
Accounts of chemical research, Volume: 36, Issue: 6		2003
Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Biopolymers, Volume: 60, Issue: 1		2001
NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain.
Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue: 16		1999
The cellular intake kinetics and acute biological effects of various oxovanadium species: a comparative study.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, Volume: 30, Issue: 1		1998
L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Journal of medicinal chemistry, Oct-13, Volume: 38, Issue: 21		1995
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (35)

ArticleYear
Effects of nitrogen-doped multi-walled carbon nanotubes compared to pristine multi-walled carbon nanotubes on human small airway epithelial cells.
Toxicology, Jul-03, Volume: 333		2015
Jiaotai Pill enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats.
Chinese journal of integrative medicine, Volume: 19, Issue: 9		2013
Steel factor enhances supraoptimal antigen-induced IL-6 production from mast cells via activation of protein kinase C-beta.
Journal of immunology (Baltimore, Md. : 1950), Jun-15, Volume: 182, Issue: 12		2009
The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Volume: 84, Issue: 3		2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
Molecular cancer therapeutics, Volume: 6, Issue: 7		2007
A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
Experimental hematology, Volume: 34, Issue: 1		2006
Effect of in vivo administered hexachlorobenzene on epidermal growth factor receptor levels, protein tyrosine kinase activity, and phosphotyrosine content in rat liver.
Biochemical pharmacology, May-01, Volume: 65, Issue: 9		2003
Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model.
Oncogene, Apr-03, Volume: 22, Issue: 13		2003
Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini.
The Journal of biological chemistry, May-23, Volume: 278, Issue: 21		2003
Normalization of retinal vascular permeability in experimental diabetes with genistein.
Investigative ophthalmology & visual science, Volume: 42, Issue: 9		2001
Gene dosage-dependent functions for phosphotyrosine-Grb2 signaling during mammalian tissue morphogenesis.
Current biology : CB, May-01, Volume: 11, Issue: 9		2001
Tyrosine phosphorylation of the kappa -opioid receptor regulates agonist efficacy.
The Journal of biological chemistry, Dec-08, Volume: 275, Issue: 49		2000
Characterization of the IGF axis in a rat liver-derived epithelial cell line.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, Volume: 9, Issue: 6		1999
Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia.
The Journal of clinical endocrinology and metabolism, Volume: 84, Issue: 11		1999
Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase.
Blood, Apr-15, Volume: 93, Issue: 8		1999
In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America, Mar-02, Volume: 96, Issue: 5		1999
The beta c component of the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin 3 (IL-3)/IL-5 receptor interacts with a hybrid GM-CSF/erythropoietin receptor to influence proliferation and beta-globin mRNA expression.
Molecular medicine (Cambridge, Mass.), Volume: 2, Issue: 6		1996
Cdc28 tyrosine phosphorylation and the morphogenesis checkpoint in budding yeast.
Molecular biology of the cell, Volume: 7, Issue: 11		1996
The Drosophila Numb protein inhibits signaling of the Notch receptor during cell-cell interaction in sensory organ lineage.
Proceedings of the National Academy of Sciences of the United States of America, Oct-15, Volume: 93, Issue: 21		1996
Direct stimulation by tyrosine phosphorylation of microtubule-associated protein (MAP) kinase activity by granulocyte-macrophage colony-stimulating factor in human neutrophils.
The Biochemical journal, Apr-01, Volume: 291 ( Pt 1)		1993
Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate.
Genes & development, Volume: 7, Issue: 3		1993
A role of tyrosine phosphorylation in the formation of acetylcholine receptor clusters induced by electric fields in cultured Xenopus muscle cells.
The Journal of cell biology, Volume: 120, Issue: 1		1993
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
Journal of medicinal chemistry, Sep-15, Volume: 38, Issue: 19		1995
Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase.
The Biochemical journal, Jun-01, Volume: 308 ( Pt 2)		1995
enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties.
Genes & development, Mar-01, Volume: 9, Issue: 5		1995
Down-regulation of bradykinin receptors and bradykinin-induced Ca2+ mobilization, tyrosine phosphorylation, and DNA synthesis by autocrine factors, tumor necrosis factor alpha, and interferon beta in Swiss 3T3 cells.
Journal of cellular physiology, Volume: 162, Issue: 3		1995
Insulin stimulates the tyrosine phosphorylation of a Mr = 160,000 glycoprotein in rat adipocyte plasma membranes.
The Journal of biological chemistry, Jun-05, Volume: 262, Issue: 16		1987
The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.
Proceedings of the National Academy of Sciences of the United States of America, Volume: 82, Issue: 23		1985
Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons.
Endocrinology, Volume: 129, Issue: 1		1991
Insulin receptor is phosphorylated in response to treatment of HepG2 cells with insulin-like growth factor I.
The Biochemical journal, Aug-15, Volume: 270, Issue: 1		1990
An altered IGF-I receptor is present in human leukemic cells.
The Journal of biological chemistry, Jun-05, Volume: 265, Issue: 16		1990
Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase.
The Journal of biological chemistry, Jan-05, Volume: 265, Issue: 1		1990
Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking.
Journal of immunology (Baltimore, Md. : 1950), Jun-01, Volume: 148, Issue: 11		1992
Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-gamma 1.
The Journal of biological chemistry, Jan-25, Volume: 267, Issue: 3		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (1)

ArticleYear
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research, Oct-15, Volume: 9, Issue: 13		2003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
Lessons from nature: On the molecular recognition elements of the phosphoprotein binding-domains.
Biotechnology and bioengineering, Sep-05, Volume: 91, Issue: 5		2005
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]